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 Sm proteins were discovered nearly 20 years ago as a group of small antigenic 
proteins (≈ 90-120 residues). Since then, an extensive amount of biochemical and genetic 
data have illuminated the crucial roles of these proteins in forming ribonucleoprotein 
(RNP) complexes that are used in RNA processing, e.g., spliceosomal removal of introns 
from pre-mRNAs. Spliceosomes are large macromolecular machines that are comparable 
to ribosomes in size and complexity, and are composed of uridine-rich small nuclear 
RNPs (U snRNPs). Various sets of seven different Sm proteins form the cores of most 
snRNPs. Despite their importance, very little is known about the atomic-resolution 
structure of snRNPs or their Sm cores. As a first step towards a high-resolution image of 
snRNPs and their hierarchic assembly, we have determined the crystal structures of 
archaeal homologs of Sm proteins, which we term Sm-like archaeal proteins (SmAPs).  
Beginning with a Pyrobaculum aerophilum (Pae) structural genomics pilot 
project, we determined the structure of Pae SmAP1. This structure provided the first 
 xvi
direct evidence for a toroid-shaped Sm homoheptamer at the snRNP core, and provided 
many insights and implications for SmAP evolution and RNA binding in Sm cores. Then, 
in order to extend these results, we solved the structure of Pae SmAP1 and a heptameric 
methanobacterial SmAP (Mth SmAP1) bound to uridine-5’-monophosphate (UMP); the 
uracil bases line the heptamer pore in the Mth ligand-bound structure, and suggest a more 
specific model for RNA binding than we were able to propose earlier.  
Further characterization of the oligomerization and ligand-binding properties of 
Mth and Pae SmAP1s has allowed us to conclude that: (i) SmAPs form several oligomers 
besides the archetypal heptamer, including 14-mers and fibrillar polymers; (ii) Mth 
SmAP1 and Archaeoglobus fulgidus (Afu) SmAP1 recognize uracil bases in a nearly 
identical manner, suggesting a conserved RNA-binding mode for SmAPs; and (iii) Pae 
and Mth SmAP1s gel-shift supercoiled DNA, perhaps by nonspecific binding to single-
stranded DNA. Our sequence analyses shed light on the evolution of Sm proteins: the 
SmAP module is a phylogenetically well-conserved domain that probably gave rise to 
modern (eukaryotic) Sm heteroheptamers via gene duplication and neutral drift. Crystal 
structure determinations for Pae SmAP2 and SmAP3 proteins are currently in progress, 
and will deepen our understanding of Sm protein function and evolution.  
 As part of the same Pae structural genomics project, we solved two structures that 
are unrelated to the SmAP work: an archaeal homolog of survival protein E (Pae SurEα) 
and a putative Pae Nudix protein. The final two chapters of this dissertation describe 
these structures and their significance. 
 xvii
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
A synopsis of the dissertation 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 1
The research reported in this dissertation is primarily concerned with Sm-like 
archaeal proteins (SmAP), which are archaeal homologs of eukaryotic Sm proteins. The 
Sm family is a broad, phylogenetically well-conserved set of proteins that function in 
several aspects of RNA processing, as described in an introductory chapter on the 
background and significance of Sm proteins in RNA metabolism (Chapter 1). Eukaryotic 
Sm and Sm-like (Lsm) proteins bind to small nuclear RNAs to form the core of several 
ribonucleoprotein (RNP) particles, most notably the uridine-rich small nuclear RNPs (U 
snRNP) that constitute the spliceosome (which in turn splices introns out of pre-mRNA). 
Since the biological function of Sm proteins has been most characterized in the context of 
U snRNPs and their role in spliceosome assembly and intron excision, the emphasis in 
Chapter 1 is on what is known about the canonical human and yeast Sm proteins and their 
involvement in intron splicing. However, the vast diversity of RNA metabolism – 
together with the central role of Sm proteins in forming the cores of U snRNPs – makes it 
likely that Sm, Lsm, and SmAP proteins are involved in a wide range of RNP complexes 
in addition to U snRNPs, and may justify the generalization of our SmAP results to 
include non-splicing functions (e.g., Sm-like proteins as RNA chaperones). 
Over a decade of biochemical and genetic data suggests that a heteroheptamer of 
Sm proteins is the biologically relevant species at the core of eukaryotic snRNPs. In order 
to obtain a high-resolution image of the structure and function of Sm proteins, we 
determined the crystal structure of SmAP1 from Pyrobaculum aerophilum (Pae) at a 
resolution of 1.75 Å (Chapter 2 is a reprint of the article which describes this structure). 
Pae SmAP1 was found to form a homoheptameric ring perforated by a cationic pore, thus 
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providing the first direct evidence for such an assembly in eukaryotic snRNPs. 
Additionally, the structure: (i) showed that Pae SmAP homodimers are structurally 
similar to two human Sm heterodimers; (ii) supported a gene duplication model of Sm 
protein evolution; and (iii) suggested features that may be important in RNA binding 
(such as the cationic pore). In order to extend or generalize these results, we then studied 
another archaeal Sm protein – Methanobacterium thermautotrophicum (Mth) SmAP1. 
Chapter 3 describes the oligomerization and ligand-binding properties of Mth and 
Pae SmAP1s (in preparation for publication). The Mth SmAP1 structure was determined 
in three crystal forms, each with different heptamer packings. In one of the forms an Mth 
SmAP1 14-mer co-crystallized with uridine-5’-monophosphate (UMP), and showed that 
our earlier, speculative model for RNA binding is probably incorrect (intercalation of 
uracil bases between conserved pore side chains suggests that RNA may wrap around the 
pore, not thread through it). The five Pae and Mth crystal structures contain various small 
molecules bound in what appear to be conserved ligand-binding sites. We fortuitously 
discovered that Pae and Mth SmAP1 gel-shift negatively supercoiled DNA. In addition to 
presenting these ligand binding properties, Chapter 3 describes the following features of 
the oligomerization of SmAPs: (i) Pae SmAP1 forms disulfide-bonded 14-mers, whereas 
Mth SmAP1 is almost exclusively heptameric in vitro; (ii) Pae SmAP1 forms sub-
heptameric states when its inter-subunit disulfide bonds are reduced; (iii) both Pae and 
Mth SmAP1 polymerize into polar fibers by the head-to-tail stacking of heptamers. Our 
crystal structures of Pae SmAP1 in two crystal forms and Mth SmAP1 in three crystal 
forms corroborate these novel oligomerization and polymerization properties of SmAPs.  
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The final two chapters describe two other crystal structures that we determined – 
an archaeal homolog of survival protein E (Pae SurEα, Chapter 4) and an archaeal 
homolog of Nudix proteins (Chapter 5). These proteins are unrelated to the SmAP work, 
and were solved in the course of a P. aerophilum structural genomics pilot project 
(although a recent report of the Sm-like properties of E. coli Hfq protein suggests a weak 
link between Sm proteins and SurE – see the introduction in Chapter 3). One of the 
interesting findings of this work was that crystalline Pae SurEα is an inhomogeneous 
mixture of domain swapped and non-domain swapped dimers. The account of the SurEα 
structure in Chapter 4 is an adaptation of a manuscript submitted for publication, and the 
description of the Pae Nudix structure in Chapter 5 is adapted from a published article 
(see chapter title pages for citations). The work reported in Chapter 5 was done in 
collaboration with Dr. Shuishu Wang of UCLA. After creating a Pae Nudix M16L point 
mutant by site-directed mutagenesis, I over-expressed, purified, and crystallized this 
protein in a P21 form (“Native-2” in Chapter 5). I then used the structure of Dr. Wang’s 
P212121 “Native-1” dimer as a molecular replacement search model for the Nudix 
tetramer found in the asymmetric unit of the P21 form.   
The Appendix provides some of the more useful scripts that were used in the 
research of this dissertation. All of these utilities were written in either the UNIX C shell 
or the Perl scripting language, and a brief description of each script is provided at the 
beginning of the Appendix. Two notes regarding these programs are: (i) the 
scripted_glrf.sh, alter.pl, and process_bigrun.pl trio uses a published program (GLRF) 
to calculate cross-rotation functions that are systematically varied over the integration 
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radius and resolution limits of diffraction data, and processes the output in a user-friendly 
format; and (ii) the rare codon calculator accepts query DNA sequences at the following 
URL: http://www.doe-mbi.ucla.edu/cgi/cam/racc.html. 
As a final note on the SmAP work, sequence analysis suggests that P. aerophilum 
has two other Sm-like proteins, Pae SmAP2 and SmAP3. We have cloned and purified 
these proteins, and their structure determinations are in progress for the following 
reasons: (i) SmAP2 and SmAP3 co-crystallized with UMP, so their likely RNA-binding 
sites may be revealed and compared to known uracil binding sites; (ii) due to its Loop-4 
insertion, the SmAP3 sequence more closely resembles certain eukaryotic Sm proteins 
than does any other SmAP; (iii) the SmAP2 and SmAP3 paralogs may provide insight 
into gene duplication as a mechanism for the evolution of eukaryotic Sm 
heteroheptamers; (iv) the collection of Pae SmAP1, SmAP2, and SmAP3 crystal 
structures will provide a high-resolution picture of the entire Sm protein complement of 
Pae, and serve as a starting point for further biochemical and biophysical experiments 
that will address the function of SmAPs in archaea (which presumably do not contain 
snRNPs). Progress towards the crystal structures of these two new SmAPs is not reported 
in this dissertation, although we are far along: diffraction data to 2.0 Å have been 
processed from native SmAP2 crystals, and phases have been calculated to 2.0 Å for 
derivatized SmAP3 crystals (see pg. 32). Preliminary results suggest that SmAP2 and 
SmAP3 are also heptamers, and these structures are anticipated within the next few 
months.   
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 6
Overview of RNA metabolism 
 RNA metabolism is an extremely complex and multifaceted realm of cellular life. 
It includes the synthesis, degradation, post-transcriptional modification, and utilization of 
a variety of RNA species for biochemical tasks that range from the very general (protein 
synthesis via “messenger RNAs”) to the highly specific (RNA interference via “small 
interfering RNAs”). The known classes of RNA species include the familiar messenger 
RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA) forms, as well as a 
multitude of novel, unconventional types of RNA that are only now being identified and 
characterized. The growing number of categories of RNA includes: (i) small nuclear 
RNAs (snRNAs) that are involved in pre-mRNA processing; (ii) small nucleolar RNAs 
(snoRNAs) that are involved in pre-rRNA processing; (iii) RNAs that are responsible for 
pre-tRNA 5’ end processing, such as RNase P RNA; and (iv) a recently discovered class 
of small (≈ 20-30-nucleotide), non-coding microRNAs (miRNA) that attenuate post-
transcriptional processing of mRNA via small interfering RNAs (siRNAs) or small 
temporal RNAs (stRNAs)1,2,3 (see review in ref. 4). Precise regulation of these RNA 
metabolic processes by other RNAs, proteins, or small molecule ligands is another 
characteristic feature of RNA metabolism.  
 In fact, the complexity and diversity of the reactions in which RNA engages has 
led to the “RNA World” hypothesis, in which RNA can act as substrate, product, catalyst 
(ribozyme), or structural cofactor (see ref. 5 for a treatise on the RNA world). The basic 
idea behind this view of the origin of life is that pre-biotic, self-replicating RNAs existed, 
and that some of these RNAs – because they could copy themselves imperfectly – formed 
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a platform for gradual evolution into the current RNA-DNA-protein world via early 
living systems based only on RNA and protein. Presumably, this intermediate 
RNA/protein-only world was the birthplace of many of the fundamental 
ribonucleoprotein (RNP) assemblies that are utilized in modern organisms (e.g., the 
ribosome). The existence of RNP complexes in archaea, eubacteria, and eukaryotes 
underscores their importance (and early appearance) in the evolution and biochemistry of 
each of these three kingdoms. 
 A modular approach to studying RNPs and their roles in RNA metabolism is shown 
in Fig. 1.1. Some of the known forms of RNA processing are given in the top level of this 
hierarchy: (i) rRNA processing by nucleolar snoRNPs (reviewed in ref. 6); (ii) RNase P-
based splicing and maturation of tRNA (reviewed in ref. 7); (iii) hairpin formation and 
processing of the 3’ end of histone mRNA by U7 snRNP (ref. 8 and references therein); 
(iv) mRNA decapping and decay;9 and (v) chromosome maintenance by the RNA 
component of telomerase.10 Each of these processes employs RNPs that contain Sm or 
Sm-like (Lsm) proteins. Indeed, a central theme of Fig. 1.1 – and the motivation behind 
this dissertation – is that many RNA processing events (on a cellular scale) can be traced 
back to the Sm proteins (on a molecular scale). The roles of Sm proteins in the 
spliceosomal removal of introns from precursor mRNAs have been investigated more 
than in any of the other types of RNA processing shown in Fig. 1.1. Therefore, the 
remainder of this chapter will focus on mRNA processing by the spliceosome – the large 
macromolecular machine that catalyzes intron excision. 
 8
Spliceosome-mediated excision of introns and mRNA processing 
 Maturation of primary pre-mRNA transcripts into a final form that is ready for 
protein translation is a multi-step process that involves 5’ cap methylation of the mRNA, 
3’ cleavage and polyadenylation, and intron excision. Introns are remarkably pervasive in 
eukaryotes; since being discovered in adenovirus by Sharp and coworkers over twenty 
years ago,11 these non-coding, intervening sequences have been found in all three major 
kingdoms (eukaryotes, eubacteria, and archaea) and in all three major types of RNA 
(mRNA, tRNA, and rRNA). Such vast variation in the phylogenetic distribution and 
genomic location of introns is matched by the variation in known mechanisms for intron 
processing. For example, bacterial rRNA and tRNA introns are self-splicing (groups I, II, 
see refs. 12, 13 and references therein), while eukaryotic rRNA is processed by the 
snoRNPs of the nucleolus.14 For pre-mRNA maturation, the last processing step (intron 
excision) occurs on the spliceosome. 
 The spliceosome is a large, transiently stable assembly of uridine-rich small 
nuclear RNPs (U snRNPs). Roughly the same size as the ribosome, this large RNP 
particle has a mass of ≈ 5 x 106 Da and sedimentation coefficient of 60S in one of its 
several catalytic states (Fig. 1.2).15 It ligates two exons with concomitant release of the 
intron as a lariat structure, and it achieves this by catalyzing two successive trans-
esterification reactions. These reactions occur on the pre-mRNA at the intron/exon 
junctions (i.e., the 5’ and 3’ splice sites (SS)) and at a strictly conserved branch-point 
adenosine within the intron (and just upstream of an optional polypyrimidine region). In 
the first step, a catalytically active form of the spliceosome results from the dissociation 
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of the U1 and U4 snRNPs; at this point, the spliceosome is composed of the U2, U5, and 
U6 snRNPs (the “A1” state in Fig. 1.2(a)). Bound by the A1 spliceosome, the 2’ 
hydroxyl group of the branch-point adenosine attacks the phosphate center at the 5’ SS 
and results in (or is driven by) formation of the “A2-2” state of the spliceosome. In the 
second step, the free 3’ hydroxyl group at the 5’ SS attacks the terminal phosphate of the 
3’ SS, resulting in ligation of the exons and release of the intron lariat. Completion of 
these steps with single nucleotide precision results in an mRNA with a correctly 
registered protein-encoding sequence.  
The accepted view of spliceosome assembly (Fig. 1.2(a)) stipulates that several of 
the steps outlined above involve large-scale conformational changes and remodeling of 
the spliceosome, and that the active sites that catalyze these reactions exist only 
transiently (i.e., they are not pre-formed as in most protein enzymes). However, new 
results from Abelson and colleagues refute this notion: their recent isolation of stable 
yeast “penta-snRNPs” (U1-U2-U4/U5•U6)16 devoid of pre-mRNA suggests that a pre-
formed spliceosome may exist irrespective of pre-mRNA binding. Indeed, several 
fundamental features of this catalytic process are unclear. One of the most intriguing 
questions is if the spliceosome is a ribozyme – i.e., do U2, U5, or U6 snRNA mediate 
catalysis, or is one of the >80 spliceosomal proteins catalytically active? Similarities 
between the pre-mRNA splicing reaction and the self-splicing group II introns, as well as 
the Mg2+-dependence of spliceosome activity, suggest that spliceosomal snRNA may be 
catalytic (reviewed in ref. 17). Other major questions are concerned with the spliceosome 
assembly pathway,18 the structural roles of its snRNP constituents,19 and regulation of the 
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splicing cycle by non-spliceosomal factors. Since there is no evidence of a direct catalytic 
role for the Sm proteins in splicing, next we will consider the structural roles of Sm 
proteins in assembling the U snRNPs that form the spliceosome.   
Archetypal RNPs of the spliceosome: The assembly and structure of U snRNPs 
As shown in the two middle layers of Fig. 1.1, there are several types of 
spliceosomes, and an even more bewildering array of snRNPs (reviewed in refs. 20, 21). 
For instance, there is a minor class of spliceosomes that process the less abundant U12-
type introns, and which are formed from U11, U12, U4atac, and U6atac snRNPs (instead 
of the corresponding U1, U2, U4, and U6 snRNPs of the major spliceosome).21 Since the 
major spliceosome is the most thoroughly studied, the five core spliceosomal snRNPs 
(U1, U2, and the U4/U5•U6 tri-snRNP) are the best understood. A growing body of data 
suggests that many – if not most – structural characteristics are conserved between the 
U2/U12, U4/U4atac, etc. pairs of homologous snRNPs (ref. 19 and references therein).   
U snRNP biogenesis in higher eukaryotes is illustrated in Fig. 1.3, which 
demonstrates the central role of Sm proteins in this pathway. Except for U6, all of the U 
snRNAs are transcribed by RNA polymerase II, modified with an N7-
monomethylguanosine (m7G) cap, and then exported from the nucleus as part of a multi-
protein export complex (U6 snRNA is transcribed by pol. III, acquires a 5’ γ-monomethyl 
cap, and assembles with Lsm proteins entirely within the nucleus). Binding of 
cytoplasmic Sm heteromers to the exported snRNA occurs next (Fig. 1.3), and may be 
modulated by recently discovered interactions between some Sm proteins and the 
survival of motor neurons (SMN) protein complex.22 A recent deluge of results has 
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shown the symmetric dimethylation of arginine residues in some of the RG dipeptide 
repeats of Sm23,24,25 and Lsm26 proteins by a putative “methylosome”,27 and such post-
translational methylation may be of great importance in targeting the Sm heteromers to 
the SMN complex. Formation of the U snRNP Sm core complex apparently triggers two 
more modifications to the snRNA (3’ trimming and cap hypermethylation to 2,2,7-
trimethyl-guanosine (m3G)) that cause the snRNP Sm core to bind to a complex of 
snurportin-1 and importin-β. Along with an uncharacterized Sm core nuclear localization 
signal (NLS) receptor, this large import complex transits to the nucleus. Once there, the 
import complex dissociates, final nucleotide modifications are made to the snRNA (such 
as pseudouridylation), and U snRNP-specific proteins bind to give a mature U snRNP.   
To simplify our understanding of this complicated biogenesis pathway, each U 
snRNP can be thought of as an RNA-protein complex composed of two parts: the 
respective U snRNAs (U1, U2, etc.), and several (up to dozens) proteins. Dissection of 
the snRNPs is illustrated in the two bottom layers of Fig. 1.1. The protein components 
fall into two classes: snRNP-specific proteins, e.g., U2A’ and U2B’’ proteins of the U2 
snRNP, and core proteins that are common to each snRNP (reviewed in ref. 28, 19). The 
snRNP-specific proteins most likely mediate highly specific RNA-RNA, protein-RNA, 
and protein-protein interactions, and function in ways that are unique to a given snRNP. 
Examples of such putative functions, chiefly inferred from sequence homology to known 
proteins, include putative DEAD- or DxxH-box RNA helicases, unwindases, GTPases, 
peptidyl cis/trans isomerases, and many RNA recognition motif (RRM)-containing 
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proteins. In contrast, the function(s) of the shared core snRNP proteins – the Sm or Lsm 
proteins – are presumably much less specific.  
The biological functions of Sm proteins: formation of U snRNP cores 
The primary structural or catalytic function of Sm proteins is still uncertain. Since 
being discovered as a group of eight small (≈ 90-110 amino acids) antigenic proteins in 
autoimmune diseases such as systemic lupus erythematosus,29,30 an extensive amount of 
biochemical and genetic data has shown that cytoplasmic Sm proteins assemble with 
snRNAs to form core snRNP complexes as described above and in Fig. 1.3. Sm proteins 
bind to short single-stranded regions of snRNA that are usually flanked by two stem-loop 
structures (Fig. 1.4). The consensus Sm binding site is the short uridine-rich sequence 
PuAU≈4-6GPu (Pu = purine), although this selectivity is not very stringent and there is 
redundancy in Sm•RNA binding.31 Sm binding is highly sensitive to modification of the 
flanking stem-loop structures and the snRNA Sm site, and even varies from one snRNA 
to another (Fig. 1.4).32 The Lsm complex binds at the single-stranded 3’ terminus of U6 
snRNA (Fig. 1.4(c)), thus illustrating the variation in local secondary structure for Sm 
and Lsm binding sites. Stepwise binding to snRNA occurs with the Sm D1•D2 and 
E•F•G heteromers associating concomitantly to yield a “subcore” snRNP complex.33 The 
final component to join the Sm complex (B/B’•D3) triggers the hypermethylation of the 
cap that, along with the Sm complex, forms a bipartite nuclear localization signal.  
In addition to these two poorly characterized methylation and localization 
functions, Sm proteins probably mediate critical RNA-RNA and RNA-protein 
interactions near the snRNP core. Recent work by Zhang et al. showed that the extended 
 13
and highly charged C-terminal tails of human Sm B, D1, and D3 are involved in 
sequence-independent binding to pre-mRNA substrate, and may stabilize U1 snRNP•pre-
mRNA interactions.34,35 An example of the possible role of Sm snRNP cores in recruiting 
other proteins to the assembling spliceosome is that the 70K protein of the U1 snRNP can 
be chemically cross-linked to the Sm B and D2 proteins.36 Lying at the core of snRNPs, 
Sm proteins undoubtedly engage in a vast network of protein-protein and protein-RNA 
interactions. Thorough reviews by Will and Lührmann37,19 have summarized what few 
interactions are known for Sm proteins, and suggest putative ones. 
Phylogenetic conservation of Sm proteins and their broader significance 
The Sm protein motif – traditionally described as Sm1 and Sm2 signature 
sequences joined by a variable linker – is strongly conserved in many species.38 
Stimulated by the current flood of genomic sequences, database searches show that Sm 
proteins are not exclusive to metazoans or other higher eukaryotes; indeed, several new 
Sm protein homologs have been found in eukaryotic species as divergent from humans as 
yeast39 and trypanosomes.40 Sm homologs also have been found in several archaeal 
species,41 suggesting an ancient lineage of Sm proteins. An exciting recent discovery is 
that the E. coli Hfq protein (a host factor required for bacteriophage replication) is an Sm-
like protein that preferentially binds to uridine-rich RNA42,43 (along these lines, the 
Herpesvirus saimiri virus produces RNA transcripts that recruit host Sm proteins44). 
Thus, the phylogenetic diversity of Sm proteins is broader than was initially thought, 
including eubacteria as well as eukaryotes and archaea. These new Sm proteins expand 
the realm of possible Sm protein functions beyond splicing alone.  
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Biochemical and structural studies imply an ancient origin for Sm and Lsm 
proteins. Several sets of Lsm proteins have been discovered and characterized in 
organisms already known to have Sm proteins.45 Electron microscopic and biochemical 
characterization of some of these proteins has verified their similarity to canonical Sm 
proteins,46,38 and this dissertation treats them as roughly equivalent. The deep 
evolutionary origin of Sm proteins is further substantiated by the similarity of all known 
crystal structures of Sm proteins and their homologs (see Chapters 2 and 3).  
What is known about RNA processing in the archaea? 
 Little is known about RNA processing in the archaea – particularly mRNA 
processing – mainly due to the lack of a convenient, genetically-manipulable model 
organism. However, many introns have been found in archaeal tRNA and rRNA genes 
(reviewed in ref. 47). Archaeal tRNA introns typically occur in the anticodon loop, while 
rRNA introns occur at diverse locations. Whereas bacterial introns are usually self-
splicing (e.g., group I introns), several forms of archaeal intron removal resemble their 
eukaryotic counterparts in terms of a protein requirement, e.g., endonuclease-mediated 
splicing of archaeal tRNA introns (reviewed in ref. 7) or rRNA processing.48 Recent 
discovery of archaeal homologs of U3 snoRNP proteins suggests that snoRNP-based 
rRNA processing may be another shared feature between archaea and eukaryotes.49 
Archaeal RNA processing other than intron removal is also beginning to be 
characterized, e.g., tRNA 5’- and 3’- end processing.50,51 Another RNA processing 
complex that may be conserved between archaea and eukaryotes is the exosome, a large 
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complex of RNA exonucleases, RNA-binding proteins, and RNA helicases that mediates 
the 3’→5’ degradation of many RNA species (including mRNA).52  
It is generally assumed that archaea do not have standard, spliceosomal U snRNP-
like particles, since archaeal mRNA processing is so poorly characterized and it is not 
known whether or not their pre-mRNAs contain introns. However, a recent report 
provides the first evidence for archaeal mRNA introns: the gene of an archaeal homolog 
of eukaryotic centromere-binding factor 5 (Cbf5p) was found to contain an intron that is 
spliced in vivo (as detected by reverse transcriptase-PCR).53 The intron/exon boundaries 
in this gene are predicted to adopt bulge-helix-bulge motifs, which are the motifs 
recognized by the splicing endonucleases involved in processing of archaeal pre-tRNAs 
and rRNAs. Although the regulation and diversity of RNA metabolism in archaea may 
not be as sophisticated as in eukaryotes, these examples illustrate the complexities of 
archaeal RNA processing. The central role of the highly conserved Sm proteins in 
eukaryotic mRNA processing suggests that archaeal RNA processing may utilize Sm-like 
archaeal proteins in similar RNP assemblies (snRNP-like or otherwise).  
Seeking an atomic-resolution understanding of snRNP cores and Sm proteins 
Until the crystal structure determinations of human Sm D1•D2 and D3•B 
heterodimers by Kambach et al. in 1999,54 there was no atomic-level information for the 
structure of the Sm core complex. Several lines of biochemical and genetic data provided 
indirect evidence that the Sm core is a hetero-oligomer of seven Sm proteins. 
Ultrastructural investigations of U snRNP core particles by electron microscopy 
suggested that the Sm55 and Lsm46 cores are composed of a “doughnut-shaped 
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heteromer” (Fig. 1.5(a)). The gradual realization that Sm and Lsm proteins are always 
found in groups of at least seven subtypes within the genome of a given organism lends 
credence to this structural model. The homoheptameric nature of an Sm-like protein from 
the archaeon Archaeoglobus fulgidus (Afu) was recently established by multivariate 
statistical analysis of electron micrographs (significantly, in biochemical assays this Afu 
Sm protein specifically bound oligo(U) RNAs).56  
The fold of each human Sm monomer consists of a strongly bent five-stranded 
antiparallel β-sheet capped by a short N-terminal α helix (Fig. 1.5(b)). The human Sm 
D1•D2 and B•D3 structures show that the four monomers have nearly identical 3D 
structures to within 1 Å root mean-squared deviation (rmsd) for Cα atoms. Moreover, the 
D1•D2 and B•D3 heterodimers are nearly identical. The structure of the Sm-Sm protein 
interface in both heterodimers is conserved, and is created by the hydrogen-bonded 
juxtaposition of one β strand from each monomer. Kambach et al. speculated that the 
heterodimeric Sm crystal structures form the starting point for a seven-membered Sm 
ring arrangement, and created the first atomic model for the Sm core heteromer by 
extrapolation from the heterodimer structures.54,57  
Efforts toward atomic-resolution structures of snRNP Sm cores have been highly 
successful over the past two years. In the low-resolution range, Stark et al. were able to 
construct a 10-Å resolution map of the entire U1 snRNP by cryo-electron microscopy.58 
Several known U1 components were identified (Fig. 1.5c, d), and these results 
underscored the importance of the Sm heptamer at the snRNP core. The solution structure 
of the SMN Tudor domain (which interacts with Sm proteins to form snRNP cores)22 has 
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provided an unexpected result: the SMN and Sm monomers have the same fold, and 
nearly identical structures. This raises the intriguing possibility that the SMN protein 
interacts with the Sm complex by forming mixed heteromers. 
Finally, direct evidence for the structure of snRNP cores was provided by the 
crystal structures of three different heptameric Sm-like archaeal proteins, solved 
concurrently by Collins et al.,59 Mura et al.,41 and Törö et al.60 Details of these structure 
determinations and motivation for current and future structural experiments are provided 
in Table 1.1. The determination and interpretation of these SmAP structures is the main 
subject of this dissertation. Elucidation of the crystal structure of an intact snRNP is the 
logical next step, and the U1 snRNP – which is one of the simplest and best-characterized 
snRNPs – may be a good candidate. Given the usual advantages of working with 
thermostable/archaeal proteins for structural studies, it also will be worthwhile to pursue 
the identification and characterization of possible archaeal snRNP-like particles.   
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Figure and Table legends 
Figure 1.1: A modular approach to RNA metabolism. Placing the Sm protein family 
in a biochemical context underscores the central importance of these proteins in RNA 
metabolism. This figure shows how several RNA processing events (on a cellular scale) 
can be traced back hierarchically to the Sm proteins (on a molecular scale). One of the 
most characterized and well-studied examples is the excision of introns from pre-mRNA, 
which can be dissected as: intron splicing ⇒ major spliceosome ⇒ U1, U2, U4/U6, and 
U5 snRNPs ⇒ Sm core of snRNPs. This figure is by no means comprehensive (i.e., not 
all of the known connections are shown), and new, non-mRNA splicing related examples 
are being discovered continuously.   
Figure 1.2: The spliceosomal cycle and the complexity of pre-mRNA processing via 
intron excision. The spliceosome is a large, transiently stable macromolecular machine, 
and the complexity of its catalytic cycle is diagrammed in (a). The precursor mRNA is 
shown at the top, with its branch point adenosine and splice sites noted. The upstream 
(5’) and downstream (3’) exons are denoted by E1 and E2, and are shown as ligated 
product mRNA in the bottom left corner (the intron lariat is shown above that). The five 
spliceosomal snRNPs are illustrated as gray-shaded shapes, and various states of this 
dynamic assembly are denoted by their yeast or mammalian labels (e.g., “CC (E)” = 
commitment complex). An electron micrograph of a spliceosome bound to β-globin pre-
mRNA is shown in (b). Note the large dimensions of this particle, which is roughly the 
same size as the ribosome. Panel (a) was adapted from ref. 21 and (b) is from ref. 61.    
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Figure 1.3: The central role of Sm proteins in snRNP assembly. This diagram of the 
U1 snRNP biogenesis pathway exemplifies the key roles of Sm proteins in snRNP 
assembly (adapted from ref. 19). Some of the involved proteins are shown as shaded 
ovals, and the U1 snRNA is drawn as thin lines. A recently discovered interaction 
between the SMN protein and Sm D1 and D3 proteins is shown as a dashed arrow. The 
key assembly step with snRNA is shown in the dashed box to the right. Assembly of the 
snRNP Sm core complex triggers hypermethylation of the m7G guanosine cap to a 
trimethylated state (m3G). Together with subsequent association of the Sm core complex 
and several other proteins (e.g., snurportin-1), this results in nuclear import and the final 
stages of snRNP maturation.  
Figure 1.4: Secondary structures of some snRNAs and their Sm binding sites. 
Predicted secondary structures are shown for a sample of spliceosomal snRNAs: U1 (a, 
b), U2 (a), and base-paired U4•U6 (c). The shaded U1 snRNA stem-loops in (a) are 
colored in agreement with the cryo-EM reconstruction shown in Figures 5(c, d). The 
uridine-rich Sm binding sites are indicated in each panel, as well as a few other features 
(e.g., 5’ guanosine caps or the branch point adenosine). The snRNA consensus sequence 
for Sm binding is PuAU≈4-6GPu (Pu = purine); however, the stringency of this site is not 
very strict, as illustrated by the interrupting guanosine in the U1 site (b). Note that the 
snRNA may base pair with both intronic and exonic elements (a), and that the Sm core 
may mediate RNA-RNA as well as RNA-protein interactions. These secondary structures 
were taken from Burge et al.21 
 26
Figure 1.5: Progress towards an atomic-resolution understanding of eukaryotic Sm 
proteins and snRNPs. Panels (a) – (d) trace the progress in our knowledge of the 
structures of snRNPs and their Sm cores. This work has extended from the low 
resolution, ultrastructural studies that first suggested that Sm proteins form ring-shaped 
oligomers (a), to a recent 10-Å resolution reconstruction of the U1 snRNP by cryo-
electron microscopy (c, d). The first Sm protein crystal structure that was determined – 
that of the human D1•D2 heterodimer – is shown in (b). A model of the human Sm 
heptamer was built from this structure (the entire heptamer is unstable without snRNA 
and was not crystallized).54 The experimental U1 snRNP envelope shown in (c) permits 
docking of various structural elements, such as a hypothetical model of the human Sm 
heptamer (d). Although it is not based on direct experimental evidence, this model allows 
the Sm core of U1 snRNP to be identified unambiguously, and underscores the likely 
importance of the Sm heptamer in nucleating snRNP assembly. The EM is from Achsel 
et al.,46 and (c) and (d) are from Stark et al.58 
Table 1.1: A summary of all known Sm and SmAP structures. A comprehensive list 
of Sm and SmAP structures is provided. Details of a given structure determination are 
provided (resolution, PDB code, heptamer packings in various space groups), along with 
its significance. The first Sm protein structure was reported by Kambach et al.,54 and the 
first heptameric structures of Sm-like proteins were revealed concurrently by Collins et 
al.,59 Mura et al.,41 and Törö et al.60 As outlined in the Synopsis (pg. 5), structure 
determinations for Pae SmAP2 and SmAP3 are in progress.  
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Figure 1.1: A modular approach to RNA metabolism. 
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Figure 1.2: The spliceosomal cycle and the complexity of pre-mRNA processing via intron excision. 
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Figure 1.3: The central role of Sm proteins in snRNP assembly. 
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Figure 1.4: Secondary structures of some snRNAs and their Sm binding sites. 
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Figure 1.5: Progress towards an atomic-resolution understanding of eukaryotic Sm  
   proteins and snRNPs. 
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Table 1.1: A summary of all known Sm and SmAP structures. 
 Structure determination /  Protein asymmetric unit contents Significance / Motivation Reference  
 2.0 Å (D3•B) 
(PDB 1D3B) 
6 heterodimers arranged 
as hexamers (P212121) Human D3•B, 
D1•D2  2.5 Å (D1•D2) 
(PDB 1B34) 1 heterodimer (P62) 
The first Sm protein structures: the human D3•B and D1•D2 
heterodimers are nearly identical, and the monomers fold as 
strongly-bent, five-stranded antiparallel β-sheets 
Kambach et al. 
(1999) 
2.5 Å  
(PDB 1I4K) 4 heptamers (P21) 
 
2.75 Å  
(PDB 1I5L) 
2 heptamers (P21) +  
2 U3’s 
this first structure of an Sm heptamer revealed the binding site of 
oligouridine (U3)  
Törö et al. 
(2001) 
Afu 
SmAP1 
2.0 Å  
(PDB 1I81) 1 heptamer (P21) the first structure of an Sm heptamer, model for RNA binding? 
Collins et al. 
(2001) 
1.85 Å  
(PDB 1JBM) 1 heptamer (P1) 
another crystalline packing, obtained concurrent with (but 
independent of) the work of Collins et al. 
2.80 Å  
(PDB 1JRI) 2 heptamers (P212121) 
yet another crystalline packing, but one that reveals the likely 
structure of the fibers observed by EM 
Mth 
SmAP1 
1.90 Å  
(PDB 1LOJ) 
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yet another packing, but one that (i) reveals the binding site of 
uridine, and (ii) reveals the structure of a 14-mer with pseudo-72 
point group symmetry (thus corroborating the Pae SmAP1 14-mer) 
Mura et al.  
(Chapter 3) 
2 heptamers (P21) +  
14 UMPs + 
14 MPDs 
1.75 Å  
(PDB 1I8F) 1 heptamer (C2) 
the first structure of an Sm heptamer suggested a model for RNA 
binding (which is probably incorrect) 
Mura et al. 
(2001) Pae 
SmAP1 2.05 Å  Pae 14-mers (with 72 symmetry) exist in this crystal form, comparison of the Pae uridine binding site with the conserved 
ligand-binding sites found in Afu and Mth SmAP1
Mura et al.  
(Chapter 3) 
1 heptamer (C2221) + 
(PDB 1LNX) 7 UMPs 
2 heptamers (P4212) 
to get a complete picture of the SmAP content of a single 
archaeal species, and to compare to the other two Pae SmAPs –– 
Pae 
SmAP2 
in progress  
(data to 2.0 Å) 
to get a complete picture of the SmAP content of a single archaeal 
species, and because the SmAP3 sequence resembles certain 
eukaryotic Sm proteins more than does any other SmAP 
Pae 
SmAP3 
in progress  4 heptamers (P21) –– (data to 2.0 Å) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2: 
 
The crystal structure of a heptameric archaeal Sm protein: Implications 
for the eukaryotic snRNP core* 
 
 
 
 
 
 
 
 
 
 
 
 
 
* This chapter is a reprint of the following published article: 
 
The crystal structure of a heptameric archaeal Sm protein: Implications for the 
eukaryotic snRNP core 
C. Mura, D. Cascio, M.R. Sawaya, & D. Eisenberg. Proc. Natl. Acad. Sci. USA (2001), 
98, 5532-5537 
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Abstract 
 
Intron splicing is one example of the many types of RNA processing that directly 
utilize small nuclear ribonucleoprotein (snRNP) complexes. Sm proteins form the cores 
of most snRNPs, so to further elucidate structural principles of snRNP assembly, we 
have characterized the oligomerization and ligand-binding properties of Sm-like 
archaeal proteins (SmAPs) from Pyrobaculum aerophilum (Pae) and Methanobacterium 
thermautotrophicum (Mth). Ultracentrifugation shows that Mth SmAP1 is exclusively 
heptameric in solution, whereas Pae SmAP1 forms either disulfide-bonded 14-mers or 
sub-heptameric states (depending on the redox potential). By electron microscopy, we 
show that Pae and Mth SmAP1 polymerize into sheets composed of well-ordered polar 
fibers that are formed by head-to-tail stacking of heptamers. The crystallographic results 
reported here corroborate these findings by showing heptamers and tetradecamers of 
both Mth and Pae SmAP1 in several new crystal forms. The 1.9-Å resolution structure 
of Mth SmAP1 bound to uridine-5’-monophosphate (UMP) reveals conserved ligand-
binding sites. The likely RNA binding site in Mth agrees with that determined for 
Archaeoglobus fulgidus (Afu) SmAP. Finally, we find that both Pae and Mth SmAP1 
gel-shift negatively supercoiled DNA. These results distinguish SmAPs from eukaryotic 
Sm proteins, and suggest possible differences in their functions. 
 
 
 
Abbreviations: snRNP, small nuclear ribonucleoprotein; SmAP, Sm-like archaeal protein; Pae, 
Pyrobaculum aerophilum; Mth, Methanobacterium thermautotrophicum; Afu, Archaeoglobus 
fulgidus; UMP, uridine-5’-monophosphate; MPD, 2-methyl-2,4-pentanediol; EM, electron 
microscopy; NCS, non-crystallographic symmetry; wt, wild type; nt, nucleotide; DTT, 
dithiothreitol; ss(D/R)NA, single-stranded (D/R)NA; OB-fold, oligosaccharide/oligonucleotide-
binding fold 
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Introduction 
 
Excision of non-coding regions (introns) is one of the most vital steps in the 
maturation of precursor mRNAs. Most eukaryotic protein-coding genes contain multiple 
introns,1 so high-fidelity pre-mRNA processing is essential to ensure a mature mRNA 
with correctly registered exons. A transiently stable assembly of five small nuclear 
ribonucleoproteins (snRNPs) catalyzes the simultaneous excision of introns and splicing 
of exons in eukaryotic pre-mRNA. This large assembly of uridine-rich snRNPs (U 
snRNPs) is known as the spliceosome. It contains five small nuclear RNAs (snRNAs) 
and at least 80 proteins,2 making it roughly the same size as the ribosome (sedimentation 
coefficient of ≈ 60S).3 At various stages in its catalytic cycle, the spliceosome consists of 
the U1, U2, U4/U6, and U5 snRNPs.4 The recent isolation of a novel U1•U2•U4/U6•U5 
“penta-snRNP” devoid of mRNA suggests needed modification of the long-held belief 
that spliceosome assembly requires pre-mRNA.5  
Extensive biochemical and genetic data have shown that stepwise binding of 
seven cytoplasmic Sm proteins to exported snRNAs is a key step in snRNP biogenesis 
(recently reviewed in ref. 6). Each U snRNP complex is composed of a ≈ 110-180 
nucleotide uridine-rich snRNA and two classes of proteins: (i) snRNP-specific proteins 
that provide snRNP-specific functions (e.g., U1A protein of U1 snRNPs), and (ii) a set of 
Sm or Sm-like (Lsm) proteins that are common to each snRNP core.7 The snRNA 
component contains a single Sm or Lsm binding site with the uridine-rich consensus 
sequence PuAU≈4-6GPu (Pu = purine). However, specificity for this sequence is not very 
stringent and there can be redundancy in Sm•snRNA binding.8 The Sm sites are predicted 
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to be single-stranded RNA (ssRNA) regions flanked by stem-loop structures (reviewed in 
refs. 2, 4). Sm binding is highly sensitive to modifications of the flanking stem-loops and 
the Sm site of a given snRNA, and varies from one snRNA to another.9 Sm•snRNA 
binding may be modulated by recently discovered interactions between some Sm proteins 
and the survival of motor neurons (SMN) protein complex,10 and by symmetric 
dimethylation of arginine residues in some of the RG dipeptide repeats of Sm11,12,13 and 
Lsm14 proteins by a putative “methylosome”.15 In eukaryotes, the Sm D1•D2 and E•F•G 
heteromers simultaneously bind to snRNA to yield a “subcore” snRNP complex.6,16,17 
The final component to join the Sm complex (the B/B’•D3 heterodimer) triggers 
hypermethylation of the 5’ m7G cap of snRNA to a trimethylated cap (m3G). The m3G 
cap and the snRNA•Sm core complex form a bipartite nuclear localization signal that 
results in transit of the snRNP core to the nucleus, where association of various snRNP-
specific proteins completes the assembly process.  
Aside from their roles in assembly and nuclear import of snRNP cores, the 
primary structural or catalytic function of Sm proteins is not known. Forming the core of 
snRNPs, Sm proteins probably mediate critical RNA-RNA, RNA-protein, and protein-
protein interactions, and may recruit both snRNP and non-snRNP proteins to the 
assembling spliceosome. The vast network of protein-protein and protein-RNA 
interactions in which Sm proteins probably engage was recently reviewed by Will and 
Lührmann7,6 and experimentally verified by genome-wide two-hybrid screens of yeast 
Lsm proteins.18 An example of such interactions is the discovery that the extended and 
highly charged C-terminal tails of Sm B, D1, and D3 are involved in sequence-
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independent binding to pre-mRNA substrate, and may stabilize U1 snRNP•pre-mRNA 
interactions.19,20 Chemical cross-linking of the U1 snRNP 70K protein to the Sm B and 
D2 proteins provides suggests a possible role of snRNP Sm cores in recruiting other 
proteins to the assembling spliceosome.21 The importance of Sm proteins in RNP 
assemblies is underscored by their phylogenetic distribution: in addition to the canonical 
Sm and Lsm proteins found in eukaryotes ranging from yeast to humans, the Sm-like 
archaeal protein (“SmAP”) family has been discovered.22,23 The recent demonstration that 
the E. coli bacteriophage host factor Hfq is an Sm-like protein provides the first example 
of a eubacterial Sm protein.24,25 These results imply fundamental roles for Sm proteins in 
the early evolution of RNA metabolism. 
 Sm proteins have a remarkable tendency to associate into ring-shaped oligomers. 
Prompted by biochemical and genetic data, electron microscopic (EM) investigations of 
U snRNP particles revealed the “doughnut-shaped” ultrastructure of Sm and Lsm 
cores.26,27 The realization that Sm and Lsm proteins occur in groups of at least seven 
paralogs within the genome of a given organism suggests that snRNP cores are formed 
from Sm heteroheptamers, and two recent results verify this. First, Stark et al. 
reconstructed a 10-Å resolution map of the U1 snRNP by cryo-EM and found that a 
model of the Sm heptamer could be docked into the ring-shaped body of the snRNP.28 
Next, the in vivo stoichiometry of Sm proteins in yeast spliceosomal snRNPs was 
determined by a differential tag/pull-down assay, showing that the snRNP core domain 
contains a single copy of each of the seven Sm proteins.29 Intriguingly, stable sub-
heptameric Sm complexes have been suggested as intermediates along the snRNP core 
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assembly pathway (e.g., a D1•D2•E•F•G complex capable of binding snRNA),17 and 
ultracentrifugation and EM show that some of these oligomers (e.g., a (E•F•G)2 hexamer) 
can form ring-like structures that resemble intact, heptameric snRNP cores.30 Such 
findings emphasize the importance of the Sm heptamer at the snRNP core, and suggest 
the possibility of other oligomeric states. 
There is no atomic-resolution structure of a eukaryotic snRNP core; however, the 
crystal structures of Sm-like archaeal proteins from Afu,31 Pae,23 and Mth32 reveal a ring-
shaped Sm heptamer and provide a model for snRNA binding in the snRNP core. Sm 
monomers fold as strongly bent, five-stranded antiparallel β-sheets,33 and form toroidal 
heptamers that are perforated by a conserverd cationic pore. The inner surface of this 
pore appears to be the oligouridine binding site. The structural similarity between the 
SmAP1 monomers and dimers and the nearly identical human Sm D1•D2 and B•D3 
heterodimers34 justifies SmAP1-based models for the heptameric snRNP core. In order to 
elucidate further structural principles of snRNP assembly, we have characterized the 
oligomerization and ligand-binding properties of Pae and Mth SmAP1. Many of our 
results distinguish these two Sm-like archaeal proteins from eukaryotic Sm proteins, and 
suggest that the functions of archaeal Sm proteins may be quite different from the 
snRNP-based roles of eukaryotic Sm proteins. 
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Materials and Methods 
 
Cloning, expression, and purification of Pae and Mth SmAP1s 
 
 A genomic phosmid clone that contains the Pae SmAP1 open reading frame 
(ORF) was kindly provided by the laboratory of Jeffrey H. Miller (UCLA), and genomic 
DNA containing the Mth (strain ΔH) SmAP1 ORF was kindly provided by the laboratory 
of John Reeve (Ohio State University). Based on the ORF DNA sequences, we used these 
primers for PCR amplification with Deep VentR polymerase (New England Biolabs):  
(Pae sense)  5’ CCATATGGCCTCGGATATATCT 3’ 
(Pae antisense) 5’ AAGCTTTCCCCGTCCTGGTACT 3’ 
(Mth sense)  5’ CCATATGATAGATGTGAGTTCAC 3’ 
(Mth antisense) 5’ AAGCTTTCCCCGGGATATGTA 3’ 
Blunt-end PCR products were cloned into a pET-22b(+) expression vector (Novagen) via 
intermediate subcloning into the pCR-Blunt vector (Invitrogen). Ligation products were 
directly transformed into chemically competent NovaBlue E. coli (Novagen), and 
plasmids from overnight cultures of positive transformants (as assayed by PCR screening 
of colonies) were mini-prepped (Qiagen). DNA sequencing (David Sequencing) of these 
plasmids verified that the expressed proteins would contain a C-terminal His-tag after a 
10-residue serine protease-sensitive linker. That is, the constructs were designed as: wild 
type (wt) SmAP1 + GR*GKLAAALEHHHHHH (single letter amino acid codes, * 
indicates intended protease site). Recombinant proteins were over-expressed in 
BL21(DE3) E. coli at 37°C by standard protocols using 1 mM isopropyl-β-D-
thiogalactoside induction of the T7lac-based promoter. At least 120 mg of soluble protein 
was expressed per liter of cell culture. The Cys8→Ser mutant of Pae SmAP1 was created 
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in a similar manner, except that site-directed mutagenesis was achieved via overlap-
extension PCR with an additional pair of primers that contained the mutant site. 
 Harvested cells (stored at –20°C overnight) were thawed and re-suspended in a 
high salt concentration buffer (20 mM NaHEPES pH 7.8, 1.5 M NaCl, 0.5% v/v Triton 
X100, 30 mM PMSF). Cells were lysed by a combination of lysozyme treatment (0.3 
mg/ml chicken egg white lysozyme) and French-press (1000 psig). Initial purification of 
the thermostable proteins was achieved by heating the cleared supernatant to ≈ 80°C, 
followed by high-speed centrifugation (37,000g) to remove the bulk of denatured E. coli 
proteins. The SmAP1-His6x proteins were further purified by affinity chromatography on 
a Ni2+-charged iminodiacetic acid-sepharose column (both proteins eluted as broad peaks 
over the range 170-400 mM imidazole). Both Mth and Pae SmAP1 were >99% pure by 
this point (as determined by SDS-PAGE and MALDI-TOF mass spectrometry). Since the 
His6x tag prevents heptamer formation for some SmAPs (unpublished data, Mura & 
Eisenberg), the next step was proteolytic removal of the C-terminal tag for both Pae and 
Mth SmAP1 (wt Mth SmAP1 is 81-amino acid residues, and has a MW of 9,029 Da; wt 
Pae SmAP1 is 80-amino acid residues, and has a MW of 8,800 Da). 
 The His-tag and most of the linker were removed by limited proteolysis with 
trypsin (since thrombin was ineffective). The peak fractions from the Ni2+-column that 
were judged as pure by SDS-PAGE were pooled and dialyzed at room temperature into 
phosphate-buffered saline (PBS) supplemented with 15 mM EDTA (to prevent His-tag 
mediated aggregation). The EDTA concentration was gradually reduced to zero over 2-3 
buffer exchanges. Porcine trypsin was added to the SmAP1 (at ≈ 1 mg trypsin per 100 mg 
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SmAP1), and complete removal of the tag occurred after ≈ 4 h at 37°C (the extent of 
proteolytic digestion was assayed by MALDI-TOF spectra of time points). Transfer of 
the protein to 4°C and addition of a protease inhibitor (50 mM PMSF) terminated the 
reaction. The amino acid composition of Mth and Pae SmAP1 led to calculated 
isoelectric points of ≈ 5.2 and 5.8, resepectively; therefore, anion exchange 
chromatography was used to separate cut (i.e., wt) SmAP1 from trypsin, uncut protein, 
and any other contaminants. In preparation for anion exchange chromatography on a 
quaternary ammonium matrix (UNO-Q6, BioRad), Pae SmAP1 was dialyzed against 20 
mM Tris, pH 8.55. Mth SmAP1 was insoluble at 4°C or in the Tris-alone buffer, and had 
to be dialyzed versus 20 mM Tris pH 8.55, 30 mM EDTA pH 8.0 at room temperature 
(EDTA did not interfere with chromatography). Both SmAP1s eluted at ≈ 80 mM NaCl 
in the salt concentration gradient. Pure fractions (assayed by SDS-PAGE and MALDI-
TOF) were pooled and dialyzed into a buffer for crystallization.  
Crystallization of Pae SmAP1 and Mth SmAP1 
 
For Pae SmAP1 crystallization, the protein buffer was “XB” (10 mM Tris pH 7.8, 
5 mM EDTA pH 8.0), and for Mth (which requires higher ionic strength buffers for 
solubility) it was “XB6β” (10 mM Tris pH 7.8, 5 mM EDTA pH 8.0, and 0.1 M NaCl). 
Protein concentrations in these buffers were increased to various values for crystallization 
(noted below) by using 3 kDa molecular weight cutoff Centripreps to reduce sample 
volume. Initial sparse matrix screening of crystallization conditions utilized the 
commercially available kits from Hampton Research and Emerald Biosystems, Inc. Final, 
optimized Pae SmAP1 crystals of the C2221 form were grown by the hanging-drop vapor 
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diffusion method in 24-well Linbro trays. An 11 μl drop [4 μl well buffer + 5 μl wt 29.6 
mg/ml Pae SmAP1 + 1 μl 0.1 M dithiothreitol (DTT) + 1 ml 0.1 M uridine-5’-
monophosphate (UMP)] was equilibriated against a 800 μl well [0.1 M sodium acetate 
pH 8.20, 0.1 M ammonium acetate, 8.6% w/v PEG-4000, and 23.8% v/v glycerol] at 
room temperature (≈ 19.8˚C). Orthorhombic crystals reached maximum dimensions of 
0.1 × 0.1 × 0.3 mm within 5 days. Hanging drops contained a mixture of the new C2221 
crystals and the previously reported C2 form (used to solve the original Pae SmAP1 
structure23). 
Three forms of Mth SmAP1 crystals were obtained under three conditions by 
hanging-drop vapor diffusion at room temperature. For the P1 form, Mth SmAP1 was at 
56 mg/ml in buffer XB6β. The drop was 4 μl of protein + 4 μl of well buffer. The well 
was 600 μl of [0.1 M sodium citrate pH 5.60, 15% w/v PEG-4000, 0.2 M ammonium 
acetate]. Crystals grew to maximum dimensions of ≈ 0.1 × 0.1 × 0.25 mm within 7 days. 
For the P212121 form, Mth SmAP1 was at 42 mg/ml in buffer XB6β. The drop was 3 μl 
of protein + 3 μl of well buffer. The well was 600 μl of [0.1 M Tris pH 8.50, 10% v/v 
isopropanol]. Crystals grew to maximum dimensions of ≈ 0.3 × 0.3 × 0.6 mm within 3 
days. For the P21 form, Mth SmAP1 was at 30.3 mg/ml in a modified form of buffer 
XB6β that contained a 26-nt single-stranded DNA [10 mM Tris pH ≈ 7.7, 3 mM EDTA 
pH 8.0, 55 mM NaCl, 0.6 mM ssDNA]. The drop was 2.5 μl of protein/ssDNA + 2.5 μl 
of well buffer + 1 μl of 0.1 M UMP. The 600 μl well contained 55 μl of 1.0 M sodium 
citrate (pH 5.6), 5 μl of 1.0 M sodium citrate (pH 8.0), 60 μl of 2.0 M ammonium acetate, 
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180 μl of neat MPD and 300 μl of sterile dH2O (interestingly, 2.5 M 1,6-hexanediol 
could be substituted for MPD). Crystals grew to maximum dimensions of ≈ 0.15 × 0.15 × 
0.25 mm within 7 days. 
Cryoprotection and data collection 
 
 The C2221 Pae SmAP1 and P21 Mth SmAP1 crystals did not require the addition 
of a cryosolvent, due to the 23.8% v/v glycerol or 30% v/v MPD in those drops, 
respectively. The other two Mth SmAP1 crystal forms had to be cryoprotected as follows: 
(i) for the P1 form, ethylene glycol was added directly to the drop to a final concentration 
of ≈ 20% v/v, and crystals were allowed to soak for 20 sec prior to mounting in a cryo 
loop; (ii) for the fragile P212121 crystals, the cryoprotectant was ethylene glycol (mixed 
with well buffer), and had to be introduced gradually over several hours (in ≈ 5% v/v 
increments). The P212121 crystals were allowed to soak for only a very short time (2-3 
sec) at the final ethylene glycol concentration (30% v/v). Diffraction data were collected 
either at the synchrotron (P1 and P21 form Mth xtals) or in-house (P212121 Mth and 
C2221 Pae crystals) on an ADSC Quantum-4 charge-coupled device (CCD) detector. All 
crystals were mounted in a cryogenic nitrogen stream at -168°C for data collection.  
After autoindexing, all images were indexed/integrated/reduced in DENZO, and 
reflections were scaled and merged in SCALEPACK.35 Complete data sets were collected 
from single crystals (Table 3.1). Unit cell dimensions for the Pae C2221 form are a = 
91.83, b = 113.76, c = 126.59 Å; for the Mth crystals they are: a = 45.07, b = 54.08, c = 
62.35 Å, α = 87.58°, β = 72.86°, γ = 81.45° (P1); a = 65.25, b = 109.96, c = 83.76 Å, β = 
95.81° (P21); a = 40.37, b = 114.70, c = 238.60 Å (P212121). The large unit cell edge of 
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the Mth P212121 crystals (c = 238.60 Å) led to spot overlap for high-resolution reflections 
(d < 3 Å), so multiple data sets were collected at two 2θ values (0°, -12°) for two crystal 
alignments (related by a 45° azimuthal rotation). 
Structure determination, refinement, and validation 
 
 Initial phases for the C2221 Pae SmAP1 structure were determined by the 
evolutionarily-programmed molecular replacement algorithm (EPMR).36 The most 
reasonable Matthews coefficient (VM = 2.58 Å3/Da) corresponded to a heptamer in the 
asymmetric unit (a.u.), so the search model was the identical Pae SmAP1 heptamer from 
the C2 crystal form.23 The EPMR solution was used for manual model building in the 
program O,37 and model refinement in CNS.38 Refinement in CNS proceeded by standard 
protocols, using the maximum-likelihood target function for amplitudes (mlf), bulk 
solvent correction, and anisotropic B-factor correction terms. Seven-fold non-
crystallographic symmetry (NCS) was determined by calculation of a locked self-rotation 
function, but NCS restraints were not imposed at any time. Solvent molecules were added 
as necessary (water, glycerol, acetate). Refinement of individual atomic positions, 
isotropic temperature factors, and simulated annealing torsion angle dynamics was 
performed in most rounds. Each refinement round ended with inspection of the 
agreement between the model and σA-weighted 2Fo – Fc, Fo – Fc, and simulated 
annealing omit maps (the latter only as necessary).  
Determination of the Mth P1 structure proceeded in two steps. First, a homology 
model of the Mth SmAP1 heptamer was built from the Pae SmAP1 structure using an in-
house script (unpublished, Mura & Eisenberg), and was used as a search model for 
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molecular replacement with EPMR (VM = 2.29 Å3/Da for a single heptamer in the P1 
cell). Next, the unambiguous EPMR solution was converted to a polyalanine model and 
subjected to free-atom model refinement with the ARP/wARP program in the “molrep” 
mode (side chains from the Mth sequence were built in the final wARP stage). This Mth 
P1 structure was refined in the usual manner with CNS, as described above for the Pae 
C2221 structure. The P21 and P212121 Mth structures were solved by molecular 
replacement (EPMR) with the refined P1 Mth model. Self-rotation functions and |Fo|2 
Patterson maps were calculated to deduce the NCS between heptamers in the P21 and 
P212121 forms (each of which contains 14 monomers per a.u.). Solvent was added as 
necessary for all structures (see Table 3.1), and no NCS restraints were enforced at any 
point in the refinements.  
Refinement statistics for the single Pae and three Mth structures are shown in 
Table 3.1. Each of the four protein models is complete, except for anywhere from 6-11 
missing N-terminal residues in various models (see PDB files). The stereochemistry and 
geometry of each SmAP1 monomer was validated with the programs PROCHECK39 and 
ERRAT,40 and found to be acceptable (e.g., no residues in the disallowed region of φ,ψ 
space for the Pae C2221 model). Final model coordinates and diffraction intensity data 
were submitted to the PDB, with ID codes 1JBM, 1LOJ, 1JRI, and 1LNX (see Table 3.1).  
Analytical ultracentrifugation 
 
The wt Pae protein in 75 mM NaCl, 10 mM Tris, pH 7.8, was examined by 
sedimentation velocity in a Beckman Optima XL-A analytical ultracentrifuge at 52,000 
rpm and 20°C using absorption optics at 273 nm and a 12 mm pathlength double sector 
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cell. The sedimentation coefficient distribution was determined from a g(s) plot using the 
Beckman Origin-based software (Version 3.01). The peak sedimentation coefficient was 
corrected for density and viscosity to an S20,wat value by using a value for the partial 
specific volume at 20°C of 0.743 (calculated from the amino acid composition41 and 
corrected to 20°C42). 
 Sedimentation equilibrium runs were performed on all three proteins – wt Mth, wt 
Pae, and the Pae C8S mutant – in 150 mM NaCl, 10 mM Tris, pH 7.8, again using a 
Beckman Optima XL-A analytical ultracentrifuge. Each protein was examined at three 
different concentrations and four speeds, using 12 mm pathlength six-sector cells. Protein 
concentrations used were 3.4, 0.69 and 0.19 mg/ml for wt Pae; 5.9, 1.26 and 0.32 mg/ml 
for the C8S mutant of Pae; and 4.1, 0.85 and 0.22 mg/ml for wt Mth. Rotor speeds were 
8,000, 10,000, 12,500 and 14,500 rpm. Protein concentration was monitored by 
absorption at 280 nm and, for the lowest protein concentrations, at 232 nm. A partial 
specific volume of 0.743, calculated as described above, was used for all three proteins. 
Individual scans were analyzed using the Beckman Origin-based software (Version 3.01) 
to perform a nonlinear least-squares exponential fit for a single ideal species, thus giving 
the weight-averaged molecular weight for each protein. 
Transmission electron microscopy 
 
The following protein samples were prepared for electron microscopy: (1) 0.5 
mg/ml wild-type Mth SmAP1 in 10 mM Tris pH 7.5, 60 mM NaCl, (2) 1.2 mg/ml wild-
type Pae SmAP1 in 25 mM Tris pH 7.5, 30 mM NaCl, (3) 1.1 mg/ml C8S mutant Pae 
SmAP1 in the same buffer as the wt protein, and (4) 1.2 mg/ml wild-type Pae SmAP1 in 
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reductant buffer (25 mM Tris pH 7.5, 30 mM NaCl, 10 mM DTT). Carbon-coated 
parlodion support films mounted on copper grids were made hydrophilic immediately 
before use by high voltage, alternating current glow-discharge. Protein samples were 
applied directly onto the grids and allowed to adhere for 2 min. Grids were rinsed with 
distilled water and negatively stained with 1% w/v uranyl acetate. Specimens were 
examined in a Hitachi H-7000 electron microscope at an accelerating voltage of 75 kV. 
Gel-shift assays 
 
For gel-shift experiments, negatively supercoiled plasmid DNA was prepared by 
transforming the plasmid into E. coli BL21(DE3) cells and mini-prepping (Qiagen) it 
from spun down cells that had reached stationary phase. Several different plasmids were 
tested, including ones derived from pUC18, pACYC, pET-22b(+) (Novagen), and pCR-
Blunt (Invitrogen). Titration of plasmids with ethidium bromide was used to verify the 
negative superhelicity of the DNA via electrophoretic mobility changes in agarose gels. 
Single-stranded DNAs of various lengths and sequences were synthesized by Integrated 
DNA Technologies, Inc., and were re-hydrated in 10 mM Tris pH 7.8 (e.g., the 26-mer in 
Fig. 3.8(b) with the following sequence: 5’CGGATCCTCAGTAAAAAGTGCGGAAA3’). 
Stock solutions of protein were wt Pae at 5.6 mg/ml in buffer XB (see above) or wt Mth 
at 5.6 mg/ml in buffer XB6β (see above). Except as noted, buffer, DNA, and protein 
samples were mixed to produce 25- or 50-μl reactions that were incubated at room 
temperature (generally for 30-60 min). Gel-shift of the DNA was assayed by 
electrophoresis at a constant voltage (120V) in 1.3% or 1.5% w/v TAE/agarose gels. 
Examples of typical reactions are shown in Fig. 3.8. 
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Results 
 
Crystallization and determination of the Pae and Mth SmAP1 structures 
 
 As with many proteins, crystallization of Pae SmAP1 was not straightforward. 
Wild-type (wt) Pae SmAP1 crystallized only in the presence of dithiothreitol (DTT), as 
described in the Methods section. Identical crystallization buffers that lacked DTT failed 
to produce crystals, and presumably this additive is required because it reduces the seven 
disulfide bonds that form between Cys8 residues in the Pae tetradecamer (which can 
therefore be thought of as a dimer of heptamers rather than as a heptamer of dimers). We 
found that other reductants (e.g., β-mercaptoethanol) can substitute for DTT to yield 
crystals, although such crystals are of poorer quality than the DTT-based condition. 
Apparently, reduction of the disulfides frees heptamers to crystallize independently in 
orientations that relax crystal lattice strain, even when the 14-mer persists in the crystal 
(as in the C2221 form reported here). The only other notable (but unnecessary for 
crystallization) additive to the Pae crystallization condition was uridine-5’-
monophosphate (UMP).  
As shown in Table 3.1, diffraction data extended to at least 2.05-Å resolution for 
the C2221-form Pae SmAP1 crystals. Previously, we determined the crystal structure of 
Pae SmAP1 in spacegroup C2 by multiple-wavelength anomalous dispersion phasing.23 
Thus, the C2221 structure reported here was solved by the stochastic molecular 
replacement method in the EPMR program, using the C2 heptamer as a search model (the 
Matthews coefficient and 7-fold NCS in the locked self-rotation function suggested a 
heptamer in the C2221 asymmetric unit). However, NCS restraints were not imposed 
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during crystallographic refinement. As discussed in detail below, only the uridine 
fragment of UMP was built into the final refined model, and atomic occupancies (q) were 
refined only for uridine (not for any other ligand or protein atoms). Partial occupancies 
for uridine atoms were restricted to a reasonable range (0.2 < q < 1.5). The final structure 
was refined to an R/Rfree of 18.2%/22.6%, with reasonable model geometry (Table 3.1) 
and no outliers in a Ramachandran plot. 
 Crystallization of Mth SmAP1 was relatively simple, and in fact this protein could 
be crystallized in three forms (P1, P21, P212121) under three dissimilar conditions (also, a 
fourth form was crystallized by Collins et al.32). The most intriguing result is that Mth 
SmAP1 crystallized in the P21 form only in the presence of a single-stranded DNA 
(ssDNA) to which it was thought to bind, even though ssDNA was not found in the 
crystal structure. Since diffraction data were obtained from the P1 form before the first 
Mth SmAP1 structure was reported by Collins et al., we solved the P1 Mth structure by a 
combination of molecular replacement and free-atom model refinement (in ARP/wARP). 
Briefly, a homology model of Mth SmAP1 was built from the Pae SmAP1 structure. An 
unambiguous molecular replacement solution was found for this search model against the 
Mth P1 data (using EPMR). In order to reduce Pae model bias, this solution was 
converted to polyalanine and phases from this initial model were used to autobuild a 
completely new model with the ARP/wARP program. Initial phases for the P21 and 
P212121 Mth data were obtained by molecular replacement with the refined P1 model (as 
summarized in Table 3.1). No NCS restraints were applied in refinement of any of the 
Mth structures, and various non-protein molecules were built into electron density as 
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appropriate (based on the crystallization condition and Fo – Fc density >+3σ in strength). 
Electron density for the UMP-binding sites was more interpretable in Mth SmAP1 than in 
the Pae structure, and permitted model building of six complete UMPs (only uridine 
fragments were built for the other eight UMPs in the Mth 14-mer). As with the Pae•UMP 
model, partial occupancies of UMP atoms were refined (0.2 < q < 1.5). All three Mth 
structures were refined to reasonable values of R/Rfree and model geometries (Table 3.1). 
Comparisons of known SmAP monomer, dimer, and heptamer structures 
 
 Several structures of Sm proteins and SmAPs are now available, and make 
possible the comparative structural analyses of these proteins. The previously reported 
Mth SmAP1 heptamer structure32 is virtually identical to the Mth structures reported here 
(0.65 Å RMSD for superimposition of the P1 heptamer using mainchain atoms). The 
results from pairwise comparisons of the Pae, Mth, and Afu SmAP1s are shown in Fig. 
3.1 and Table 3.2, and show that the compact, ≈ 80-amino acid SmAP monomer 
structures are nearly identical. The most similar monomer structures are the Afu/Mth pair 
(0.51 Å RMSD), and the most dissimilar are Mth/Pae SmAP1 (1.02 Å RMSD). These 
values do not correlate to pairwise sequence similarities. The increase in pairwise 
RMSDs in going from monomer alignments to dimers and heptamer alignments (Table 
3.2) suggests that there are slight rigid-body variations in the monomer orientations in the 
higher-order oligomers (i.e., slight variations in interfaces cause the RMSDs to propagate 
when comparing heptamers to dimers and dimers to monomers).  
The absolute conservation of the dimer interface in three different SmAP1s is 
emphasized by the view in Fig. 3.1. Sequence conservation is low for interfacial residues 
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relative to the rest of the SmAP monomer sequence; this is probably because the interface 
is largely formed by hydrogen bonding between mainchain atoms of the β4 strand of one 
monomer and the β5 strand of an adjacent monomer. The interface structure is also 
conserved between SmAPs and human Sm heterodimers.23 The main structural difference 
in the three SmAP1 heptamers is the width of the pore: ≈ 8-9 Å diameter for Pae versus ≈ 
12-15 Å in Mth and Afu. Such variation largely arises from differences in the structures of 
the pore-forming loops L2 and L4 (Fig. 3.1). Mapping of the phylogenetic conservation 
of SmAP residues onto the Pae, Mth, or Afu heptamer structures shows that most of the 
conserved residues cluster about the pore region (data not shown, Mura & Eisenberg). 
One of the least conserved features of the SmAP1 heptamer structures is the calculated 
electrostatic potential of the surfaces: the Pae and Mth heptamers display a strongly 
acidic L4 face, while the surface of the Afu heptamer is much more basic (ref. 23 for Pae, 
ref. 31 for Afu, and unpublished data for Mth, Mura & Eisenberg). 
Various oligomeric states of SmAP1, including sub-heptamers and 14-mers 
 
Biophysical characterization of Pae and Mth SmAP1 by a variety of methods 
reveals peculiar oligomerization properties. These methods include: mass spectrometry, 
size exclusion HPLC, native polyacrylamide gel electrophoresis (PAGE), and analytical 
ultracentrifugation. Sedimentation velocity ultracentrifugation revealed that wt Pae: (i) is 
monodisperse in solution; (ii) has a symmetric and narrow Gaussian-shaped distribution 
of sedimentation coefficients, with a coefficient at 20°C of S20,w = 6.49 S; and (iii) has a 
frictional coefficient ratio close to one (f/fo = 1.2, where f = experimentally derived 
frictional coefficient and fo = ideal frictional coefficient for a sphere with the MW of 
 59
SmAP1). These preliminary results suggested a roughly spherical, high-order Pae 
oligomer (SmAP1)n with n ≈ 12 ± 2 (data not shown, Mura, Phillips, & Eisenberg).  
The results of equilibrium sedimentation analyses of wt Mth, wt Pae, and the C8S 
mutant of Pae SmAP1 are shown in Fig. 3.2. Molecular weights were estimated by fitting 
experimental curves to single exponential models, and include a roughly 2-3% error 
(residuals are shown in the top panels). The calculated molecular weight of wt Pae 
suggests that it exists as a tetradecamer. Other data suggested a disulfide-bonded 14-mer 
(see Discussion), so the single cysteine of Pae SmAP1 was mutated to serine to give the 
C8S mutant of Pae SmAP1. Sedimentation results with this mutant can be fit only by 
species with molecular weights much less than that of a heptamer (e.g., the 46.7 kDa 
species shown in Fig. 3.2(b)), suggesting pentameric or hexameric states (n = 5 gives a 
MW of ≈ 45 kDa). The monodispersity of the data in Fig. 3.2(b) suggests a single, stable 
sub-heptameric complex. In contrast to Pae, sedimentation equilibrium data for Mth 
SmAP1 show that it only forms a stable, monodisperse heptamer (Fig. 3.2(c)). The 
concentration dependence of the experimentally calculated MWs (not shown), as well as 
the slight upward concavity of the residuals in Fig. 3.2(b) and 2(c), provide additional 
evidence for Pae and Mth SmAP1 monomer ↔ oligomer association reactions. 
Polymerization of SmAP1 into polar fibers 
 
 The polymerization of both Pae and Mth SmAP1 into well-ordered fibers was an 
unexpected result, and is shown in the transmission electron micrographs (EM) of Fig. 
3.3. Protein samples were in standard buffers (e.g., 25 mM Tris pH 7.5, 30 mM NaCl for 
Pae SmAP1), and reproducibly formed the striated sheets of fibers seen in these EMs. 
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Measurement of the sheet and fiber dimensions, together with the diameters of SmAP1 
heptamers from crystal structures (≈ 70-75 Å), suggests a model in which the fibers are 
formed by head-to-tail stacking of heptamers, with the SmAP1 7-fold axis roughly 
parallel to the fiber axis (see white arrows in Fig. 3.3(b)). Several fibers may associate 
laterally to form sheets, such as those seen most clearly in Figs. 3(a) and (b).  
In order to test this head-to-tail stacking model, we assayed fiber formation by wt 
Pae and the C8S mutant. Under oxidative conditions, wt Pae SmAP1 forms disulfide-
bonded 14-mers in which the highly acidic L4 faces are exposed at either end of the 
barrel-shaped structure (see the Pae 14-mer in Fig. 3.4(c)). Such a 14-mer would be 
constrained to form only head-to-head interfaces (i.e., loop L4 face-to-loop L4 face) in a 
fiber, and would probably not do so because of the unfavorable electrostatic cost of 
closely apposing these anionic faces (at least not at the neutral pHs or low ionic strength 
conditions in which the SmAP1s were buffered). As expected, wt Pae forms only ring-
shaped structures under oxidative conditions (Fig. 3.3(c)). However, when the seven 
disulfide bonds that link heptamers into 14-mers are eliminated, Pae SmAP1 assembles 
into fibers with roughly similar morphologies as Mth fibers. Polymerization can be 
achieved either by addition of a reducing agent (as in Fig. 3.3(d)) or by mutation of the 
cysteine (C8S mutant in Fig. 3.3(e)). Such fiber formation has been hitherto unreported 
for Sm proteins. 
Packing of Mth and Pae SmAP1 heptamers in four crystal forms 
 
 Crystallization of Mth and Pae SmAP1 in several forms is a fortuitous result, 
since different packing geometries of SmAP1 heptamers in these various crystal forms 
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shed light on the oligomerization results described above. The Pae SmAP1 C2221 
structure differs from the original C2 form in that heptamers pack face-face in the 
orthorhombic lattice to give a 14-mer with 72-point group symmetry. The crystal packing 
is shown in Fig. 3.4(a) and interacting surfaces are shown in Fig. 3.4(b). This 14-mer is 
likely to be significant because: (i) it is consistent with the oligomerization results 
described above from biophysical characterization, (ii) it persists in the C2221 lattice 
despite the requirement of DTT for crystallization (the sulfhydryls in Fig. 3.4(c) are 
separated by >8-9 Å), (iii) the heptamer-heptamer interface occludes 7,550 Å2 of surface 
area, and (iv) it is corroborated by an Mth 14-mer in the asymmetric unit of the P21 form. 
The total buried surface area in the heptamer interface of the P21 Mth 14-mer is probably 
significant (3,000 Å2), although less than half as much as the Pae interface.  
In the Mth P1 and P212121 lattices, SmAP1 heptamers form quasi-hexagonal 
layers that stack upon one another to give a crystal. In the P1 form these layers are 
staggered; however, in the P212121 form these layers are in register. Fig. 3.4(c) shows 
how the head-to-tail stacking of SmAP1 heptamers in this crystal form produces 
cylindrical tubes. A slight tilt of each heptamer (≈15°) with respect to the tube axis results 
in the SmAP1 7-fold axes being parallel, but not coaxial. Since they are formed by head-
to-tail stacking of asymmetric heptamers, these tubes have a defined polarity, and, when 
rendered as molecular surfaces, they bear a striking resemblance to the EM fibers shown 
in Fig. 3.3. The tubes are also consistent with EM fiber dimensions. Therefore, the 
P212121 crystal structure provides a model for the atomic structure of SmAP1 fibers. In 
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addition to providing insights into oligomerization states, two of the crystal forms (Pae 
C2221 and Mth P21) were used to investigate the ligand-binding properties of SmAP1s.  
Crystal structures of Mth and Pae SmAP1 bound to various ligands 
 
 The 1.90-Å resolution crystal structure of Mth SmAP1 bound to uridine-5’-
monophosphate (UMP) is shown in Fig. 3.5. The protein was co-crystallized with this 
ribonucleotide in an effort to determine its likely RNA-binding site (co-crystallization 
efforts were unsuccessful with single-stranded DNA or RNA oligonucleotides). As 
shown in Fig. 3.5(a), SmAP1 binds UMP with a 1:1 stoichiometry, so that 14 UMPs are 
bound to the 14-mer near the pore region. The orthogonal view in Fig. 3.5(a) shows that 
the UMPs are bound near the flat face of the heptamer, opposite the highly acidic loop L4 
face. The structure of the SmAP1•UMP complex is shown in more detail in Fig. 3.5(b), 
where it can be seen that the binding site is well defined by electron density. The uracil 
ring intercalates between the guanidinium group of Arg72 and the imidazole ring of 
His46 (both of these residues are highly conserved in SmAPs). The planes of these three 
moieties are spaced ≈ 3.6 Å apart, as expected for energetically favorable stacking 
interactions between these conjugated π-systems. Individual protein-UMP contacts are 
discussed in greater detail below.  
In addition to the expected UMP binding site, we found that each Mth SmAP1 
monomer binds a molecule of MPD. The MPD binding site is somewhat solvent-exposed, 
near the periphery of the SmAP1 ring (Fig. 3.5(a)). Protein-MPD recognition is the same 
in each of the 14-monomers, and is shown in detail in Fig. 3.5(c). The primary contact is 
hydrogen bonding between the Ser21 hydroxyl and MPD, and there are several water-
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mediated SmAP···H2O···MPD contacts. The cryoprotectant in the P1 and P212121 Mth 
SmAP1 structures was ethylene glycol (Table 3.1), and in these structures some of the 
SmAP1 monomers bind ethylene glycol in the same site as MPD. 
 A UMP binding site was found in the Pae SmAP1•UMP co-crystal structure as 
well, but it is not as clearly defined in electron density as for Mth SmAP1•UMP. Fig. 3.6 
shows the Pae•UMP structure, which was refined to a resolution of 2.05-Å. UMPs bind 
to the same face of the heptamer as in Mth (i.e., the “flat face” opposite L4), but are much 
more distant from the pore. As shown by the 2Fo – Fc maps in Fig. 3.6(b), only the planar 
uracil fragment of UMP is clearly defined in electron density. Protein-UMP contacts are 
scarce in this binding site. Asn46···UMP distances are shown by dashed lines in Fig. 
3.6(b) only for the sake of completeness – the geometries of these interactions do not 
satisfy standard hydrogen bond criteria (in terms of both distances and angles), and 
favorable interactions probably do not exist between the UMP O4 oxygen and the amide 
nitrogen of the Asn46 side chain or between the UMP N3 nitrogen and the amide oxygen 
of Asn46. Also, there are no aromatic side chains in this region to participate in π-
stacking interactions with the uracil base. As with Mth SmAP1, additional small-
molecule binding sites exist in Pae SmAP1: many of the modeled glycerol molecules are 
bound identically near the loop L4 faces (see Fig. 3.6(a)). The significance of such 
binding sites is unknown.  
The structure of an Afu SmAP1•U3 complex was determined recently by Törö et 
al.,31 and permits a comparison of the mode of uridine recognition in Afu and Mth 
SmAP1. The UMP binding site and SmAP1···UMP interactions clearly differ in Mth and 
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Pae SmAP1, and, since the binding site was poorly resolved in the Pae•UMP complex, 
this structure was not included in the comparative analysis shown in Fig. 3.7. In the Mth 
and Afu structures, the aromatic pyrimidine ring intercalates between the side chains of 
the highly conserved Arg/His pair, and specific uracil recognition is achieved by 
hydrogen bonding of the uracil ring to the side chain of a strictly conserved asparagine 
residue (Asn48Mth). The main chain amide nitrogen of a highly conserved aspartate 
(Asp74Mth) also participates in hydrogen bonding to a uracil carbonyl oxygen. The pattern 
of hydrogen bond donors/acceptors in the Asn48/Asp74Mth pair makes binding specific 
for a uracil (if RNA) or thymine (if DNA) base. Additional specificity for uracil may be 
achieved by two means: (i) recognition of the 2’ hydroxyl of the ribose (RNA versus 
DNA discrimination) and (ii) the C5 carbon of the pyrimidine ring of uracil is only 3.8 Å 
from the backbone carbonyl oxygen of Leu45Mth from an adjacent monomer, thus 
providing steric and polar discrimination against the methyl on the C5 carbon of thymine. 
We crystallized Pae and Mth SmAP1 in the presence of various other nucleoside 
monophosphates (e.g., AMP, CMP, GMP), but there was no evidence for binding of 
these non-uridine NMPs (data not shown, Mura & Eisenberg). The only significant 
differences in uridine recognition by Mth and Afu SmAP1 are highlighted by green 
arrows in Fig. 3.7(b). These are: (i) hydrogen bonding of an Mth Arg72 side chain from 
an adjacent monomer to the 2’ hydroxyl of the ribose, and (ii) hydrogen bonding between 
a phosphate oxygen and an imidazole nitrogen from the His46 residue of an adjacent 
monomer. Overall, it appears that the mode of uridine recognition is conserved in the 
SmAP family.  
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Pae and Mth SmAP1 gel-shift negatively supercoiled DNA 
 
 In our initial attempts to determine the biochemical function of Pae SmAP1, we 
inadvertently found that this protein gel-shifts supercoiled plasmid DNA. This activity 
was further investigated for both the Mth and Pae SmAP1s, and examples of it are shown 
in Fig. 3.8. Migration of the negatively supercoiled plasmid “p5L1c1” is severely 
retarded by incubation with μM amounts of Mth heptamer in Fig. 3.8(a). Interestingly, 
the extent of gel-shift increases at higher concentrations of Mth SmAP1, until saturation 
of the effect occurs at ≈ 60 μM (compare lanes 7 and 8). A similar gel-shift occurs to 
supercoiled DNA when it is incubated with wt Pae SmAP1, as shown in lane 4 of Fig. 
3.8(b). This experiment also shows that the gel-shift can be eliminated by incubation with 
a 26-nucleotide single stranded DNA (ssDNA). Inhibition of the gel-shift activity is 
titratable, and at higher concentrations of ssDNA there is no gel-shift (lane 8).     
 Similar DNA gel shift assays and control experiments have revealed that: (i) the 
Pae activity is specific for supercoiled (sup) plasmid DNA, whereas Mth SmAP1 gel-
shifts both sup and linearized (lin) plasmids; (ii) Pae activity is eliminated by MgSO4, 
whereas the dependence of Mth activity on divalent metals such as Ca2+, Mg2+, and Mn2+ 
is not as straightforward; (iii) ssDNA of any sequence and length >≈ 20-nt inhibits the 
gel-shift activity of Pae and Mth in a concentration dependent manner; (iv) both Pae and 
Mth activities are nonspecific with respect to the sup DNA; (v) Pae and Mth are not 
linearizing or otherwise cutting both strands of the sup DNA; (vi) Mth gel shift activity is 
not temperature-dependent at and above room temperature, whereas the extent of Pae-
induced gel shift abruptly increases at ≈ 55-60°C. All of these results come from 
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experiments in which the migration of a large (>4,000 nt) plasmid DNA is assayed in 
agarose gels. Binding of Mth SmAP1 to any one of the ssDNAs that inhibit the sup DNA 
gel shift (e.g., Fig 8(b)) has been assayed in preliminary native PAGE experiments; these 
results suggest that ssDNA inhibits the sup DNA gel shift by directly binding to SmAP1. 
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Discussion 
 
Comparative structural analysis of Sm proteins and SmAPs 
 
Recent work has shown that SmAPs form a phylogenetically well-conserved 
family of proteins whose sequences are similar to eukaryotic Sm and Lsm proteins, and 
whose structures are nearly identical to the human Sm D3•B and D1•D2 heterodimer 
structures.32,23,31 The Sm and SmAP monomers form antiparallel, five-stranded β-sheets 
capped by a short N-terminal α-helix. The Sm β-sheet is highly bent, into a β-barrel like 
structure that closely resembles proteins of the oligosaccharide/oligonucleotide binding 
(OB) fold family.43 As shown by Fig. 3.1 and Table 3.2, the Afu, Mth, and Pae SmAP1 
monomers and homodimers are nearly identical to one another. Besides the N- and C-
termini, the only significant deviations in Sm and SmAP monomer structures occur in the 
loops: the L2 and L4 loops are the most structurally variant regions in Fig. 3.1, and 
several eukaryotic Sm proteins have insertions of up to 30 amino acids in loop L4. Work 
in progress with another SmAP homolog that contains a similar L4 insertion (Pae 
SmAP3) shows that it too forms heptamers. The recent solution structure of the SMN 
Tudor domain, which interacts with Sm proteins to form snRNP cores, has provided an 
unexpected result: the SMN and Sm monomers have the same fold, and nearly identical 
structures.10 This raises the intriguing possibility that the SMN protein interacts with the 
Sm complex by forming mixed heteromers. Overall, there is a high degree of 
phylogenetic and structural conservation of the SmAP domain from archaea to 
eukaryotes 
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Afu, Mth, and Pae SmAP1s form heptamers with remarkably similar structures, 
primarily because the structure of the homodimer interface is extremely well conserved 
(Fig. 3.1). Greater RMSDs for heptamers compared to dimers (and dimers compared to 
monomers) shows that a large fraction of the structural variation in higher-order SmAP 
oligomers (Table 3.2) is due to rigid-body displacements of monomers with respect to 
one another. A feature of the SmAP1 heptamers that is highly conserved in terms of 
sequence and overall structure is the central cationic pore. The largest difference between 
SmAP monomers (L2, L4 loops) results in the largest difference between SmAP 
heptamers: variation in the width of the pore in Pae (≈ 8-9 Å diameter) versus Afu and 
Mth (≈ 12-15 Å) is due to main chain and side chain rotamer variations in the L2 and L4 
loops. The other significant difference between Afu, Mth, and Pae SmAP1s is the 
calculated electrostatic potential of the heptamer surface: the L4 face of the Afu surface is 
very basic, while these Pae and Mth faces are intensely acidic. Such differences are likely 
to be important for modulating putative SmAP-RNA interactions. Overall, the near 
identity of the human Sm D3•B and D1•D2 heterodimers to Afu, Mth, and Pae SmAP 
homodimers qualifies the SmAP1 homoheptamer as an accurate model for the Sm 
heteroheptamer of eukaryotic snRNP cores. 
The oligomerization properties of SmAPs 
 
Like the Lsm (but not Sm) proteins, Pae, Mth, and Afu SmAP1 form heptamers in 
the absence of RNA. We also found that SmAP1 exhibits complex self-association 
properties that result in 14-mers and sub-heptameric oligomers, in addition to the 
expected heptamers. Various oligomeric states were characterized in vitro (primarily by 
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ultracentrifugation, Fig. 3.2), revealing roughly spherical disulfide-bonded Pae SmAP1 
14-mers and a monodisperse population of Mth SmAP1 heptamers. Additionally, we 
created a cysteine-free point mutant of Pae SmAP (C8S), and found that it forms sub-
heptameric states (most likely pentamers). Interestingly, similar plasticity of 
oligomerization behavior has been reported for human Sm proteins. Lührmann et al. 
found that a human Sm E•F•G complex forms a stable oligomer – most likely a (E•F•G)2 
hexamer – whose ring-shaped structure resembles intact Sm heteroheptamers by EM.17,30 
One of these studies also found that stable, sub-heptameric complexes of human Sm 
proteins (e.g., a D1•D2•E•F•G pentamer) may be intermediates in the Sm-RNA assembly 
pathway.17 Recently, another Afu SmAP was reported to form hexamers (personal 
communication cited in ref. 29), and in the structure of the human Sm D3•B the 
heterodimers pack as (D3•B)3 hexamers in the asymmetric unit of the crystal.  
We found that Pae and Mth SmAP1 reproducibly oligomerize into 14-mers, either 
in vitro (Pae) or in various crystal forms (Pae and Mth). The highly acidic L4 faces are 
exposed in the barrel-shaped 14-mers (Fig. 3.4), as expected from electrostatics. The 
heptamer-heptamer interface buries a large amount of surface area in both Pae (7,550 Å2) 
and Mth (3,005 Å2), suggesting the significance of these oligomers. Preliminary 
crystallographic data from another SmAP homolog (Pae SmAP3) show that it also forms 
14-mers in the asymmetric unit (unpublished results, Mura & Eisenberg). The propensity 
of ring-shaped SmAPs to crystallize as head-head oligomers with dihedral symmetry is 
shared by another single-stranded RNA binding protein: the trp RNA-binding attenuation 
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protein (TRAP) forms a toroidal 11-mer that forms both head-head and head-tail 22-mers 
in the crystal44 (in fact, the structures of Sm and TRAP monomers are quite similar).        
 Perhaps the most novel property of SmAP1s is their polymerization into 
extremely well-ordered fibers. Pae and Mth SmAP1 samples at physiological conditions 
form these fibers, which we observe by EM. Three lines of evidence suggest that these 
fibers form by the head-to-tail stacking of heptamers (Fig. 3.3): differential fiber 
formation by C8S and wt Pae SmAP1, comparison of measured fiber dimensions with 
SmAP1 heptamer dimensions, and electrostatic considerations for the packing of highly 
charged heptameric disks. The packing of Mth SmAP1 heptamers in the P212121 lattice 
supports our head-to-tail polymerization model, and provides an atomic-resolution 
structure for the fibers (Fig. 3.4). Such peculiar oligomerization properties have not been 
reported for eukaryotic Sm proteins, and the biological significance of SmAP1 14-mers 
and homogeneous, fibrillar polymers is not yet known.  
Comparison and analysis of the ligand-binding properties of SmAPs 
 
 Comparison of the structures of Mth SmAP1 bound to UMP and Afu SmAP1 
bound to oligouridine (U3) suggest a highly conserved mode of RNA recognition in 
SmAPs. UMP binds near the 7-fold axis, suggesting the pore as a putative RNA binding 
site. Diagrams of SmAP1···UMP interactions show that these proteins specifically bind 
the uracil base by a combination of π-stacking and hydrogen bond interactions with 
strictly conserved SmAP residues (Fig. 3.7). Differences between UMP binding in Mth 
and Afu are limited to interactions with the ribophosphate moiety, and may not be 
significant since Mth SmAP1 was co-crystallized with free UMP nucleotide, whereas Afu 
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SmAP1 was crystallized with a U3 oligouridine. The oligo(U) specificity of RNA binding 
to Afu SmAP1 mimics the substrate specificity of eukaryotic Sm proteins.45,31 The 
geometry of binding of several of the UMPs in Mth SmAP1 allows them to be strung 
together into a hypothetical oligouridine that may mimic biologically relevant RNA 
binding in the Sm core of snRNPs. Failure of other NMPs to co-crystallize with Mth or 
Pae SmAP1 supports the specificity of uridine binding that we infer from the crystal 
structures.   
 In addition to the Mth UMP-binding site, several other ligand-binding sites exist 
in Mth and Pae SmAP1. Unlike the well-defined UMP site in Mth, the uridine-binding 
site in Pae is distant from the pore and not easily interpretable in electron density maps, 
suggesting low affinity binding at this site (Fig. 3.6). Also, the Pae SmAP1 residues in 
the region of this uridine are not very conserved. If all SmAPs specifically bind to an 
oligouridine site in RNA in vivo, then geometric considerations require any such RNA to 
bind near the 7-fold symmetry axis (i.e., the pore), and therefore the Pae binding pocket 
described here cannot be biologically relevant. Presumably, breaking of 7-fold symmetry 
in eukaryotic Sm heteroheptamers is reconcilable with RNA binding away from the pore 
(although there is no evidence for this). We note that the UMP-binding site in Afu and 
Mth exists in Pae SmAP1, and that UMP can be docked into this putative Pae binding 
site with only minimal changes required for side chain rotamers. We also found other 
sites in Mth and Pae occupied in each monomer by MPD, ethylene glycol, or glycerol. 
Though these ligands are clearly defined by electron density and many of the residues in 
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these binding sites are phylogenetically conserved, any biological significance of these 
additional sites is not yet clear.  
 The gel-shift activity of Mth and Pae SmAP1 on negatively supercoiled DNA 
substrates (Fig. 3.8) is especially interesting given the similarity of SmAP monomers to 
the OB fold. We found that SmAP1s non-specifically gel-shift a variety of supercoiled 
DNA substrates and that ssDNA oligonucleotides of >20-nt inhibit the gel-shift (Fig. 
3.8(b)), possibly by direct binding to SmAP1. Since eukaryotic Sm proteins bind to 
ssRNA, and since SmAP homoheptamers probably do not function identically to Sm 
heteroheptamers, we propose that SmAPs may have a generic single-stranded nucleic 
acid binding activity (e.g., as a nucleic acid chaperone). The striking resemblance of the 
SmAP and OB folds corroborates this idea, given that several OB-fold proteins bind to 
ssDNA non-specifically. The following recently determined structures are all very similar 
(and in some cases nearly identical) to the Sm fold: the single-stranded DNA-binding 
domain of replication factor A,46 the S1 RNA-binding domain,47 the single-stranded 
telomeric DNA binding protein,48 and the Streptococcus pneumoniae SP14.3 protein 
(which is fused to a domain that is homologous to ribosomal protein S3).49   
Emerging differences between SmAPs and canonical Sm proteins 
 
 Eukaryotic Sm and Lsm proteins and their archaeal homologs, which we term 
Sm-like archaeal proteins, share a number of structural and functional features. Most 
significant is the similarity in Sm and SmAP 3D and quaternary structures: the monomers 
are nearly identical, and the SmAP homoheptamer parallels the Sm heteroheptamer that 
forms snRNP cores. Also, both sets of proteins apparently bind specifically to 
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oligouridine-containing RNA. However, several differences are emerging between 
SmAPs and the canonical Sm proteins. The results presented here show that SmAPs 
associate into many oligomeric states besides the standard heptamer (e.g., 14-mers and 
sub-heptamers), and can polymerize into homogeneous fibers. Such behavior is 
unreported for eukaryotic Sm proteins. No structural information is available for Sm 
proteins bound to RNA (or any other ligand), so it is difficult to evaluate the similarity of 
uridine binding by eukaryotic Sm proteins and SmAPs. Cross-linking experiments 
corroborate RNA binding near the pore in human Sm heptamers.50 The near identity of 
the Sm and SmAP dimer structures, as well as the strictly conserved mode of uridine 
recognition between Afu and Mth SmAP1, suggest that the SmAP1 UMP-binding site is 
an accurate model for RNA binding in the snRNP core. In this model, snRNA wraps 
around the circumfrence of the pore, but does not thread through it. Further elucidation of 
the similarities and differences between archaeal SmAP complexes and the Sm cores of 
eukaryotic snRNPs will be the aim of future experiments, and will provide insight into 
the structure and assembly of snRNPs. 
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Figure and Table legends 
 
Table 3.1: Statistics for several crystal forms. Crystallographic statistics are given for 
the Mth and Pae SmAP1 structures in different spacegroups (with various packing 
geometries) and with bound ligands (UMP, MPD, etc.). Data were collected either in-
house (λ = 1.54 Å) or at the synchrotron (λ = 1.10 Å). Statistics for the highest resolution 
shell are given in [square brackets]. Rcryst = Σhkl ||Fobs| – |Fcalc|| / Σhkl |Fobs|, and Rfree was 
computed identically, except that 5% of the reflections were omitted as a test set. Non-
protein molecules were added based on the chemical composition of the crystallization 
condition and sufficiently strong Fo – Fc density (>3σ). 
Table 3.2: Pairwise RMSDs between Pae, Mth, and Afu SmAP1. RMSDs are shown 
for pairwise 3D alignments of Pae, Mth, and Afu SmAP1 monomers, dimers, and 
heptamers (using mainchain atoms only). The Afu-Mth pair superimposes best, while the 
Pae-Mth monomer structures are most dissimilar.  
Figure 3.1: 3D structural alignment of Pae, Mth, and Afu SmAP1 dimers. A depth-
cued stereoview is shown of the Cα trace for aligned Pae (red hues), Mth (blue hues), 
and Afu (green hues) SmAP1 dimers. N- and C-termini, as well as loops L2 and L4 are 
indicated. The greatest structural variation is in the positions of these two pore-forming 
loops, and the dimer interface is strictly conserved (asterisks). The large difference in the 
width of the heptameric pores in Pae (≈8-9 Å diameter) versus Afu and Mth (≈12-15 Å 
diameter) is due to two structural features: (i) side chain variation: the position of the 
positively-charged, pore-lining side chain R29 is extended into the pore in Pae, but K31 
extends along the direction of the pore in Mth, and (ii) backbone variation: the distance 
 80
between identical Cα atoms in loop L2 of the seven monomers is greater in Mth than in 
Pae, i.e., the backbone protrudes further into the pore in the Pae heptamer. 
Figure 3.2: The oligomeric states of Pae and Mth SmAP1s in solution. 
Representative sedimentation results for analytical ultracentrifugation of wt Pae 
SmAP1 (a), the C8S mutant of Pae SmAP1 (b), and wt Mth SmAP1 (c) are shown. 
Data were collected at 20°C, at a rotor speed of 12,500 rpm, with absorbance measured 
at 280 nm. Protein concentrations were 0.69 mg/ml (a), 1.26 mg/ml (b), and 0.85 
mg/ml (c). Weight-average molecular weights (given in kDa) were determined by 
fitting experimental data (circles) with a single exponential (solid line), and include 
roughly 2-3% error (residuals are in top panels); note that the protein samples are 
monodisperse. The molecular weight of the wt Pae protein suggests that it exists as a 
14-mer, while the wt Mth data closely fits a heptamer. The molecular weight of the 
C8S mutant is significantly less than that of a heptamer, suggesting that it may exist in 
lower oligomerization states (4-, 5-, or 6-mers). Such heptamer "subcomplexes" have 
been detected for eukaryotic Sm proteins (see text for details). 
Figure 3.3: Polymerization of SmAP1s into polar fibers. Transmission EMs are shown 
for wt Mth (a, b), wt Pae (c oxidized, d reduced), and the C8S mutant of Pae SmAP1 (e). 
The scale bar represents 10 nm for panel (c), and 50 nm for all other panels. The striated 
sheets formed by Mth SmAP1 (a, b) and non-disulfide bonded Pae SmAP1 (d, e) are 
extremely well ordered. The distance between the inner arrow tips in (b) corresponds to ≈ 
8.3 nm (in agreement with the heptamer diameters from crystal structures), and suggests 
that the fiber axis is parallel to the heptameric 7-fold. The ≈ 50 nm distance between the 
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outer white arrows in (b) corresponds closely to six heptamer widths. Together with 
heptamer packings in various crystal forms, these EMs suggest that SmAP1 fibers form 
by head-to-tail stacking of heptamers (see Fig. 3.4). Doughnut-shaped SmAP1s are 
visible in the background of these EMs (most clearly for the wt Pae sample in panel (c)). 
Figure 3.4: Various crystalline oligomers of Pae and Mth SmAP1. Panel (a) provides 
orthogonal views of the quasi-hexagonal packing of Mth SmAP1 heptamers in the 
P212121 crystal form. Heptamers stack upon one another to form cylindrical tubes, thus 
providing a model for the structure of the EM fibrils (see text for explanation). The head-
to-tail association of heptamers gives the tubes a defined polarity (colored arrows). 
Molecular surfaces show that the lateral packing of tubes in the crystal may generate the 
striated sheets seen by EM. A unit cell of the Pae SmAP1 C2221 crystal form is shown in 
(b), along with examples of crystallographic 2-fold and 21 screw axes. The asymmetric 
unit is a heptamer (shown as Cα traces in red or blue), and a Pae SmAP1 14-mer is 
formed from adjacent asymmetric units as shown in (c). Interaction surfaces and 
cysteines are illustrated. The 14-mer has 72-point group symmetry, with a 2-fold axis 
coinciding with a crystallographic 2-fold, and buries 7,547 Å2 of surface area at the 
heptamer-heptamer interface. 
Figure 3.5: Ligand-binding sites in the structure of the Mth 14-mer bound to UMP. 
Orthogonal views are shown for the two Mth heptamers (red, blue) in the asymmetric unit 
of the P21 form (a). A single molecule of MPD binds identically to each monomer, and is 
shown in space-filling (colored by atom type, yellow carbons). Space-filling models of 
the 14 UMP ligands show that they bind in the pore region (colored by atom type, gray 
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carbons). Electron densities for the UMP and MPD binding sites are shown in (b) and (c), 
respectively. The 2Fo – Fc density is contoured at +1.2σ (green) and Fo – Fc maps are 
contoured at –3.2σ (red) or +3.2σ (blue). Conserved residues that form these ligand-
binding sites are labeled, and residues from different monomers are distinguished by 
primes. Hydrogen-bond distances are not shown in (b) for the sake of clarity (see Fig. 3.7 
and the text for details of the SmAP1-ligand interactions).     
Figure 3.6: Ligand-binding sites in the structure of the Pae 14-mer bound to UMP. 
Orthogonal views are shown in (a) for the Pae SmAP1 14-mer that is found in the C2221 
lattice (heptamer per asymmetric unit). Ten glycerol molecules bind to each heptamer 
(shown in space-filling, green-colored carbons), and seven of them occupy identical sites. 
The uridine fragments of UMP were modeled, and are shown in space-filling (gray-
colored carbons). Electron density for one of the UMP-binding sites is shown in (b), 
contoured at +1.2σ for 2Fo – Fc density (green) and at +/–3.2σ for Fo – Fc density 
(blue/red). While electron density for the uracil moiety is clearly defined, this ligand-
binding site may not be a biologically relevant RNA-binding site (see text for discussion). 
Figure 3.7: Conserved mode of uridine recognition by Mth and Afu SmAP1. 
Interactions between SmAP1 and uridine are diagrammed for Afu (a) and Mth (b). The 
remainder of the U3 oligouridine from the Afu structure (indicated by a U2~~) has been 
omitted in (a) for the sake of clarity.31 Parenthesized letters after residue labels denote 
individual monomers. In both structures, the aromatic uracil base intercalates between a 
highly conserved pair of Arg/His side chains – e.g., the guanidinium of Arg72 and 
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imidazole of His46 for Mth SmAP1. Specific interactions and differences between Afu 
and Mth are discussed in the text. This figure was derived from a LIGPLOT51 output.  
Figure 3.8: Gel-shift of supercoiled DNA by Mth and Pae SmAP1. The ability of Mth 
and Pae SmAP1 to shift the electrophoretic mobility of supercoiled plasmid DNA is 
shown in the agarose gels of (a) and (b), respectively. In (a), increasing concentrations of 
Mth SmAP1 were incubated with a negatively supercoiled plasmid (“p5L1c1”). The first 
onset of gel-shift is apparent at the lowest concentration of Mth (1.1 μM heptamer, arrow 
in lane 3), and saturates by the highest concentration (60 μM, lane 8). The ability of a 26-
nucleotide ssDNA to inhibit the gel-shift induced by Pae SmAP1 is shown in (b). Lane 1 
provides a DNA ladder, lanes 2 and 3 serve as negative controls, and the arrow in lane 4 
shows the maximal gel-shift in the absence of ssDNA (which may inhibit the gel-shift by 
binding to SmAP1). 
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Table 3.1: Statistics for several crystal forms. 
 
Crystal form P1 (Mth) P21 (Mth with UMP) P212121 (Mth) C2221 (Pae with UMP) 
Data collection     
X-ray wavelength (Å) 1.1000 1.1000 1.5418 1.5418 
Resolution range (Å) 90.0 – 1.85 100.0 – 1.90 100.0 – 2.80 100.0 – 2.05 
# reflections (total / unique) 145,416 / 44,472 337,336 / 89,378 329,838 / 28,487 330,687 / 40,722 
Completeness (%) 93.8 [67.4] 97.0 [92.4] 99.0 [92.5] 97.4 [95.5] 
I / σ(I) 20.4 [4.1] 25.8 [2.3] 19.3 [3.3] 17.9 [4.1] 
Rmerge (%) 5.4 [25.5] 4.8 [56.5] 11.2 [38.7] 11.5 [50.9] 
Molecular replacement     
Search model Homology model of Pae SmAP1 structure (1I8F) 
Refined P1 Mth SmAP1 
structure (1JBM) 
Refined P1 Mth SmAP1 
structure (1JBM) 
Refined C2 Pae SmAP1 
structure (1I8F) 
Search method 
Search w/ EPMR, then ARP/ 
wARP of polyalanine-ized 
version (to reduce model bias) 
EPMR EPMR  EPMR 
Crystal packing Heptamer per a.u. 
Face-face tetradecamer 
per a.u. (pseudo-72 point 
group symmetry) 
Edge-edge tetradecamer 
per a.u. 
Heptamer per a.u.; face-face 
tetradecamer in crystal (72 
point group symmetry) 
Model refinement     
Resolution range (Å) 20.0 – 1.85 20.0 – 1.90  15.0 – 2.80 20.0 – 2.05 
<B-factor> (prot / water, Å2) 27.9 / 37.2 41.7 / 48.6 50.9 / 40.1 25.1 / 34.8 
water 273 water 387 water 86 water 325 
ethylene glycol 11 MPD 14 ethylene glycol 13 glycerol 10 
acetate 5 UMP 14 chloride 3 acetate 2 
Number of solvent  
or ligand molecules  
included in model: 
      UMP 7 
RMSDs:  bonds (Å) 0.021 0.014 0.007 0.013 
 angles (º) 2.06 1.85 1.44 1.61 
PDB code for submission 1JBM 1LOJ 1JRI 1LNX 
Rcryst / Rfree, (%) 19.6 / 23.8 20.7 / 25.0 19.9 / 29.0 18.2 / 22.6 
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Figure 3.1: 3D structural alignment of Pae, Mth, and Afu SmAP1 dimers. 
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Table 3.2: Pairwise RMSDs between Pae, Mth, and Afu SmAP1. 
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Figure 3.2: The oligomeric states of Pae and Mth SmAP1 in solution.  
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Figure 3.3: Polymerization of SmAP1s into polar fibers.  
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Figure 3.4: Various crystalline oligomers of Pae and Mth SmAP1.  
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Figure 3.5: Ligand-binding sites in the structure of the Mth 14-mer bound to UMP.  
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Figure 3.6: Ligand-binding sites in the structure of the Pae 14-mer bound to UMP.  
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Figure 3.7: Conserved mode of uridine recognition by Mth and Afu SmAP1.  
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Figure 3.8: Gel-shift of supercoiled DNA by Mth and Pae SmAP1.  
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Chapter 4: 
 
The structure and potential function of an archaeal homolog of  
survival protein E (SurEα) 
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Abstract 
 
The survival protein E (SurE) family was discovered by its correlation to 
stationary phase survival of Escherichia coli and various repair proteins involved in 
creating this and other stress-response phenotypes. In order to better understand the 
structures and functions of this ancient and well-conserved protein family, we have 
determined the 2.0 Å-resolution crystal structure of SurEα from the hyperthermophilic 
crenarchaeon Pyrobaculum aerophilum (Pae). This first structure of an archaeal SurE 
reveals significant similarities and differences to the only other known SurE structure, 
that from the eubacterium Thermatoga maritima (Tma). Both SurE monomers adopt 
similar folds; however, unlike the Tma SurE dimer, crystalline Pae SurEα is 
predominantly non-domain swapped. Comparative structural analyses of Tma and Pae 
SurE monomers suggest conformationally variant regions, such as a hinge loop that may 
be involved in domain swapping. The putative SurE active site is highly conserved, and 
implies a model for SurE bound to one of its substrates, Guanosine-5’-monophosphate 
(GMP). Analyses of the sequences, phylogenetic distribution, and genomic organization 
of the SurE family reveal examples of genomes encoding multiple surE genes, and 
suggest that SurE homologs may constitute a broad family of enzymes with phosphatase-
like activities.  
 
 
 
Abbreviations: SurE, survival protein E; Pae, Pyrobaculum aerophilum; Tma, Thermatoga 
maritima; GMP, Guanosine-5’-monophosphate; MAD, multi-wavelength anomalous dispersion; 
SeMet, L(+)-selenomethionine; (non-)DS, (non-)domain swapped; RMSD, root mean square 
deviation; DDM, error-scaled difference distance matrix; Mbp, mega-base pairs; nt, nucleotide; 
ORF, open reading frame 
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Introduction 
 
The survival protein E (SurE) family was discovered nearly ten years ago by Clarke 
and colleagues by its correlation to stationary phase survival of E. coli and various repair 
proteins thought to be involved in creating this stress-response phenotype, e.g., protein-L-
isoaspartate(D-aspartate)-O-methyltransferase (pcm, EC 2.1.1.77).1 The E. coli surE gene 
lies immediately upstream of the pcm gene, overlapping it by four nucleotides; together, 
these genes are thought to form a bicistronic operon that is essential for E. coli viability 
under stressful conditions, such as elevated temperatures, osmotic stress, or high cell 
density. The surE and pcm genes are co-transcribed as detected by in vitro transcription 
assays,1 although each gene may also be transcribed independently from its own 
promoter.2 Several bacteria contain an additional conserved gene of unknown function 
(ORF0) directly upstream of surE. Taken together, these several genes are thought to 
cluster into a stationary phase stress-survival operon, surE-pcm-nlpD-rpoS, where nlpD is 
an outer-membrane lipoprotein gene and rpoS encodes an alternative RNA polymerase σ 
factor (σs) that plays a regulatory role by inducing the transcription of several other 
stationary phase survival genes.3  
The results of Visick et al. (1998) showed that both the surE and pcm genes are 
ancient and well-conserved, with orthologous genes being found in several eubacterial 
and archaeal species.4 The only prokaryotes in which a surE gene is not found are gram-
positive bacteria and mycobacteria. The phylogenetic distribution of surE genes is 
apparently more extensive than was initially thought, with SurE homologs having been 
found in eukaryotes ranging from simple protozoa (e.g., the yeast Saccharomyces 
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cerevisiae) to metazoa (e.g., Arabidopsis thaliana). The results reported here emphasize 
the distribution and genomic organization of surE genes in the archaea.  
The increased accumulation of isoaspartyl damage and diminished viability of 
stationary phase E. coli that have various combinations of surE and pcm mutations 
further supports the idea that these two proteins interact either directly or indirectly (or in 
parallel pathways) to provide a stress-survival phenotype: pcm/surE double mutants 
accumulated much higher levels of isoaspartyl residues than did the parent strain or either 
single mutant, and a surE null mutation was able to suppress stress-survival defects in a 
pcm mutant strain.4 Recently, it was shown that the stress-survival operon noted above 
(surE•••rpoS) was duplicated by several E. coli strains that were evolved over 2000 
generations at high temperatures.5 Moreover, the few E. coli strains which adapted to 
high temperatures without duplicating this surE-including region did display elevated 
expression from their single surE gene. A conclusion of these results is that surE plays a 
significant physiological role in stress-response.          
The earliest hint about the biochemical function of SurE came from genetic 
experiments with a protein from the yeast Yarrowia lipolytica. This Y. lipolytica protein 
(P30887, or PHO2) bears weak sequence similarity to the N-terminal domain of the SurE 
family, and was found to complement mutations in two of the major acid phosphatases of 
S. cerevisiae.6 Because of its lack of sequence similarity to known phosphatases (or any 
other functionally characterized protein), PHO2 was described as a novel acid 
phosphatase. Most recently, the crystallographic and biochemical work of two groups has 
illuminated both the structure and function of SurE in greater detail. Lee et al. (2001) and 
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Zhang et al. (2001) independently determined the crystal structure of a SurE homolog 
from the eubacterium Thermatoga maritima (Tma).7,8 Their primary findings were that: 
(i) the Tma SurE monomer consists of an N-terminal globular domain of ≈ 180 residues 
that resembles a Rossmann fold and a novel, extended C-terminal region of ≈ 70 
residues; (ii) monomers assemble into dimers (and possibly tetramers) with extended C-
terminal α-helices that domain swap; (iii) Tma SurE exhibits a divalent cation-dependent 
acid phosphatase activity that is inhibited by vanadate or tungstate; (iv) divalent metal 
ions bind in a putative conserved active site; and (v) the Tma enzyme shows no protease 
or nuclease activity, but has a slight preference for Guanosine-5’-monophosphate (GMP) 
or Adenosine-5’-monophosphate substrates. These results suggested for the first time that 
SurE may be a novel acid phosphatase. 
In order to better understand the structures and functions of members of this ancient 
and well-conserved protein family, we determined the 2.0 Å-resolution crystal structure 
of SurEα from the hyperthermophilic crenarchaeon P. aerophilum (Pae, Tmax = 104°C).9 
Comparison to the eubacterial Tma SurE structure reveals several significant similarities 
and differences between these SurEs; such comparison are justified because the Pae 
structure was determined independently of Tma, by multi-wavelength anomalous 
dispersion (MAD) phasing. An analysis of the phylogenetic distribution and genomic 
organization of surE genes is also provided, and these results are discussed in terms of 
the SurEα structure and its likely biochemical function. 
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Materials and Methods 
 
Cloning, expression, and purification of Pae SurEα 
 
A genomic phosmid clone that contained the Pae SurEα open reading frame was 
kindly provided by the laboratory of Jeffrey H. Miller (UCLA). Using its DNA sequence, 
we designed the following primers (Invitrogen/Life Technologies, Inc.) for polymerase 
chain reaction (PCR) amplification with Deep VentR polymerase (New England Biolabs):  
5’GGCCATATGAAGATCTTGGTCACTAATG 3’ (sense) 
5’AAGCTTTGATAGCGACGCGTTAATGTAC 3’ (antisense) 
 
Blunt-end PCR products were cloned into a pET-22b(+) expression vector (Novagen) via 
intermediate subcloning into the pCR-Blunt vector (Invitrogen). DNA sequencing (Davis 
sequencing, Inc.) of transformants into chemically-competent NovaBlue E. coli 
(Novagen) verified that the cloned protein would be identical to wild-type (wt) SurEα, 
except for the addition of the following 14-residue His-tag to the C-terminus: 
SKLAAALEHHHHHH. Due to rare usage of the arginine codons AGG and AGA in E. coli, 
Pae SurEα was over-expressed only after co-transformation with a tRNAArg-encoding 
vector (see the rare codon calculator at http://www.doe-mbi.ucla.edu/cgi/cam/racc.html). 
Otherwise, the recombinant protein was over-expressed in BL21(DE3) E. coli at 37˚C by 
standard protocols using 1 mM isopropyl-β-D-thiogalactoside (IPTG) induction of the 
T7lac-based promoter. Approximately 10 mg of soluble protein were expressed per liter 
of cell culture. Selenomethionine (SeMet)-substituted SurEα was prepared for MAD 
phasing in exactly the same way as the wild-type protein, except that the expression was 
performed in M9 minimal media supplemented with SeMet (as described in ref. 10). 
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Harvested cells (stored at –20˚C overnight) were thawed and re-suspended in a 
high-salt concentration buffer (20 mM NaHEPES pH 7.8, 1.5 M NaCl, 0.5% v/v Triton 
X100, 30 mM PMSF). Cells were lysed by a combination of lysozyme treatment (0.3 
mg/ml chicken egg white lysozyme) and French-press (1000 psig). Initial protein 
purification was achieved by heating the cleared supernatant to ≈ 80˚C (>85% purity as 
estimated by density scans of SDS-PAGE lanes), followed by high-speed centrifugation 
to remove the bulk of denatured E. coli proteins. The SurEα-His6x was further purified 
by chromatography on a Ni2+-charged iminodiacetic acid-sepharose column (Pharmacia); 
the protein was eluted in an imidazole gradient, and it may be significant that yellow-
colored fractions from an earlier point in the gradient reproducibly contained a single 
protein of ≈ 20 kDa. Affinity chromatography resulted in >99% pure protein as estimated 
by several independent techniques (SDS-PAGE, MALDI-TOF and electrospray mass 
spectrometries, and gel-filtration chromatography). These methods also verified that the 
final, purified protein consists of full-length wild-type SurEα with the appended 14-
residue His-tag, and mass spectrometry was used to verify the incorporation of SeMet. 
After affinity chromatography, all attempts to exchange the protein into a buffer 
incapable of chelating divalent metal ions (e.g., any buffer lacking imidazole or EDTA) 
were unsuccessful – the protein would invariably precipitate out of solution, presumably 
due to His-tag mediated polymerization in the presence of divalent cations. Therefore, for 
crystallization efforts SeMet-labelled Pae SurEα was exchanged by dialysis into the 
following buffer: 10 mM Tris-Cl, 5 mM EDTA pH 8.0.  
Crystallization and x-ray data collection 
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 SeMet-labelled SurEα was concentrated to ≈ 11 mg/ml in Amicon ultrafiltration 
devices (10 kDa molecular weight cutoff), and several initial crystallization leads with 
different habits were obtained by hanging-drop vapor diffusion and sparse matrix 
screening (Hampton Research; Emerald BioSystems). Initial leads had to be extensively 
optimized by systematic variation of crystallization parameters, particularly protein and 
precipitant (PEG) concentrations. In terms of a crystallization response surface,11 the 
most critical parameter was the sampling of a different region of crystallization space – in 
this case, via the addition of a reductant (dithiothreitol, DTT). The efficacy of adding 10 
mM DTT to the crystallization condition is easily rationalized, because biophysical 
characterization of Pae SurEα shows that it forms disulfide-bonded dimers in vitro 
(unpublished data, Mura and Eisenberg). The final, optimized crystallization condition 
for the trigonal SurEα crystals grown in hanging-drops at 19.8˚C follows: 5 μL drops 
(2.5 μL well + 2.5 μL 11.4 mg/ml SeMet SurEα) over 600 μL wells (0.083 M Tris pH 
8.55, 21.7% v/v PEG-4000, 0.17 M NaOAc, 15% v/v glycerol). A single SeMet crystal of 
reasonable diffraction quality appeared within one year, and grew as trigonal prisms of 
maximum size ≈ 0.2 mm x 0.4 mm (crystals of the native protein were never obtained). 
 Initial auto-indexing of diffraction patterns with DENZO revealed that the SeMet 
crystal was of a hexagonal Bravais lattice, and further scaling of data revealed the space 
group to be either P3121 or P3221, with unit cell dimensions a = 90.5 Å, c = 129.95 Å. 
The molecular mass of Pae SurEα-His6x (30,733.1 Da), together with these cell 
dimensions, suggested a dimer in the asymmetric unit. For Z = 12 monomer/cell, the 
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calculated Matthew’s coefficient (VM = 2.50 Å3/Da) corresponds to a solvent content of 
50.8% by volume.    
 After initial screening of crystals on a RAXIS-IV++ image plate detector 
(UCLA), final SeMet MAD data sets were collected on an ADSC Quantum-4 charge-
coupled device (CCD) detector at ALS beamline 5.0.2. A crystal was transferred directly 
from the hanging drop in which it grew to a cryocane stored in liquid nitrogen. Data were 
collected on this crystal in a cryogenic nitrogen stream at –168°C (105 K). All images 
were indexed/integrated/reduced in DENZO, and reflections were scaled and merged in 
SCALEPACK.12 X-ray fluorescence scans about the K absorption edge of the SeMet 
crystal (≈12.6578 keV) were used to select appropriate wavelengths for inflection, peak, 
and high-energy remote data sets. Complete data sets were collected from the single 
SeMet crystal (Table 4.1). 
Crystallographic MAD phasing and initial refinement 
 
 There were two indications that the SeMet crystal would be suitable for multi-
wavelength anomalous dispersion (MAD) phasing: (i) χ2 values > 1 for the merging of I+ 
and I- reflections indicated the presence of a reasonable anomalous signal (Table 4.1), 
and (ii) there were large anomalous difference (ΔFano2) Patterson peaks for the data set 
collected at the selenium peak wavelength. The integrated Patterson and direct methods 
program SHELXD (http://shelx.uni-ac.gwdg.de/SHELX/) was used to locate 8 Se sites 
per asymmetric unit (out of an expected 12 sites), using a single-wavelength anomalous 
scattering approach with the peak data set. The sites were verified by comparing their 
predicted self- and cross-vectors with observed peaks in the anomalous difference 
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Patterson maps. The program MLPHARE13 was used for maximum likelihood heavy 
atom and MAD phase refinement to 2.8 Å (that being the high resolution limit of the 
high-energy remote data set); the inflection point data set was treated as a native data set 
for refinement of Se occupancies, as it has the smallest dispersive scattering component 
of the three wavelengths used (f’ = –10.1e). Phases for the centrosymmetric solution 
were also calculated and refined – i.e., the inverted hand of the Se positions in the 
enantiomorphic space group (P3221).  
Next, density modification using solvent flattening and histogram matching was 
performed with the program DM14 in order to distinguish the correct enantiomorph of Se 
sites and to improve electron density map quality. Maps calculated from these 
experimental phases were of excellent quality (Fig. 4.1), with protein secondary structure 
elements clearly identifiable. Phases were extended from 2.8 to 2.0 Å with DM 
(including 2-fold NCS averaging). Rigid secondary structure elements were initially fit 
into 2.5 Å-resolution maps automatically with the program MAID15, and this served as a 
useful starting point for automated model building of ≈ 87% of the protein backbone (485 
out of 560 residues/dimer in 13 chains) with the program ARP/wARP.16   
 Manual model building was done with the program O17, and the program CNS18 
was used for model refinement. Refinement in CNS proceeded by standard protocols, 
using the maximum-likelihood target function for amplitudes (mlf), bulk solvent 
correction, and anisotropic B-factor correction terms. Initially, the two monomers in the 
asymmetric unit were refined with only weak NCS restraints imposed, and for the final 
rounds of refinement the two monomers were refined independently. Solvent molecules 
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(water, glycerol, and acetate) were added as necessary. Refinement of individual atomic 
positions, isotropic temperature factors, and simulated annealing torsion angle dynamics 
was performed in most rounds. Also, the occupancies of the Se atoms were refined. Each 
refinement round ended with inspection of the agreement between the model and σA-
weighted 2Fo – Fc, Fo – Fc, and simulated annealing omit maps (the latter only as 
necessary).  
Final occupancy refinement and model validation 
 For the purpose of distinguishing the domain swapped (DS) from the non-domain 
swapped (non-DS) conformation of the hinge loop region (residues ≈ 244-248), the 
occupancies of atoms in these residues were refined as groups in the program CNS. 
Calculation of 2Fo – Fc, and Fo – Fc maps from models that used these refined 
occupancies, together with the values of these occupancies, suggested that the crystal 
consists of a mixture of DS and non-DS states (see Fig. 4.5 and the Results section). 
Further efforts led to a final, refined model consisting exclusively of the non-DS 
conformer, with occupancies for the hinge loop residues (and all other atoms except for 
selenium) set to one. This final model contains 276/280 residues for one monomer, and 
278/280 for the other. A total of 287 water molecules, 7 glycerols, and 2 acetates were 
modeled as solvent. Final R/Rfree values are 18.5%/22.3%, with reasonable root mean 
square deviations (RMSDs, Table 4.1). The programs ERRAT19, PROCHECK20, and 
Verify3D21 were used in model validation. Experimental structure factors and the refined 
Pae SurEα structure have been submitted to the PDB (code 1L5X).  
Sequence and structure analyses 
 
 104
 Homologs of Pae SurEα were found via iterative PSI-BLAST searches of the 
most current non-redundant database of deposited protein sequences at NCBI. This final 
list of 43 SurE homologs is shown in Table 4.3. Multiple sequence alignments over the 
entire list, as well as just the seven archaeal sequences, were performed with 
CLUSTALW.22 Pairwise sequence similarity scores were calculated by the Smith-
Waterman algorithm, as implemented in the GCG software package.23 An unrooted 
phylogenetic tree for all 43 SurEs was inferred from the distance matrix methods in the 
Phylogeny inference program PHYLIP.24  
 Structural alignments were created with various programs as necessary. For 
example, active site regions (which are similar in structure) were aligned with the Kabsch 
least squares method in the program ALIGN (Cohen, unpublished result cited in ref. 25), 
whereas entire monomeric or dimeric Pae and Tma structures (which are more dissimilar) 
were optimally aligned by the combinatorial extension algorithm.26 Calculations of the 
electrostatic potentials at surfaces were performed in GRASP,27 and buried surface areas 
were calculated by the Lee & Richards approach28 as implemented in CNS. Comparative 
structural analyses of several SurE models was performed via error-scaled difference 
distance matrices29 in the program ESCET.30 To this end, the ESCET analysis was 
performed twice: (i) using an ensemble of the 8 crystallographically independent Tma 
SurE models refined by Lee et al7 and Zhang et al8 or (ii) using a single Tma/Pae pair of 
structures (e.g., a single Tma monomer from PDB code 1J9J and a single Pae monomer). 
In the latter case, the ESCET analysis was restricted to portions of the two chains that 
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aligned in 3D (as determined by combinatorial extension). The programs GRASP and 
PyMOL31 were used for electron density figures and other structural illustrations.  
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Results 
 
Structure determination, refinement, and validation 
 
 Since molecular replacement efforts with Tma SurE failed, the Pae SurEα crystal 
structure was determined by MAD phasing of data that were collected from a single 
crystal (Table 4.1). As described in the Methods section, native crystals were never 
obtained, so the final model was refined against the best data from the SeMet-substituted 
crystal. Despite the poor phasing statistics (Table 4.1), electron density maps calculated 
with experimental MAD phases were of excellent quality (Fig. 4.1). The high-resolution 
limit of the data (2.0 Å) at the peak wavelength permitted automatic model building for 
much of the structure by successive steps of secondary structure fragment matching 
(MAID) and free-atom model refinement (wARP). No non-crystallographic symmetry 
restraints were imposed on the SurEα dimer after the first few rounds of model 
refinement. The final model was refined to an R/Rfree of 18.5% / 22.3%, with reasonable 
geometry (Table 4.1).  
As discussed in further detail below, crystalline Pae SurEα is a mixture of 
domain swapped (DS) and non-domain swapped (non-DS) states. Residues ≈ 244-248 in 
Pae SurEα correspond to the putative hinge loop region in the DS Tma SurE structures.7,8 
Electron density for this region was poorer than in any other part of Pae SurEα. Because 
of the ambiguity in building these residues, and to substantiate a non-DS model for the 
SurEα dimer, the final Pae structure underwent extensive model validation with ERRAT, 
PROCHECK, and Verify3D. Results from some of these verification methods are shown 
in Fig. 4.1a and b, along with a representative example of the agreement between the 
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final model and experimental (Fig. 4.1c) and 2Fo – Fc electron densities (Fig. 4.1d). The 
Ramachandran plot shows a single residue (Ser99) in a strictly disallowed region of φ, ψ 
space (Fig. 4.1a); however, the electron densities shown in Fig. 4.1 illustrate that this 
residue is modeled correctly.  
The topology and fold of SurEs 
 Like Tma SurE, Pae SurEα is a Rossmann-like fold with an extended C-terminal 
domain; the topology of this mixed α/β protein is shown schematically in Figs. 2 and 3. 
The N-terminal core domain of ≈ 170 residues adopts a Rossmann-like fold, and the C-
terminal region of ≈ 90 residues forms an irregular structure that is dominated by a 40-
residue β-hairpin. This hairpin protrudes from the body of the protein, and mediates 
possible tetramerization of both Pae and Tma SurE (discussed below). Despite its 
Rossmann fold, no structures in the PDB are significantly similar to Pae (or Tma) SurEα. 
Three homology searches were performed with the DALI program: using the entire 
SurEα monomer, using the highly conserved N-terminal domain alone, or using the C-
terminal region alone. The closest match was the Rossmann fold of phosphofructokinase 
against the N-terminal domain of SurEα, but this has a Z-score of only 6. Similar results 
were found by Lee et al. and Zhang et al. for Tma SurE.7,8 As has been observed for other 
nucleotide-binding proteins that utilize Rossmann folds, the most highly conserved 
residues in the SurE family (Fig. 4.2) map to the C-terminal loops of the β-strands that 
form the core of this fold (Fig. 4.3). Two of the largest structural differences between 
Tma and Pae SurEα are also indicated in this figure: (i) the more extended β-sheet core 
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of Tma SurE contains 7 strands rather than 5, and (ii) the C-terminal α-helices exchange 
in Tma to form a domain swapped dimer. 
Comparative structural analysis of SurE monomers 
In order to dissect more quantitatively the structural differences between the Tma 
and Pae structures, we utilized error-scaled difference distance matrices (DDMs). This is 
a recent structure comparison approach that explicitly takes into account the 
crystallographic data for the two models under comparison (e.g, resolution, B-factors, 
Rfree) via a diffraction precision index.29 The output from a pairwise comparison of 
models is a DDM, which is a symmetric matrix with the common core of the two models 
represented by the rows and columns. The entries of this matrix are the statistical 
signficance of the deviation from the mean of the two structures (expressed as a standard 
deviation). Recently, a genetic algorithm has been devised to allow simultaneous 
comparison of all pairwise DDMs of an ensemble of structures.30 Two applications of this 
method were made for SurE: (i) the ensemble of 8 crystallographically-independent Tma 
SurE models was analyzed (two monomers in the asymmetric unit of each of the PDB 
entries 1J9J, 1J9K, 1J9L, 1ILV) and (ii) various Tma-Pae SurEα pairs were compared.  
 The results of this analysis, along with a standard 3D structure superimposition, 
are shown in Fig. 4.4. The superimposition in Fig. 4.4a shows that the N-terminal β-sheet 
core is highly conserved (1.1 Å RMSD over all atoms). Minor structural differences 
occur in the β-turn between strands B3 and B4 (green arrow) and the N-terminal region 
of the interrupted helix H4 (purple arrow). The largest differences occur in the C-terminal 
β-hairpin (orange arrow, Fig. 4.4a) and C-terminal α-helix, which is either swapped 
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(Tma) or mostly non-swapped (Pae) depending on the hinge loop (red arrow, Fig.4.4a, c). 
For an ensemble of 8 structures, there are 28 unique DDMs. An example of one of these 
difference distance matrices as applied to the ensemble of 8 Tma SurEs is shown in Fig. 
4.4b, and an example of the difference distance matrices between Tma and Pae SurEα is 
shown in Fig. 4.4c. In the latter figure, the lower diagonal represents the statistical 
significance of the scaled structural differences and the upper diagonal gives the actual 
difference in measured distances. Regions of relatively minor structural variation 
between Pae and Tma are apparent from the DDM analysis (see arrows in Fig. 4.4c and 
corresponding differences in Fig. 4.4a). For example, β-strand B4 hydrogen bonds to the 
adjacent strand (B2) in Tma to extend the β-sheet core, whereas in Pae SurEα this strand 
curves away from the sheet (see Fig. 4.3 and green arrows in Fig. 4.4a, c).  
Biochemical characterization of Pae SurEα 
 
Biochemical characterization of the phosphatase activity of Pae SurEα is currently in 
progress. In preliminary results, SurEα exhibits acid phosphatase activity on some 
substrates, e.g., p-nitrophenyl phosphate (unpublished data, Katz and Clarke). The SurEα 
activity is ≈ 20-fold less than that of the Tma SurE; however, the Pae SurEα was assayed 
in solution conditions that were determined to be optimal for the Tma enzyme, and which 
may not be optimal for the Pae enzyme (e.g., Pae SurEα apparently has a higher Topt than 
the Tma enzyme). In addition to determining the optimal condition for activity, future 
biochemical assays will characterize the phosphatase function of Pae SurEα with both 
DNA and RNA substrates (particularly rRNA and tRNA).   
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Discussion 
 
Significance of domain swapping in SurEs 
Throughout the crystallographic refinement, inspection of 2Fo – Fc, Fo – Fc, and 
Fo – Fc  simulated annealing omit maps made it apparent that the crystal consists neither 
entirely of domain swapped (DS) SurEα dimers nor non-domain swapped dimers (non-
DS). Evidence for such an inhomogeneous crystalline mixture of DS and non-DS states is 
two-fold: (i) neither conformation alone could be satisfactorily fit into the various maps 
mentioned above (Fig. 4.5) and (ii) refinement of occupancies for residues in the putative 
hinge loop region invariably led to values significantly less than 1 (but greater than 0.5). 
Attempts to refine alternate conformations of the hinge loop in a mixed DS/non-DS 
model provided little improvement over the non-DS model, suggesting that the majority 
of the crystal contains non-DS dimers. Also, the non-DS model agrees more closely with 
relatively unbiased Fo – Fc simulated annealing omit maps (compare Figs. 5c and d). 
Parallel refinement of a DS and a non-DS model of Pae SurEα reinforced the conclusion 
that SurEα is (mostly) non-domain swapped (compare Figs. 5a and b). We note that 
stereochemically reasonable models of SurEα with no φ, ψ dihedral violations can be 
built for both the DS and non-DS conformations of the hinge loop region (data not 
shown).  
Another example of a crystalline mixture of domain swapped states was recently 
reported by Zhang and coworkers for the 64-residue B1 domain of protein L.32 However, 
in that case the non-DS protein is naturally monomeric, and the homogeneity of the 
mixture allowed both DS and non-DS states to be distinguished in the crystal. Both of 
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these examples support the hypothesis that protein oligomers may have evolved from 
monomers by passing through a DS stage,33 and the possibility of mixed DS/non-DS 
states in a single crystal seems plausible for other domain swapped oligomers.  
 A consideration of the various dimerization states of Pae and Tma SurE is 
required in order to decide if domain swapping is of general significance for SurE 
proteins. Because there is no evidence for an independently stable, closed monomer form 
of Tma SurE in vitro, the tertiary packing of the exchanged C-terminal α-helix leads us to 
classify the Tma dimer as a candidate for 3D domain swapping, adopting the 
nomenclature of Schlunegger et al.34 The Pae SurEα structure reported here provides 
strong evidence for both non-DS dimers (composed of “closed” monomers) and DS 
dimers (composed of “open” monomers) in the same crystal. Although crystallographic 
evidence for the non-DS conformer is stronger, this mixture of both DS/non-DS states 
classifies the SurE proteins as a bona fide example of domain swapping. Apparently 
domain swapping is a feature of SurE proteins, but its function is not yet known. 
Similarities and differences between Pae and Tma SurE monomers 
Comparative structural analyses of Pae and Tma SurEs via error-scaled difference 
distance matrices suggest that the conformationally variable regions comprise much of 
the irregular C-terminal region, including the hinge loop that connects the swapped helix 
to the N-terminal core. The most conformationally invariant region of Tma SurE is the 
strongly conserved N-terminal ≈ 170-residue core (Fig. 4.2), and even within the Tma 
ensemble alone there are significant deviations in the β-hairpin and the hinge loop region 
that precedes the domain swapped α-helix. Whether such conformational variance is 
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primarily due to high-amplitude fluctuations in certain dynamic regions of Tma SurE or 
discrete, slowly exchanging conformations is unclear. Note that we found similar 
conformationally invariant regions in the Tma-Pae comparison (Fig. 4.4c) and in the 
ensemble analysis of Tma alone (Fig. 4.4b). This consistency lends support to the 
interpretation of these results and to the generalization of these results to include other 
SurEs. 
Significant differences between Pae and Tma SurE dimers and tetramers 
 
 Several lines of evidence suggest that the biologically relevant oligomerization 
state of Pae and Tma SurEs is a dimer, and more tenuous evidence suggests a tetramer. 
Briefly, Lee et al. and Zhang et al. found an identical domain swapped dimer in the 
asymmetric unit of their Tma crystal structures, and detected dimers in vitro by various 
biophysical methods.7,8 Zhang et al. further suggested that a Tma SurE tetramer exists on 
the basis of size exclusion chromatography and their crystal packing (the tetramer being 
generated by a crystallographic 2-fold). Our in vitro data for Pae SurEα reveal only a 
dimer, although we observe a crystalline SurEα tetramer that has the same overall 
structure and 222-point group symmetry as the Tma tetramer (data not shown).     
The non-DS Pae SurEα dimer has a much less extensive dimer interface than the 
DS Tma SurE dimer, largely because of the non-swapped C-terminal helix. These 
interfaces are compared in Fig. 4.6, which shows the substantial difference (≈ 1000 Å2) 
between the total buried surface area in the Tma (open) dimer interface (6892 ± 43 Å2) 
and the Pae (closed) dimer interface (5835 Å2). Aside from the swapped α-helix, the two 
dimer interfaces are structurally similar; there are only slight rigid-body rotations of the 
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monomers with respect to one another in the Pae vs. the Tma dimer (as evidenced by a 
2.1 Å RMSD for alignment of dimers vs. 1.1 Å RMSD for alignment of monomers). 
Table 4.2 provides the buried surface area statistics for the Pae and Tma SurE dimers as 
well as tetramers. Notice that much more surface area is buried in the crystallographic 
Pae tetramer (3716 Å2) than in either Tma tetramer (2215 ± 208 Å2). The structural basis 
for this disparity is that a slightly different conformation of the extended β-hairpins in the 
Pae structure (Fig. 4.4) allows a much closer approach and more extensive contacts 
between the two SurEα dimers than is the case with the Tma dimers. Because the two 
dimers are related by a crystallographic 2-fold, this difference (and, in fact, the entire 
tetramer) may be an artefact of crystal packing.  
Two results support the significance of a SurE tetramer: (i) the tetramer interface 
is extensive and well-defined (e.g., 3716 Å2 for Pae) and (ii) Pae and Tma SurE form 
identical tetramers in three independent crystallization efforts (i.e., that of Lee et al.,7 
Zhang et al.,8 and this report). However, two data that refute the importance of a tetramer 
are: (i) no Pae SurEα tetramer is found by size exclusion chromatography (unpublished 
data, Mura and Eisenberg), and (ii) in the tetramer, the conserved active site is largely 
occluded by the C-terminal β-hairpins of the second dimer (data not shown). Of special 
interest will be any connection between these large discrepancies in dimerization and 
tetramerization behavior and the biochemical functions of Pae, Tma, and other SurEs. 
The conserved active site and a substrate-binding model 
 The putative active site is a highly conserved, acidic cleft on the surface of both 
Tma and Pae SurEs (Fig. 4.7). Structural and biochemical characterization of Tma SurE 
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showed it to have acid phosphatase activity, and allowed a putative active site to be 
identified based on the crystallographically-located divalent metal ion binding sites.7,8 
The most striking attribute of the electrostatic potential of both Tma and Pae SurEα 
surfaces in Fig. 4.7a and b is also the most conserved feature (Fig. 4.7c): there is a 
relatively large acidic cleft that forms the putative SurE active site and continues as a 
narrow anionic channel in Tma SurE. An interesting feature that is not shared between 
Pae and Tma SurE is the weak – but significant – amount of basal level anionic charge 
that covers most of the Tma SurE surface (Fig. 4.7b). This property may be related to the 
fact that the Tma protein is an acid phosphatase: most of the protein surface would be 
neutralized only at the acidic pHs in which Tma SurE is optimally functional.  
 In order to gain further insight into substrate binding and the potential functions 
of SurEs, we created a model of guanosine-5’-monophosphate (GMP) bound to the 
conserved Pae SurEα active site. GMP was chosen as a ligand because it was found to be 
the best substrate among the phosphate-containing compounds tested by Zhang et al.8 and 
Lee et al.7 In the complex shown in Fig. 4.8, the GMP was docked so that its phosphate 
moiety coincided with the binding site of the inhibitory tungstate described by Lee et al.7 
In addition, several other favorable protein-GMP interactions are formed in this complex, 
e.g., the aromatic stacking interaction between the guanine ring and the highly conserved 
Tyr192 side chain.  
In addition to showing that GMP can be easily accommodated in the Pae SurEα 
active site, the hypothetical SurE•GMP complex elucidates the importance of many 
conserved active site residues, and suggests that the catalytic mechanism may rely on 
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nucleophilc attack by a polarized water. The Tma SurE protein binds a divalent metal ion 
(Mg2+ or Ca2+) in the active site such that the metal is chelated by several conserved 
residues, including the strictly conserved Asp8/Asp9 pair. There is also a water molecule 
that is tightly bound 2.2 Å away from Mg2+ in the structure of Lee et al.7, and this 
polarized water may serve as a nucleophile for attack on the substrate’s phosphate center. 
As Pae SurEα could be crystallized only in the presence of EDTA, no divalent metal ions 
were found at the active site. However, waters were found in the two sites just described: 
one water occupies the same divalent metal ion binding site as in Tma, and the other 
water is hydrogen bonded to this one. Both of these waters are compatible with the 
location of the modeled GMP in Fig. 4.8. 
Phylogenetic distribution of surE genes 
 
 The only SurE structure known prior to the archaeal Pae SurEα structure reported 
here is that from the thermophilic eubacterium Tma. In order to better understand the 
phylogenetic distribution and possible evolution of other SurEs, we compiled a 
comprehensive list of all open reading frames (ORFs) with sequence similarity to Pae 
SurEα. These 43 putative SurE proteins are shown in Table 4.3, and were found via 
iterative PSI-BLAST searches of a non-redundant database at NCBI. The SurE database 
compiled here consists of 32 eubacterial sequences, 4 eukaryotic sequences, and 7 
archaeal proteins, represented by a total of 39 species (including the extremely 
radioresistant eubacterium Deinococcus radiodurans). We found examples of organisms 
with more than one surE gene: the genomes of Synechocystis sp. PCC 6803, Nostoc sp. 
PCC 7120, Arabidopsis thaliana, and P. aerophilum each contain pairs of SurE paralogs, 
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which we designate SurEα and SurEβ (Table 4.3 and Fig. 4.9a). Our finding of two surE 
genes in the hyperthermophile Pae (which grows up to 104°C) is especially interesting 
given a recent report that the single surE gene in E. coli is duplicated in strains that are 
evolved for 2,000 generations at elevated temperatures.5 The authors speculated that such 
duplication – along with the pcm, rpoS, and nlpD genes – may facilitate thermal 
adaptation in E. coli. However, duplication of surE genes is unlikely to be strongly 
correlated to extremophile survival, since (i) the three other organisms with duplicate 
SurE paralogs are mesophiles, and (ii) several thermophilic or halophilic species harbor 
only a single surE homolog (Table 4.3).  
An unrooted phylogenetic tree was inferred by the application of distance matrix 
methods to multiple sequence alignments of the 43 surE sequences, and shows a large 
dispersion in the SurE lineages. That is, the tree displays very few bifurcated nodes, and a 
large fraction of the 43 SurE sequences cannot be grouped into clades. Interestingly, the 
unrooted tree also shows that the SurE sequences do not cluster by kingdom: archaeal 
SurEs are interspersed with eukaryotic and eubacterial ones in an apparently random way 
(Fig. 4.9a). The phylogenetic relationships of SurE paralog pairs – such as Pae SurEα/β 
or Nostoc SurEα/β – suggest that the second member of these SurE pairs may not have 
arisen by gene duplication and neutral drift within these genomes. If gene duplication led 
to two SurEs in these genomes, it is likely that the two paralogs would have a greater 
degree of sequence similarity and would share a stronger phylogenetic similarity than that 
shown in Fig. 4.9a. For example, the two SurEs from two subspecies of H. pylori are 
closely related, as are the E. coli and S. enterica SurEs; however, members of the four 
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α/β pairs are apparently only distantly related. Thus, duplicate surE genes may have 
arisen by horizontal gene transfer.  
Genomic organization of archaeal surE genes 
 
 Phylogenetic analysis of the SurE family illuminates the inter-genomic 
distribution of surE genes. What about features of the intra-genomic organization of surE 
genes, especially in terms of the possibility that they cluster with archaeal homologs of 
other stress-survival genes? Also, what are the gene neighbors of Pae SurEα and SurEβ, 
and where do any pcm, rpoS, or nlpD-like genes lie in the archaeal genomes (e.g., is there 
any operon-like clustering)?  
These questions were addressed by: (i) looking at the ORFs encoded in all six 
reading frames upstream and downstream of all the archaeal surE genes (± 2,500 bp) and 
(ii) using sequence similarity searches to search for archaeal homologs of the pcm, rpoS, 
and nlpD genes. Notably, we found no strong sequence homologs of the rpoS or nlpD 
genes in Pae or any other archaea: nlpD homologs were found only in the eubacteria, and 
rpoS homologs could be found only in eubacteria and a few eukaryotes (primarily of the 
plant lineage Viridiplantae). Sequence searches revealed one significant pcm homolog in 
Pae. However, unlike the case in several eubacterial genomes, this pcm is not located 
near either surE gene in Pae, but is almost 0.5 Mbp away (Fig. 4.9b). The same result 
was found in other archaeal genomes: in each case the nearest gene neighbors of surE 
were not homologous to the pcm, rpoS, or nlpD genes. In fact, several of the ORFs 
adjacent to surE in archaeal genomes have no strong sequence matches to proteins of 
known function, and are annotated as conserved hypothetical proteins.  
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The genomic organization of – or even presence of – putative stress-survival 
genes is clearly not conserved in the eubacteria and archaea. However, in several cases a 
homolog of known function can be found for surE gene neighbors. For example, the 
nearest gene neighbor of Pae surEα encodes a putative purine NTPase (≈1500 nt 
upstream and in the same reading frame). A homolog of CTP-synthase lies ≈1200 nt 
upstream of – and in the same reading frame as – Pae surEβ (Fig. 4.9b). Three other 
examples of archaeal gene neighbors are: (i) a putative protein tyrosine phosphatase 
(PTP) upstream of M. thermautotrophicum surE; (ii) a homolog of ribose-5’-phosphate 
isomerase downstream of (and overlapping) the A. fulgidus surE gene; and (iii) an 
adjacent dihydropteroate synthase (DHPS) gene in A. pernix (encoded in a reverse 
reading frame). Some representative reactions catalyzed by these enzymes are shown in 
Fig. 4.10. In a reaction analogous to that catalyzed by DHPS, the nearest Pae SurEβ gene 
neighbor (CTP-synthase) mediates the condensation of UTP and an amino group (from 
either glutamine or ammonia) to form Cytosine-5’-triphosphate.  
A final example of how the genomic organization of surE and its homologs may 
illuminate its function is the fact that the S. cerevisiae SurE ortholog is a large protein 
(>700 residues) that can be divided into two regions: an N-terminal half with sequence 
similarity to SurE, and a C-terminal domain of >300 residues that has significant 
sequence homology to tubulin-tyrosine ligase (TTL). TTL catalyzes the ATP-dependent 
post-translational addition of a tyrosine residue to the carboxy-terminus of α-tubulin, and 
is thought to be phosphorylated in its Mg2+/ATP-binding domain (reviewed in ref. 35). 
Note that several of the reactions catalyzed by homologs of the gene neighbors of surE 
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either directly or indirectly involve some form of phosphate ester hydrolysis. These 
results are consistent with the recent discovery of an acid phosphatase activity for Tma 
SurE, as well as our Pae SurEα structure.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 120
Conclusions 
 
Until the recent reports of Lee et al.7 and Zhang et al.8 for Tma SurE, there was no 
structural or biochemical knowledge about the SurE family and its in vivo function. In 
order to extend and generalize their results, we determined the crystal structure of Pae 
SurEα to 2.0 Å-resolution. The Pae and Tma monomers adopt similar structures, 
consisting of N-terminal Rossmann-like folds and irregular, C-terminal domains that 
mediate oligomerization. Crystalline Pae SurEα differs from Tma SurE in that it forms 
an inhomogeneous mixture of domain swapped and non-domain swapped dimers, with 
the non-domain swapped form predominating. This shows that SurE proteins can exist in 
both monomeric and dimeric forms, and suggests that the transition could be of 
functional significance. More minor differences in the two structures were revealed by 
the application of error-scaled difference distance matrices. The considerable structural 
similarity of the SurE active sites allowed us to model the protein bound to substrate 
(GMP), and the SurE•GMP model elucidates the importance of conserved active site 
residues and suggests that phosphoester bond hydrolysis may proceed via nucleophilic 
attack of an active site water molecule. Finally, analyses of the phylogeny and genomic 
organization of SurE reveal examples of genomes with multiple surE genes and suggest a 
generic phosphatase-like function for other members of the SurE family.  
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Figure Legends 
Figure 4.1: Structure validation and sample electron density for Pae SurEα. A 
Ramachandran plot for the refined model is shown in (a), and Verify3D scores for each 
of the two monomers (A in red and B in blue) are plotted in (b). Out of 560 residues per 
dimer, only 2 are disallowed (Ser99 in chains A, B) and an additional 6 are generously 
allowed. Similarly, most of the profile scores in (b) are significantly greater than zero; the 
poorest-scoring region (near residue 200) is near the C-terminal β-hairpin, and the 
positive scores for the putative hinge loop region (near residue 245) suggest that it is 
correctly modeled (in a non-DS conformation). Representative examples of electron 
density (contoured at +1.4σ) illustrate the close agreement between the map calculated 
from experimental MAD phases {Fo, ΦMAD} (c) and that calculated from final model 
phases {2Fo – Fc, Φmodel} (d). Together with the lack of significant positive or negative Fo 
– Fc density in this region, these maps show that Ser99 – the only strong outlier in the 
Ramachandran plot – is modeled correctly.   
Figure 4.2: Sequence analysis of all archaeal SurEs. A multiple sequence alignment is 
shown for all known archaeal SurE sequences. Clusters of conserved residues are shaded 
in black (stringent) or grey (less stringent), and the consensus sequence is given in the 
last line (conservative substitutions are italicized, and identities are capitalized). 
Numbering is for the Pae SurEα sequence. Regular secondary structure elements are 
shown as arrows and cylinders, and pleated lines indicate regions that can only loosely be 
classified as β-strands or turns. Secondary structures that form the irregular C-terminal 
region are shaded in a gray box (see Fig. 4.3). The strictest conservation occurs in the N-
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terminal ≈ 150-residue core, which is also where all of the putative active site residues 
are located (underlined). 
Figure 4.3: Pae SurEα is a Rossmann-like fold with an extended C-terminal domain. 
A cartoon of the Pae SurEα monomer topology is shown, illustrating the N-terminal 
Rossmann fold and the extended C-terminal region (with gray-shaded background). The 
intensity of shading conveys the approximate 3D structure: lighter-colored elements are 
below the plane of the paper and darker elements are above it (asterisks denote positions 
that are near in 3D space). The most conserved residues in the SurE family (circles) map 
to the C-terminal loops of the β-strands which form the Rossmann fold. The primary 
differences between the Pae and Tma SurE structures (double-headed arrows) and the 
hinge loop region (dashed line) are indicated.     
Figure 4.4: Structural comparison of Pae and Tma SurE reveals conformationally 
invariant regions. (a) A stereoview is shown for Cα traces of Pae SurEα (red, thick 
sticks) superimposed on the Tma SurE structure (blue). A red ball denotes every 
twentieth residue of the Pae monomer. Major structural differences are marked by 
colored arrows and are discussed in the text. These differences are quantified in (b) and 
(c) via error-scaled difference distance matrices. An ensemble of eight 
crystallographically-independent Tma SurE monomers is analyzed in (b), and a pairwise 
comparison between matching fragments of one Tma and Pae SurEα monomer is shown 
in the lower diagonal matrix of (c). The upper diagonal of (c) provides a normal matrix of 
RMSDs between these two models. Color intensity scales with either the statistical 
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significance of the model differences ((b) and lower diagonal of (c)) or the actual values 
of differences in distances between the atomic coordinates ((c), upper diagonal).  
Figure 4.5: Crystalline Pae SurEα is predominantly not domain swapped. Electron 
density is shown for the putative hinge loop region of two refined models: (a) and (c) 
assuming that the C-terminal α-helix is non-domain swapped (non-DS), or (b) and (d) 
assuming that it is domain swapped (DS). Fo – Fc maps are colored red (–3.2σ) and blue 
(+3.2σ), and 2Fo – Fc density is colored green (+1.4σ). The path of the backbone (from 
N- to C-terminus) is indicated by arrows in (a) and (b), and side chains are omitted in (c) 
and (d) for clarity. Monomers A and B are distinguished by yellow (A) or gray (B) 
coloring of carbon atoms, and by subscript letters for the labeled hinge loop residues 
Ala246 and His247. The positive (blue) and negative (red) Fo – Fc densities for the hinge 
loop show that neither the non-DS (a) nor DS (b) model is perfectly accurate, although 
the non-DS model is better (there is less negative Fo – Fc density for the mainchain atoms 
of Ala246 and His247 in panel (a) compared to (b)). The Fo – Fc simulated annealing 
omit maps in panels (c) and (d) (+3.0σ) also show that the model of a non-DS dimer (c) 
fits this unbiased density better than the DS model (d). These electron densities, along 
with details discussed in the text, suggest that crystalline Pae SurEα is an inhomogenous 
mixture of DS and non-DS states, with the non-DS form predominating.   
Figure 4.6: Pae SurEα has a much less extensive dimer interface than Tma SurE. 
Orthogonal views of ribbon diagrams for the Pae (a) and Tma (b) SurE dimers are 
shown, with the monomeric subunits colored red and blue (Pae) or green and magenta 
(Tma). The total buried surface area in the Tma dimer interface is 6892 ± 43 Å2, while in 
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the Pae interface this value is 5835 Å2. Comparison of panels (a) and (b) shows that this 
large difference is primarily due to swapping of the C-terminal α-helix in Tma, but not in 
Pae SurEα.  
Figure 4.7: The putative SurE active site is highly acidic and strongly conserved. 
The molecular surfaces of Pae SurEα (a) and Tma SurE (b) are displayed, colored by the 
calculated electrostatic potential (–10.7 kT (red) to +8.6 kT (blue) for Pae, and –12.6 kT 
to +9.7 kT for Tma). Both dimers are in roughly the same orientation, with the C-terminal 
β-hairpins pointing towards the left (indicated by green arrows). Two orientations of a 
space-filling model of the SurEα dimer are shown in (c), viewed down the 2-fold NCS 
axis (this orientation is rotated roughly 90° with respect to panels (a) and (b)). Conserved 
residues are colored magenta, with the intensity of coloring reflecting the degree of 
conservation (presumed active site residues are labeled in red). The putative SurE active 
site is the highly acidic, concave surface seen conserved in both models.  
Figure 4.8: Hypothetical model of GMP bound to the conserved SurE active site. 
The substantial structural conservation of the putative Tma and Pae SurE active sites is 
shown in the stereoviews of (a) and more closely in (b). Side chains for the two Tma 
models are shown in blue and cyan. Pae SurEα is colored pink and its active site residues 
are drawn as thicker sticks. Except for the Ser39 loop, the active site structures are nearly 
identical. Docking of a known Tma SurE substrate (GMP) results in a reasonable model 
in which the phosphate moiety is bound in an identical manner as the inhibitory vanadate 
(shown in green) found by Lee et al. (2001). The guanine ring stacks above the highly 
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conserved Tyr192 side chain. Additional protein-GMP contacts and solvent molecules 
are not shown for clarity. 
Figure 4.9: Phylogenetic distribution and genomic organization of SurEs. An 
unrooted phylogenetic tree is displayed in (a), as calculated from a multiple sequence 
alignment of all 43 detectable SurE homologs. Eukaryotic SurEs are shown as zig-zagged 
lines, and archaeal species are dashed lines. The remaining SurEs are eubacterial. Also, 
paralogous SurE pairs (α, β) are italicized. Note the great dispersion in the SurE family 
amongst the eubacteria, eukaryotes, and archaea, and that paralogous surE genes do not 
cluster into clades. The genomic organization of Pae surE genes in shown in (b). The 
circular, 2.2 Mbp genome of Pae is marked with the relative locations of its two surE 
genes: surEα at 1.73 Mbp and surEβ at 2.11 Mbp. The two nearest ORFs to surE are a 
purine NTPase homolog (~1500 bp upstream of surEα), and a CTP-synthase homolog 
(~1200 bp upstream of surEβ). These two ORFs are encoded in the same frame as their 
respective surE neighbors.  
Figure 4.10: Representative examples of reactions catalyzed by homologs of SurE 
gene neighbors. The reactions catalyzed by homologs of surE gene neighbors from Pae 
(NTPase), M. thermautotrophicum (PTP), and A. pernix (DHPS) are shown in panels (a), 
(b), and (c), respectively (see text for details). Although these reactions are not closely 
related, each enzyme is clearly involved in some form of phosphate hydrolysis (gray 
shaded regions). These chemical activities are consistent with a possible phosphatase role 
for archaeal SurEs, similar if not identical to the acid phosphatase activity recently 
reported by Lee et al. (2001) and Zhang et al. (2001) for the prokaryotic Tma SurE.  
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Table 4.1: Crystallographic statistics for Pae SurEα. 
 
   
Data collection    
Data set Inflection Peak   High-energy remote 
Wavelength (Å) 0.97870 0.97860 0.96485 
Resolution range (Å) 100.0 – 2.40 100.0 – 2.00 100.0 – 2.85 
# reflections (total / unique) 242,223 / 47,599 297,069 / 42,129 206,830 / 28,846 
Completeness (%)* 100.0 [100.0] 99.9 [100.0] 99.9 [100.0] 
I / σ(I) 15.9 [2.3] 17.4 [2.5] 14.0 [3.3] 
Rmerge (%)† 9.8 [77.8] 9.9 [78.1] 14.7 [94.1] 
Anomalous signal (<χ2>)‡ – 4.3 [1.9] – 
MAD phasing    
# Se per a.u. (12 expected)§ – 8 – 
Resolution range (A) 38 – 2.85 38 – 2.85 38 – 2.85 
Phasing power: acentric  0.52 0.37 
 centric  0.44 0.33 
Rcullis:
¶ acentric  0.94 / 0.65 0.96 / 0.95 
 centric  0.90 0.93 
Figure of merit|| 0.43 / 0.59 – – 
Model refinement    
Resolution range (Å) 20.0 – 2.0 Rcryst / Rfree (%)
¥ 18.5 / 22.3 
# reflections  
(working set / test set) 38,377 / 2,033 RMSD bonds (Å) 0.014 
# protein residues (A / B)** 276 / 278 RMSD angles (°) 1.79 
water: 287 <B> (protein, Å2) 35.73 
glycerol: 7 <B> (water, Å2) 44.88 # solvent molecules 
acetate: 2 PDB submission code 1L5X 
 
*     Statistics for the highest resolution shell are given in [square brackets]. 
†    Rmerge(I) = Σhkl ( (Σi |Ihkl,i – <Ihkl>|) / Σi Ihkl,i ) 
‡    Anomalous signal as measured by the normalized χ2 for merging Bijvoet pairs I+, I–. That is, 
χ2 = ΣI+, I- ( (I – <I>)2 / σ2(n / n-1) ). Values > 2 suggest a usefully strong anomalous signal.  
§    The number of Se sites per a.u. calculated by SHELXD (12 sites expected per a.u.) 
¶    Rcullis = (Σhkl | |FPH ± FP| – FH,calc | ) / Σhkl | FPH ± FP |. Statistics for acentric reflections are given 
as isomorphous / anomalous. 
||    Values are given before / after density modification and phase extension to 2.0 Å. 
¥    Rcryst = Σhkl ||Fobs| – |Fcalc|| / Σhkl | Fobs |. Rfree was computed identically, except that 5% of the 
reflections were omitted as a test set.  
**  number of SurEα residues built in monomers A and B, out of 280 residues per monomer of 
recombinant protein (the His-tag and linker add 14 residues to the wild type sequence) 
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Table 4.2: Buried surface area statistics for Pae and Tma SurEs. 
 
   
 Molecular species Total surface area (Å2) 
Pae monomer sa 13215.4, 13199.3 
Pae dimer sa 20579.6 
Pae tetramer sa 37451.6 
Pae dimer interface 5835.1 Pa
e 
S
ur
Eα
 
Pae tetramer interface 3716.0 
1J9J monomer sa 13515.4, 13533.5 
1J9J dimer sa 20113.9 
1J9J tetramer sa 38614.1 
1J9J dimer interface 6935.0 Tm
a 
S
ur
E
  
(L
ee
 e
t a
l.)
 
1J9J tetramer interface 2422.0 
1ILV monomer sa 13446.1, 13429.4 
1ILV dimer sa 20025.6 
1ILV tetramer sa 37896.9 
1ILV dimer interface 6849.9 Tm
a 
S
ur
E
  
(Z
ha
ng
 e
t a
l.)
 
1ILV tetramer interface 2006.6 
 
Note 1: The “sa” entries indicate surface areas of that molecular 
species and the “interface” entries indicate the total buried surface 
area in that type of interface (e.g., counting both subunits of a 
dimer). 
 
Note 2: Only two values are given for monomer surface areas and 
only one value for the dimer surface area (and dimer interface), 
even though in a tetramer there should be four independent 
monomers and two independent values for a particular type of 
dimer interface. This is because only one SurEα dimer constitutes 
the crystallographic asymmetric unit, and, therefore, any other 
calculated numbers would almost certainly be artificially identical 
(due to crystalline symmetry).  
 
Note 3: The difference between buried surface areas in the two Tma 
structure determinations (6935.0 vs 6849.9 Å2) is due to minor 
variations in crystal packing, and probably is not biochemically 
significant. 
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Table 4.3: All 43 known SurE homologs. The next page provides a comprehensive 
list of all 43 known SurE homologs along with the species abbreviations, GenPept 
IDs, and phylogenetic kingdom (P = prokaryote, E = eukaryote, A = archaeon). Also, 
asterisks denote extremophiles. Genomes with paralogous SurEα/β pairs are 
boldfaced. 
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Species abbreviation GenPept ID Kingdom Species 
Ther_mari_SurE gi15644410 P* Thermotoga maritima 
Aqui_aeol_SurE gi15606188 P* Aquifex aeolicus 
Yers_pest_SurE gi16123508 P Yersinia pestis 
Xyle_fast_SurE gi15837460 P Xylella fastidiosa 9a5c 
Vibr_chol_SurE gi15640553 P Vibrio cholerae 
Trep_pall_SurE gi15639410 P Treponema pallidum 
Syne_sp._SurEα gi16332288 P Synechocystis sp. PCC 6803 
Syne_sp._SurEβ gi16330072 P Synechocystis sp. PCC 6803 
Sino_meli_SurE gi1754720 P Sinorhizobium meliloti 
Salm_ente_SurE gi16761699 P Salmonella enterica 
Rubr_gela_SurE gi11280179 P Rubrivivax gelatinosus 
Rals_sola_SurE gi17545923 P Ralstonia solanacearum 
Pseu_aeru_SurE gi15598821 P Pseudomonas aeruginosa 
Past_mult_SurE gi15603477 P Pasteurella multocida 
Nost_sp._SurEα gi17232338 P Nostoc sp. PCC 7120 
Nost_sp._SurEβ gi17230631 P Nostoc sp. PCC 7120 
Neis_meni_SurE gi15794586 P Neisseria meningitidis Z2491 
Meso_loti_SurE gi13471179 P Mesorhizobium loti 
Legi_pneu_SurE gi5771428 P Legionella pneumophila 
He_pylJ99_SurE gi15611932 P Helicobacter pylori J99 
He_pyl26695_SurE gi15645546 P Helicobacter pylori 26695 
Haem_infl_SurE gi16272643 P Haemophilus influenzae Rd 
Esch_coli_SurE gi15803261 P Escherichia coli O157 
Dein_radi_SurE gi15807387 P Deinococcus radiodurans 
Coxi_burn_SurE gi8141682 P Coxiella burnetii 
Chla_pneu_SurE gi15618182 P Chlamydophila pneumoniae 
Chla_trac_SurE gi15604938 P Chlamydia trachomatis 
Chla_muri_SurE gi14195226 P Chlamydia muridarum 
Caul_cres_SurE gi16126241 P Caulobacter crescentus 
Camp_jeju_SurE gi15791661 P Campylobacter jejuni 
Bruc_meli_SurE gi17987364 P Brucella melitensis 
Agro_tume_SurE gi15889009 P Agrobacterium tumefaciens 
Yarr_lipo_SurE gi400781 E Yarrowia lipolytica 
Sacc_cere_SurE gi6319570 E Saccharomyces cerevisiae 
Arab_thal_SurEα gi7485145 E Arabidopsis thaliana 
Arab_thal_SurEβ gi15218620 E Arabidopsis thaliana 
Pyro_aero_SurEα  gi18313680 A* Pyrobaculum aerophilum 
Pyro_aero_SurEβ  gi18314130 A* Pyrobaculum aerophilum 
Meth_ther_SurE  gi15679432 A* Methanobacterium thermautotrophicum 
Meth_jann_SurE  gi15668739 A* Methanococcus jannaschii 
Halo_sp. _SurE  gi15790299 A* Halobacterium sp. NRC 
Arch_fulg_SurE  gi11498547 A* Archaeoglobus fulgidus 
Aero_pern_SurE  gi14600980 A* Aeropyrum pernix 
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Figure 4.1: Structure validation and sample electron density for the refined Pae    
SurEα model. 
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Figure 4.2: Sequence analysis of all archaeal SurEs.  
 
                10        20           30               
Pyro_aero_SurEb    1 ---------------------------MKIVVTNDDGPHSPLLEPLVRGLEAVGN--EVV 
Pyro_aero_SurEa    1 ---------------------------MKILVTNDDGVHSPGLRLLYQFALSLG---DVD 
Halo_sp_SurE       1 ----------------------MDADEPEILVTNDDGIDAPGIRALADGLDAVG---NVT 
Meth_ther_SurE     1 ---------------------------MKILITNDDGVNSSGIIAARRAVEDLG---ETI 
Meth_jann_SurE     1 -----------------MLKITLIGDIMEILIVNDDGIYSPSLIALYNALKEKFSDANIT 
Arch_fulg_SurE     1 ---------------------------MKILLTNDDGLYSAGLKAAYDALSELG---EVF 
Aero_pern_SurE     1 MWVGAQLNLGLPYYTLYYSVALGCEWMLKAIVTNDDGVHSRSLRALAESLASRG--WDVV 
consensus          1                            mkilvtNDDGvhspglralydaledlg   evv 
 
 
                             40        50        60         70        80 
Pyro_aero_SurEb   32 VVVPERPRSAAGLARTYHKPLRVRRLGGY-----YVVNGFPADAVFLALKLIAP-DAELV 
Pyro_aero_SurEa   31 VVAPESPKSATGLGITLHKPLRMYEVDLCG-FRAIATSGTPSDTVYLATFGLGR-KYDIV 
Halo_sp_SurE      36 VVAPADNQSATGRAMSQEVAVHDHDLGYA-------VEGTPADCVVAGLEALGP-YPDLV 
Meth_ther_SurE    31 IVAPATQQSGIGHALTLFEPVRVSEVTLRDGSGAYAVSGTHTDAVIIGIFELMDEKPDLV 
Meth_jann_SurE    44 IVAPTNQQSGIGRAISLFEPLRMTKVKLAKDIVGYAVSGTPTDCVILGIYQILKKVPDLV 
Arch_fulg_SurE    31 VVAPAVQRSGVGRSLSIMEPIRVSEVKVNG-MRVFAVDGTPTDSVIIGMYEVIGEIPDLA 
Aero_pern_SurE    59 VAAPLGNWSGYSKSIGRFRGNRVYRFESRG--VRFFTGDMPPAALVGTAIDIAGFEPDIV 
consensus         61 vvaPa qqSgigraitlfeplrvsev l g   ayavsgtptdavilglfeia   pdlv 
 
 
                     90       100       110       120       130          140 
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Pyro_aero_SurEb   86 ISGVNVGENIGIEATYGSGTVGAALQAGVLGVPSIAASMEVG------------GDVDFM 
Pyro_aero_SurEa   89 LSGINLGDNTSLQVILSSGTLGAAFQAALLGIPALAYSAYLENW--NE-LLNNKEAVEIM 
Halo_sp_SurE      88 VSGVNEGGNLGMYVLGRSGTVSAAVEAAFFGVPAIAVSMYMREE--QFGEPTAVADYEHA 
Meth_ther_SurE    91 ISGINMGENLGKSELTTSGTIGAAMEAAVHGVPSLAVSLQVRRGDIKFHDGHVDVDFSLA 
Meth_jann_SurE   104 ISGINIGENLG-TEIMTSGTLGAAFEAAHHGAKSIASSLQITSDHLKFKELDIPINFEIP 
Arch_fulg_SurE    90 VSGINLGENLSTEAATTSGTVGAALEAATHGSKTIAISLQMPDVS--KFELTSKADFSFA 
Aero_pern_SurE   117 VSGINYGPNLGIYDFFSSGTIGGALEAALRGFKSVSISSACREE---------ETDCLPE 
consensus        121 iSGiNvGeNlgi ei tSGTvgaAleAavhGvpsiavSlqvree   f el   gdfeia 
 
 
                       150       160       170       180       190       200 
Pyro_aero_SurEb  134 IKVVEGAVASARAG--LDGVLAVSINIP-SVWKGGVYCVRKLARAVYRERLYEGVDPRGE 
Pyro_aero_SurEa  146 GAVVSSTASYVLKNGMPQGVDVISVNFPRRLGRGVRAKLVKAAKLRYAQQVVERVDPRGV 
Halo_sp_SurE     146 VDATTHLAHDAVTDGIFDTADYLNVNAPHPDADATGEMVVTRPSHAYDMTAAQTGDTVTL 
Meth_ther_SurE   151 AELTGRVASRILRRGLPEGVDFLNLNVPSHPASD-EIRITRLGDRMYNVHIKKRLDPRGR 
Meth_jann_SurE   163 AKITAKIAEKYLDYDMP--CDVLNINIPENATLETPIEITRLARKMYTTHVEERIDPRGR 
Arch_fulg_SurE   148 SKVLRGIAEIVLYKGLPEGVDLLNVNVP--AKPNGKIAVTRLARRMYRVSVEKRLDPRGR 
Aero_pern_SurE   168 ALSISLAVVETSVETLSSSAGLMVVNIP---RSPRGFKVTRPCRRVP--RFSGEIGEEGS 
consensus        181 akvtshla  vl  glpdgvdvlnvNiP   g g  ikvtrlarrmy mrv ervdprgr 
 
 
                        210        220       230       240       250       260 
B2 
H4 
H5 H6 
B7 B8 B9 
B9’ B10 
H3a B5 
H1 B1 
B5 B4 310B3 
B2 
H3b 
H2 
H4 B6 
Pyro_aero_SurEb  191 -KYYWRWGPRRSEFEPDTDAYYFYYMRGVTVLGLSESGVASVENFGRKLGQLIGAVKVDC 
Pyro_aero_SurEa  206 -RYYWLYG-RDLAPEPETDVYVVLKEGGIAITPLTLNLNAVDAHREVDMDSLNRMVEYIN 
Halo_sp_SurE     206 YDRLWEAMAAGDIHDPDGTDRRAVLDGHVSVSPLTAP------HSTEHHDALDGIATEF- 
Meth_ther_SurE   210 -PYYWIDGDPAGTDFR-VQMSTHLRLKTPPPSPPYHSTAQQALTQWRA--GLIRARN--- 
Meth_jann_SurE   221 -SYYWIDGYPIFEEEEDTDVYVLRKKRHISITPLTLDTTIKNLDEFKEKYGKILCEM--- 
Arch_fulg_SurE   206 -EYYWIYGEETEDAEEGTDIHALR-QGYVSITPLKIDLTASVEFDIVEG-WFDGLEWEV- 
Aero_pern_SurE   223 LLVEKFDHSRLFSSEHDSCDGRLFSMGYIPVSLYKIDNGWIHPLDPSRDGYLKAVEDILN 
consensus        241   yywidg r  e epdtdvy llkmg vsvtpltld  a    e r   aligme  i  
 
 
Pyro_aero_SurEb  250 ----------- 
Pyro_aero_SurEa  264 ASL-------- 
Halo_sp_SurE         ----------- 
Meth_ther_SurE       ----------- 
Meth_jann_SurE       ----------- 
Arch_fulg_SurE       ----------- 
Aero_pern_SurE   283 YKIFPSAGKQF 
consensus        301     
H6 
 
 
 
Figure 4.3: Pae SurEα is a Rossmann-like fold with an extended C-terminal domain. 
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Figure 4.4: Structural comparison of Pae and Tma SurE reveals conformationally  
invariant regions. 
 
 
 
 
 
 
 
 
 
 
 
 
(a) 
 
 (b) (c) 
 
 
 
 
 N-t
er
m
 R
os
sm
an
n 
fo
ld
 
 
β-h
ai
rp
in
 re
gi
on
 
 
 
 
 
sw
ap
pe
d 
he
lix
 
 
 
 
 
 
 137
Figure 4.5: Crystalline Pae SurEα is predominantly non-domain swapped. 
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Figure 4.6: Pae SurEα has a much less extensive dimer interface than Tma SurE. 
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Figure 4.7: The putative SurE active site is highly acidic and strongly conserved. 
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Figure 4.8: Hypothetical model of GMP bound to the conserved SurE active site. 
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Figure 4.9: Phylogenetic distribution and genomic organization of surE genes. 
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Figure 4.10: Representative reactions catalyzed by homologs of SurE gene  
                      neighbors.  
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Chapter 5: 
The crystal structure of a Nudix protein from Pyrobaculum aerophilum 
reveals a dimer with two intersubunit β-sheets* 
 
 
 
 
 
* This chapter is an adaptation of the following published article: 
Structure of a Nudix protein from Pyrobaculum aerophilum reveals a dimer with 
two intersubunit β-sheets 
S. Wang, C. Mura, M. Sawaya, & D. Eisenberg. Acta Crystallographica Sect. D (2002), 
D58, 571-578 
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Abstract 
Nudix proteins, formerly called MutT homolog proteins, are a large family of 
proteins that play an important role in reducing the accumulation of potentially toxic 
compounds inside the cell.  They hydrolyze a wide variety of substrates that are mainly 
composed of a nucleoside diphosphate linked to some other moiety X and thus are called 
Nudix hydrolases.  Here, the crystal structure of a Nudix hydrolase from the 
hyperthermophilic archaeon Pyrobaculum aerophilum is reported.  The structure was 
determined by the single-wavelength anomalous scattering method with data collected at 
the peak anomalous wavelength of an iridium-derivatized crystal.  It reveals an extensive 
dimer interface, with each subunit contributing two strands to the β-sheet of the other 
subunit.  Individual subunits consist of a mixed, highly twisted and curved β-sheet of 11 
β-strands and two α-helices, forming an α-β-α sandwich.  The conserved Nudix box 
signature motif, which contains the essential catalytic residues, is located at the first α- 
helix and the β-strand and loop preceding it.  The unusually short connections between 
secondary-structural elements, together with the dimeric form of the structure, are likely 
to contribute to the thermostability of the P. aerophilum Nudix protein. 
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Introduction 
Nudix proteins form a large family of proteins that are found in all organisms.  
They hydrolyze a wide variety of substrates that contain a nucleoside diphosphate linked 
to some other moiety, X.  Therefore, these enzymes are called Nudix hydrolases 
(Bessman et al., 1996).  Their functions are mainly to reduce the level of the potentially 
toxic compounds and the accumulation of metabolic intermediates (Safrany et al., 1998; 
O’Handley et al., 2001).  The best-studied Nudix enzyme is the MutT protein from E. 
coli (Shimokawa et al., 2000; Abeygunawardana et al., 1995; Taddei et al., 1997; 
Wagner et al., 1997; Bhatnagar et al., 1991; Frick et al., 1995; Porter et al., 1996).  It 
reduces the rate of AT to CG transversion several thousand-fold by hydrolyzing the 
mutagenic nucleotide 8-oxo-dGTP to give 8-oxo-dGMP, thus preventing it from being 
incorporated into DNA (Bessman et al., 1996).  Its catalytic activity is reported to depend 
on the ligation of an essential metal ion.  Structural and mutagenesis studies have 
identified the metal ligands as part of a signature motif conserved among the Nudix 
family, GX5EX7REUXEEXGU, where U is a hydrophobic residue and X is any amino 
acid (Harris et al., 2000; Shimokawa et al., 2000; Lin et al., 1996; Lin et al., 1997).  
Furthermore, the structure of this motif appears to be conserved among three members of 
the Nudix family for which structures have been determined: E. coli MutT, diadenosine 
tetraphosphate hydrolase (AP4A hydrolase) from Lupinus angustifolius (Sawrbrick et al., 
2000) and an ADP-ribose pyrophosphatase (ADPRase) from E. coli (Gabelli et al., 2001).  
All three structures contain an α-β-α sandwich in which the conserved residues in the 
Nudix motif are located in helix α1 and in the loop preceding it. 
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Beyond the conserved catalytic core structure, Nudix proteins demonstrate 
variations in peripheral structure and oligomerization state, perhaps contributing to the 
wide variety of substrate specificities observed in this family.  For example the AP4A 
hydrolase has a structure similar to that of the E. coli MutT but with one extra β-strand 
and two more α-helices.  On a larger scale, the structures of MutT and AP4A hydrolase 
are monomeric, whereas ADPRase is a dimer with its N-terminal domain swapping 
between the subunits.  Furthermore, in E. coli MutT, the entire adenosine moiety of the 
substrate analog AMPCPP binds in the active site cleft behind helix α1 (Lin et al., 1997); 
however, in ADPRase, the terminal ribose of the substrate binds in the cleft, while the 
adenine moiety binds to the N-terminal domain. 
 Here, we report the crystal structure of a Nudix protein from the 
hyperthermophilic crenarchaeote Pyrobaculum aerophilum (PA) determined with single- 
wavelength anomalous scattering data.  The PA Nudix protein was found to be a dimer, 
with each subunit having a similar fold as the E. coli MutT.  Unlike the structure of 
ADPRase, the PA Nudix protein dimerizes through two intersubunit β sheets that lie in 
the center of the polypeptide sequence.  The active site cleft has a distinctly different 
structure from those of other Nudix hydrolases with known structures.  In this paper, the 
structure is analyzed in terms of the putative catalytic function and thermostability. 
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Materials and Methods 
Cloning, expression, and purification of the PA Nudix 
 The open reading frame (ORF) that encodes the putative Nudix protein reported 
here was found via a BLAST search of the PA genome with the sequence of the E. coli 
MutT protein.  A phosmid clone containing the PA mutT ORF was kindly provided by 
the laboratory of Dr. Jeffrey Miller (UCLA).  The following primers were utilized for 
polymerase chain reaction (PCR) amplification of the gene with Deep VentR DNA 
polymerase (New England Biolabs): ACTATGATCGTTACCAGCGGCGTTTTA 
(sense) and AAGCTTTGAAATTTTTCCCAGTCTATATAG (antisense).  Amplified 
DNA was sub-cloned into the pCR-Blunt vector (Invitrogen) to give an intermediary 
vector that was then digested with the restriction enzymes NdeI and HindIII.  The 
fragment containing the mutT gene was purified by gel-extraction and ligated into a 
bacterial expression vector (pET22b(+), Novagen) that had been linearized by double 
digestion with the same enzymes.  The resulting recombinant plasmid (designated 
pET22b(+)-mutT) adds a C-terminal 6xHis tag to the expressed protein.  The plasmid 
was transformed into chemically competent NovaBlue E. coli cells (Novagen) for 
screening, and the DNA sequence of the mutT gene was confirmed by sequencing (Davis 
Sequencing, Inc.)  A point mutant of PA Nudix (M16L), in which a Leu was substituted 
for Met16, was prepared by site-directed mutagenesis (via overlap-extension PCR) in 
order to avoid heterogeneity resulting from a second translation initiation site at this 
position. 
 148
 Recombinant PA Nudix was over-expressed by transformation of the pET22b(+)-
mutT plasmid into chemically competent BL21(DE3) E. coli cells.  Single colonies were 
used to inoculate Luria-Bertani broth supplemented with 100 μg/ml ampicillin, and the 
cultures were grown at 37°C to an OD (at 600 nm) of about 0.8.  Isopropyl-β-D-
thiogalactoside (IPTG) at 1 mM was then added to induce over-expression, and cells 
were further grown for 3-4 hours.  Cells were harvested by centrifugation for 10 min at 
8000g, and stored at -20°C (253 K). 
 Thawed cell pellets were resuspended at room temperature in a high-ionic 
strength buffer containing 20 mM HEPES pH 7.8, 0.5 M NaCl, 0.5 mM PMSF, with or 
without 0.5% v/v Triton X-100.  Cells were lysed by lysozyme treatment (~0.5 mg/ml for 
30 min at room temperature) followed by 2-3 passes through a French press operating at 
~ 1100 psi, or by sonication on ice for 5x1 min with 1 min intervals.  Lysed cells were 
maintained on ice, and cell debris was cleared by centrifugation at ~ 37,000 g for 30 min.  
The supernatant of the cell lysate was either directly loaded onto a Ni2+-charged HiTrap 
chelating column (Pharmacia), or pretreated by heating to ~ 75-80 °C for 10 min and 
clearing the denatured, insoluble E. coli proteins by centrifugation at 37,000 g for 35 min 
(> 80% purity was achieved with this heat treatment).  The final, full-length protein was 
> 99% pure as estimated by several independent techniques (SDS-PAGE, MALDI-TOF 
and electrospray mass spectrometries). 
Crystallization and data collection 
 The purified protein was exchanged by dialysis, or by 3 cycles of dilution and 
concentration, into a dilute buffer (10 mM TRIS, 5 mM EDTA, pH 8.0, or 5 mM HEPES, 
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10 mM NaCl, pH 7.5), and then concentrated to above 10.0 mg/ml at 4 °C in a Centriprep 
ultrafiltration device.  Crystallization experiments were carried out using the hanging 
drop vapor diffusion method.  In each drop, 3 to 5 μl of protein solution was mixed with 
an equal volume of well solution.  Hampton crystal screening kits I and II were used for 
initial screening of crystallization conditions.  Crystals were obtained under several 
conditions.  The best crystals were obtained from drops set up with well solutions 
containing 5-8% PEG 4000 or PEGMME (polyethylene glycol monomethyl ether) 2000, 
5% isopropanol, 50 mM (NH4)2SO4, and 100 mM NaOAc pH 4.8 (Native-1 crystals), or 
well solutions consisting of 100 mM MES pH 6.2 and 15% 2-methyl-2,4-pentanediol 
(MPD) (Native-2 crystals), at room temperature.  Crystals were soaked for 5 minutes in 
the well solution but with 30% of glycerol, or 50% of MPD for Native-2 crystals, and 
flashed frozen in a stream of N2 gas of 100 K.  An iridium derivative was obtained by 
soaking a crystal, which was obtained under similar conditions as Native-1 crystals, in 
the well solution containing 20 mM of IrCl3 for 8 hours.  The crystal was then similarly 
flash-frozen.  Diffraction data from Ir-derivatized and Native-1 crystals were collected at 
beamline X8C, NSLS, Brookhaven National Lab, and those from the Native-2 crystal 
were collected on an in-house RIGAKU FRD generator with an RAXIS IV++ image 
plate detector.  For the iridium derivative crystal, a single set of data was collected at the 
peak anomalous wavelength of iridium.  The diffraction data were indexed, integrated 
and scaled with the programs DENZO and SCALEPACK (Otwinowski and Minor, 
1996).  Data processing statistics of the iridium derivative data and two native data sets 
are listed in Table 5.1.  The iridium and Native-1 crystals are not isomorphous, despite 
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their close similarity in cell dimensions.  Thus, the native data were not used for initial 
phasing.  After solving the structures, it became clear that the crystals have different 
packing interfaces along the crystal Z-axis.  The two crystals pack in the same way in the 
XY plane, but the packing between layers is shifted along the Y-axis by about 18.6 Å. 
Phasing and structure determination 
 Initial phases were determined for the data collected at the peak anomalous 
wavelength from the iridium derivative crystal.  Heavy atom positions were identified 
with programs XtalView (McRee, 1992) and SHELXD (Uson and Sheldrick, 1999), and 
then refined with the program MLPHARE (Otwinowski, 1991; CCP4, 1994).  Density 
modification, i.e. solvent flattening, histogram matching, multi-resolution modification, 
and two-fold NCS averaging were carried out with the program DM (Cowtan, 1994). 
 The automatic refinement procedure, ARP/warp (Perrakis et al., 1999), was then 
used for automatic model building.  The initial model and the electron density maps were 
displayed with the graphics program O (Jones et al., 1991), and the model was manually 
rebuilt to fix the side chains and to add residues that have clear electron density.  The 
model was then refined using CNS (Brunger et al., 1998) with NCS restraints.  Sigma 
weighted 2Fo – Fc and Fo – Fc electron density maps were calculated from the refined 
model, and the model was manually fixed using the program O.  This cycle was repeated 
until the refinement converged.  This refined model was used as a model for molecular 
replacement of the Native-1 data with the program AMORE (Navaza, 1994), or for the 
Native-2 data with the program EPMR (Kissinger et al., 1999), and refinement was 
similarly carried out with the programs CNS and O. 
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 The final refinement statistics are listed in Table 5.2.  Over 91% of residues in the 
native-1 structure and over 93% in the Ir derivative structure fall into the most favored 
regions in the Ramachandran plot.  Some glycerol, or MPD molecules from the cryogenic 
solution were found in the refined structures (see Table 5.2).  Positive Fo – Fc density was 
found near a cluster of four His side chains, His19, His31, His89 and His91, in the active 
site cleft.  A water molecule modelled into this site was not sufficient to account for this 
density.  Since the protein was purified from a Ni-chelating column, a Ni2+ ion was put 
into the density.  The hydroxyl group of Tyr84 side chain is also at a good position to 
function as a ligand. 
 In the Ir derivative structure, all the iridium atoms were found to bind in surface 
cavities on the edge of bulk solvent channels.  Three of them, Ir1, Ir2 and Ir3, were found 
at the crystal-packing interface, while Ir4 was found near the Nudix box residues of 
subunit A.  The strongest iridium peak, Ir1, was found at a packing interface of three 
molecules, and surrounded by five water molecules, which take five positions of an 
octahedral coordination.  The interactions between the protein atoms and Ir1 and Ir4 seem 
to be mediated by water.  Ir2 and Ir3 are related approximately by the two fold NCS, each 
bound near a sulfate ion, as well as side chains of Asp65, Asp66 and Asn67 of a 
symmetry-related molecule. 
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Results 
Protein expression and purification 
 The PA Nudix gene was cloned and over-expressed in E. coli with a His tag at the 
C-terminus.  It was found that the wild type protein was expressed as a mixture of the full 
length and a truncated form that lacks the first 15 N-terminal residues.  Apparently, the 
Met16 codon acts as a second start site for translation of this truncated protein.  The DNA 
sequence ~ 10 bp upstream of the Met16 codon corresponds to a bacterial ribosome 
binding site, thus exacerbating the problem.  Similar problems have been reported with 
other proteins (Matsumiya et al., 2001).  In order to circumvent the alternative start site, a 
point mutant (M16L) was made, in which a Leu was substituted for Met16.  This mutant 
was expressed as a single full-length polypeptide and was purified to better than 99% 
pure.  It differs from the wild type sequence only in the M16L mutation and 14 amino 
acids appended to the C-terminus (the 6xHis tag and an 8-aa linker).  This M16L mutant 
was used for all the studies reported here. 
Phasing with single-wavelength anomalous scattering data 
 The crystal structure was determined using single wavelength anomalous 
scattering data collected at a wavelength near the peak of fluorescence at the LIII edge of 
iridium.  An anomalous difference Patterson map revealed a single well-occupied Ir site 
and a few much weaker potential sites.  SHELXD (Uson and Sheldrick, 1999) was used 
to evaluate the heavy atom sites and how well they correlate with the Patterson map.  The 
two top sites were input to MLPHARE (Otwinowski, 1991; CCP4, 1994) for further 
refinement and phase calculation.  The anomalous difference Fourier map calculated 
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from these phases gave four unique peaks above the 5.5 sigma contour level.  The 
positions of the two new peaks also matched the third and fifth sites predicted by 
SHELXD.  These four sites were then input to MLPHARE for refinement and phase 
calculation.  The four iridium atoms (designated as Ir1, Ir2, Ir3 and Ir4) have occupancies 
of 0.74, 0.50, 0.36 and 0.39, and temperature factors of 57, 59, 64 and 67, respectively 
after refinement with MLPHARE.  The atom Ir1, which has the highest occupancy and 
lowest B-factor, gave the strong peak in the Patterson map. 
 Density modification with solvent flattening, histogram matching and multi-
resolution modification by DM (Cowtan, 1994) was carried out to improve the phases 
and to identify the correct absolute configuration.  The Fourier map after DM showed 
enough secondary structure elements to locate the two-fold non-crystallographic 
symmetry (NCS) axis.  Two-fold NCS averaging with DM significantly improved the 
quality of the electron density map (Figure 5.1), and the entire map was continuous and 
could be easily traced.  Automatic model building by ARP/wARP (Perrakis et al., 1999) 
at a resolution of 1.85 Å built more than 80% of the model.  The map calculated at this 
resolution with phases from the auto-built model showed clear side chains for more than 
80% of the residues, and a complete model was built in a single round of manual 
rebuilding. 
Overall structure 
 The refined crystal structure of the PA Nudix protein shows that it forms a dimer.  
Each subunit also contributes two β-strands to the β-sheet of the other subunit to form an 
extensive dimer interface.  The dimer is held together mainly by the two β-sheets to 
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which both subunits contribute strands.  Hydrogen bonding interactions occur between 
strand β5b of one subunit and β6 of the other subunit (Figure 5.2 and 3).  There are eight 
main chain hydrogen bonds between two subunits in the dimer.  In addition, a patch of 
residues with hydrophobic side chains, Ile2, Ile77, Leu94, Pro38, Pro74, Tyr61, Tyr96, 
Phe92 and Met73, located at the center of the dimer interface, also contribute to the 
binding energy of the dimer.  The molecular surface of each monomer, calculated with 
the program GRASP (Nicholls et al., 1991), is about 7500 Å2, and the total buried surface 
in the dimer interface is about 2000 Å2.  Dimer (and possibly tetramer) formation in 
solution was confirmed by analytical ultracentrifugation studies (data not shown). 
 Each subunit (referred to as A and B) is composed of a mixed β-sheet and two α-
helices (Figure 5.2).  The β-sheet is highly curved and twisted, and wraps around the 
helices.  The topology of the protein is shown in Figure 5.3.  Most of the strands are 
connected by tight turns or short loops, with the longest loop consisting of only six 
residues.  The β-sheet can be divided into a central sheet and a sub-sheet, which are 
connected through strand β2.  The N-terminal part of strand β2 forms hydrogen bonds 
with the C-terminal part of β1, but then curves and makes a sub-sheet with strands β3, β8 
and β9.  Strands β1, β4 to β7, together with β5a′ and β5b′ from the other subunit, form 
the central β sheet. 
The two dimer subunits are similar to each other in both Native-1 and Native-2 
crystal forms. However, in the Native-1 form subunit A has a long C-terminal helix that 
extends away from the molecular surface, whereas in subunit B the C-terminal residues 
turn back and form a more compact structure, making the helix shorter (Figure 5.4A). 
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Interestingly, the residues in the linker to the His6x tag are ordered in 2Fo – Fc maps for 
both the Native-1 (P212121) and Native-2 (P21) Nudix crystals, but adopt different 
conformations that give rise to these two different crystal forms in an easily 
understandable way. As mentioned, in the Native-1 form the subunit A linker residues 
extend the C-terminal helix (α2 in Figures 2 and 3), thereby making crystal contact 
interactions with adjacent, crystallographically-related A+B dimers in the P212121 lattice. 
However, in the Native-2 crystals the C-terminal helices of both subunits (A+B) are fully 
extended, thereby allowing four Nudix monomers (A+B+A’+B’) to pack into the 
asymmetric unit of the lower-symmetry P21 lattice as a tetramer with 222 symmetry 
(Figure 5.4B). The A+B and A’+B’ dimers associate via their extended C-terminal 
helices and form a tetramer which is composed of two Nudix dimers that are nearly 
identical to the ones seen in the Native-1 form (except for the C-terminal helices of 
subunits B, B’, Figure 5.4B). Since the scant interactions between the helices of these two 
dimers mainly involve residues from the hydrophobic linker to the His6x tag, this Nudix 
tetramer is not likely to be biologically significant. Nonetheless, it is a peculiar example 
of a His tag resulting in an artefactual oligomerization state for a crystallized protein. 
The conserved residues and the active site cleft 
 The Nudix box sequence signature motif, G30X5E36X7R44E45UXE48E49XG51U (the 
superscripts refer to the residue number in the PA Nudix sequence) spans the strand β4, 
helix α1 and the N-terminal part of strand β5 (Figure 5.5 and 6).  The conserved residues 
are at the same relative positions in three-dimensional space as those in the E. coli MutT 
structure (Figure 5.7).  These residues probably play similar roles throughout the Nudix 
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enzyme family.  All side chains of the conserved residues are on the same side of helix 
α1.  The semi conserved hydrophobic residues, Phe46 and Ile52, interact with the 
residues on the central β sheet, and are probably important for anchoring the catalytic 
helix to the central β sheet.  The conserved glutamate side chains are involved in 
hydrogen bonds with nearby side chain and main chain atoms (Figure 5.6), and are in 
conformations that are not capable of coordinating a metal ion.  It is possible that when in 
solution or at high temperatures the side chains can rearrange to bind the metal ion.  
However, the carbonyl oxygen of conserved Gly30 is involved in a hydrogen bond to the 
strand β1, and is not available for coordinating the metal ion.  The carbonyl oxygen of the 
corresponding glycine in E. coli MutT was found to be a ligand to the enzyme bound 
metal ion (Lin et al., 1997).  However, in both the AP4A hydrolase and the ADPRase, the 
corresponding glycine was also found to have a conformation incapable of coordinating 
the metal ion.  It is likely that it is the small size of this conserved glycine residue that is 
important for the catalytic function of the Nudix enzymes.  The side chain of conserved 
Arg44 in the PA Nudix is well ordered, and its guanidinium group interacts with the side 
chains of Glu45, Glu36 and Glu48 (Figure 5.6).  The putative function of this conserved 
arginine in the E. coli MutT is to orient the side chain of Glu45, which is proposed to 
function as a general base (Harris et al., 2000; Lin et al., 1997). 
 There is a deep narrow cleft connecting the catalytic helix α1 at the front to the 
N-terminus of helix α2 at the back (Figure 5.2B).  Strands β1, β4 and β7 form the floor 
of the cleft.  Strand β6 and part of β7, together with β5a′ and β5b′ from the other subunit, 
form one wall of the cleft, while β2-loop-β3 and β9 to the N-terminal end of α2 form the 
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other wall.  In the NMR solution structure of the E. coli MutT, the nucleoside group of 
the substrate analog AMPCPP was found to bind in the corresponding cleft (Figure 5.7).  
It is possible that in the PA Nudix protein, this cleft also functions in the recognition of 
the substrate.  The loop between β2 and β3 and the turn between β6 and β7 tilt toward the 
center of the cleft, partially covering the top of the cleft.  The positions of these residues 
differ most greatly between the two subunits in the dimer (Figure 5.8), thus indicating 
their potential flexibility for accommodating the binding of substrates. 
Sulfate-binding sites 
 For the Ir derivative and Native-1 crystals, which were obtained in the presence of 
50 mM (NH4)2SO4, a sulfate ion was found at the N-terminus of the last helix (α2) of 
each subunit, sitting at one end of the active site cleft (Figures 2B and 7).  The oxygen 
atoms of the sulfate ion form hydrogen bonds with the main chain nitrogen atoms of 
Asn124, Val125, Arg126 and Lys127.  In molecule A, both side chains of Arg126 and 
Lys127 are well ordered, and form hydrogen bonds with the oxygen atoms of the sulfate.  
However, in subunit B these two residues have partially disordered side chains.  The 
sulfate bound to subunit B has a higher B factor (Table 5.2), possibly indicating a lower 
occupancy.  Asn124 has main chain dihedral angles in the left-handed helix region of the 
Ramachandran plot (φ ~ 70° and ψ ~ 0°).  This is necessary for the optimal interaction of 
its backbone amide group with the sulfate ion.  In one crystal form (P21 space group with 
two molecules in one asymmetric unit, data not shown), molecule B has a very low 
occupancy of sulfate, and the electron density maps indicated that there are two 
conformations for Asn124, with one conformation having regular main chain dihedral 
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angles (φ ~ –75° and ψ ~ –25°).  We note that in E. coli MutT, the amino terminal Asn 
residue of helix 2 (N119) interacts with the 6-oxo group of dGTP (Lin et al., 1997). 
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Discussion 
Comparison with other Nudix hydrolases of known three-dimensional structure 
 The PA Nudix protein adopts the same fold as the E. coli MutT.  However, the 
two structures are quite different.  Figure 5.7 shows the superposition of the Cα traces of 
E. coli MutT onto that of the subunit A of PA Nudix.  Only β1, α1, and part of β7 can be 
aligned.  The rmsd over the 30 Cα atoms aligned is 1.48 Å.  When structures are aligned 
based on these secondary structure elements, most of the long β-strands are close in space 
in the two structures.  However, the short β-strands and α2 are shifted relative to each 
other.  The β-strands of the PA Nudix enzyme are highly curved compared to those in the 
MutT and the AP4A hydrolase.  As a result, the active site cleft is narrower and deeper in 
the PA Nudix structure.  This indicates that the PA Nudix hydrolase is likely to have a 
different substrate from those of MutT or AP4A hydrolase.  In the crystal structure of 
ADPRase complexed with ADP-ribose (Gabelli et al., 2001), the terminal ribose group 
binds in the active site cleft, while the adenine moiety interacts with the N-terminal 
domain which is involved in dimer formation through domain swapping.  The PA Nudix 
does not have this N-terminal domain, and thus is unlikely to have the same ADP-sugar 
hydrolase activity. 
 In the PA Nudix hydrolase structure, the N-terminal end of the long helix α2 is 
located at the other end of the active site cleft opposite to the catalytic helix, and a sulfate 
ion was found binding at the N-terminal end of α2 (Figure 5.2B and 7).  The distance 
between the Nudix box residues to the sulfate binding site is about 20 Å.  This sulfate-
binding site could potentially be a binding site for a phosphate group on the substrate, 
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although the distance is large.  It is possible that this Nudix enzyme hydrolyzes substrates 
that have a phosphate group away from the scissile bond that can bind to the N-terminal 
end of the helix α2.  An attempt to identify potential substrates for the PA Nudix protein 
showed that it is inactive against 14 typical substrates for known Nudix enzymes (ADP-
ribose, ADP-mannose, ADP-glucose, GDP-mannose, GDP-glucose, UDP-mannose, 
UDP-glucose, Ap2A, Ap3A, Ap4A, NADH, deamino-NADH, NAD and FAD) (Yang, 
Wang and Mura, unpublished results).  These results suggest that PA Nudix is potentially 
a novel Nudix enzyme.  Alternatively, PA Nudix may be inactive because of the M16L 
mutation, or because the active form lacks residues 1-15. 
Thermostability 
 P. aerophilum is a hyperthermophile that grows optimally at 100°C (373 K, Volkl 
et al., 1996).  The dimeric form of the PA Nudix might contribute to the thermostability 
of this enzyme.  Intersubunit interactions have been proposed to be a major stabilization 
mechanism for hyperthermophilic proteins (Vieille and Zeikus, 2001).  In addition, ion 
pairs and hydrophobic interactions between subunits make the dimer more resistant to 
dissociation.  Two ion pairs were found between the subunits, Glu79 of one subunit to 
Arg71 of the other.  Another factor that may contribute to the thermostability of this 
protein is that PA Nudix has very few residues in loops.  Thompson and Eisenberg (1999) 
compared the sequences of about 20 complete genomes and found that thermophilic 
proteins generally have loop deletions relative to their mesophilic homologs.  Sequence 
alignment between E. coli MutT and PA Nudix showed a deletion at loop1 of PA Nudix 
sequence (Figure 5.5).  In addition, the loops are shortened by incorporating more 
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residues in the secondary structure elements.  About 75% of residues are in β-strands and 
α-helices, compared to only about 49% in the E. coli MutT protein (Figure 5.5).  More β-
strands are present in the PA Nudix structure and the β- strands are connected mostly by 
tight β-turns. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 162
References 
Abeygunawardana, C., Weber, D. J., Gittis, A. G., Frick, D. N., Lin, J., Miller, A.-F., 
Bessman, M. J. and Mildvan, A. S. (1995).  Biochemistry 34, 14997-15005. 
 
Barton, G. J. (1993).  Protein Engineering 6, 37-40. 
 
Bessman, M. J., Frick, D. N. and O'Handley, S. F. (1996).  J. Biol. Chem. 271, 25059-
25062. 
 
Bhatnagar, S. K., Bullions, L. C. and Bessman, M. J. (1991).  J. Biol. Chem. 266, 9095-
9054. 
 
Brunger, A.T., Adams, P.D., Clore, G.M., DeLano, W.L., Gros, P., Grosse-Kunstleve, 
R.W., Jiang, J.-S., Kuszewski, J., Nilges, N., Pannu, N.S., Read, R.J., Rice, L.M., 
Simonson, T., and Warren, G.L. (1998).  Acta Cryst. D54, 905-921. 
 
Carson, M. (1997).  Methods Enzymol. 277, 493-505. 
 
Collaborative Computational Project Number 4 (1994).  Acta Cryst. D50, 760-763. 
 
Cowtan, K. (1994). DM: An automated procedure for phase improvement by density 
modification. Joint CCP4 and ESF-EACBM Newsletter on Protein Crystallography 31, 
34-38. 
 
Frick, D. N., Weber, D. J., Abeygunawardana, C., Gittis, A. G., Bessman, M. J. and 
Mildvan, A. S. (1995).  Biochemistry 34, 5577-5586. 
 
Gabelli, S. B., Bianchet, M. A., Bessman, M. J. and Amzel, L. M. (2001).  Nature Struct. 
Biol. 8, 467-472. 
 
Harris, T. K., Wu, G., Nassiah, M. A. and Mildvan, A. S. (2000).  Biochemistry 39, 1655-
1674. 
 
Jones, T. A., Zou, J. Y., Cowan, S. W. and Kjeldgaard, M. (1991).  Acta Cryst. A47, 110-
119. 
 
Kissinger, C., Gehlhaar, D. K. and Fogel, D. B. (1999).  Acta Cryst. D55, 484-491. 
 
Kraulis, P. J.  (1991).  J. Applied Crystallogr. 24, 946-950. 
 
Lin, J., Abeygunawardana, C., Frick, D. N., Bessman, M. J. and Mildvan, A. S. (1996).  
Biochemistry, 35, 6715-6726. 
 
 163
Lin, J., Abeygunawardana, C., Frick, D. N., Bessman, M. J. and Mildvan, A. S. (1997).  
Biochemistry, 36, 1199-1211. 
 
Matsumiya, S., Ishino, Y. and Morikawa, K. (2001).  Protein Sci. 10, 17-23. 
 
McRee, D.E. (1992).  J. Molec. Graphics, 10, 44-46. 
 
Navaza, J. (1994).  Acta Cryst. A50, 157-163 
 
Nicholls, A., Sharp, K. and Honig, B. (1991). PROTEINS, Structure, Function and 
Genetics 11, 281ff. 
 
O’Handley, S. F., Dunn, C. A. and Bessman, M. J. (2001). J. Biol. Chem. 276, 5421-
5426. 
 
Otwinowski, Z. (1991). Isomorphous Replacement and Anomalous Scattering (W. Wolf, 
P. R. Evans and A. G. W. Leslie, ed.), p.80. Science and Engineering Research Council, 
Daresbury Laboratory, Daresbury, U. K. 
 
Otwinowski, Z. and Minor, W. (1996).  Methods Enzymol. 276, 307-326. 
 
Perrakis, A., Morris, R.M. and Lamzin, V.S. (1999).  Nature Structural Biology 6, 458-
463. 
 
Porter, D. W., Nelson, V. C., Fivash, M. J. and Kasprzak, K. S. (1996).  Chem. Res. 
Toxicol. 9, 1375-1381. 
 
Safrany, S. T., Caffrey, J. J., Yang, X., Bembenek, M., Moyer, M. B., Burkhart, W.A. 
and Shears, S. B. (1998).  EMBO J. 17, 6599-6607. 
 
Shimokawa, H., Fujii, Y., Furuichi, M., Sekiguchi, M. and Nakabeppu, Y. (2000).  Nucl. 
Acid. Res. 28, 3240-3249. 
 
Swarbrick, J. D., Bashtannyk, T., Maksel, D., Zhang, X.-R., Blackburn, G. M., Gayler, K. 
R. and Gooley, P. R. (2000).  J. Mol. Biol. 302, 1165-1177. 
 
Taddei, F., Hayakawa, H., Bouton, M.-F., Cirinesi, A.-M., Matic, I., Sekiguchi, M. and 
Radman (1997).  Science 278, 128-130. 
 
Thompson, J.D., Higgins, D.G., Gibson, T.J. (1994).  Nucleic Acids Res. 22, 4673-4680. 
 
Thompson, M. J. and Eisenberg, D. (1999).  J. Mol. Biol. 290, 595-604. 
 
Uson, I. & Sheldrick, G. M. (1999).  Curr. Opinion in Struct. Biol. 9, 643-648. 
 164
 
Vieille, C. and Zeikus, G. J. (2001).  Microb. Molec. Biol. Rev. 65, 1-43. 
 
Volkl, P., Markiewicz, P., Baikalov, C., Fitz-Gibbon, S., Stetter, K. O. and Miller, J. H. 
(1996).  Nucl. Acid. Res. 24, 4373-4378. 
 
Wagner, J., Kamiya, H. and Fuchs, R. P. P. (1997).  J. Mol. Biol. 265, 302-309. 
 165
Figure legends 
Figure 5.1: A section of the initial electron density map superimposed on the final 
coordinates. The map was calculated at 2.5 Å with phases after 2-fold NCS averaging, 
and contoured at 1.3 σ.  The figure was generated with the program O and rendered with 
POV-RAY. 
Figure 5.2: Ribbon diagrams of the PA Nudix structure. Panel A shows the dimer 
with the 2-fold NCS axis perpendicular to the paper plane.  Each subunit is composed of 
a long, highly twisted central β sheet and a small sub-sheet connected through strand β2, 
sandwiched between two α helices.  Each subunit contributes two β strands (β5a and 
β5b) to the β sheet of other subunit to form the dimer interface.  Subunit A (on the left) 
has a long C-terminal helix α2 with the 8 amino acid linker at the C-terminal end 
extending the helix, while subunit B has a shorter helix α2 and its C-terminus and the 
linker fold back to form a more compact structure.  Panel B is a near 180° rotation of 
panel A along a horizontal axis.  A cleft formed by the β strands connects helix α1 in the 
front to the N-terminal end of helix α2 in the back.  The conserved arginine and 
glutamate side chains, as well as two sulfate ions found at the N-terminal end of α2 of 
each subunit are shown as sticks.  The figure was generated with the program RIBBONS 
(Carson, 1997). 
Figure 5.3: The topology diagram of the PA Nudix structure. The strand β1 is 
connected by a type II β turn to β2, which forms hydrogen bonds with the C-terminal part 
of β1 and then makes a curve to form hydrogen bonds to β3, making a sub-sheet with 
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strands β8 and β9.  A proline makes a kink at the end of β3, allowing β4 to have 
hydrogen bonds to the N-terminal half of β1.  A small loop connects β4 to helix α1.  
Strands β5 and β6 together form an almost continuous strand antiparallel to the longest 
strand β7.  Strands β5a and β5b go to the other subunit and form part of its central β 
sheet, while strands β5a′ and β5b′ are from the other subunit.  The last helix α2 is 
connected to β9 by a type I β turn.  There are more β strands in this protein structure than 
in the E. coli MutT.  The shaded β strands are the strands that are present in the E. coli 
MutT structure. 
Figure 5.4: A comparison of the native Nudix crystal structures in the tetrameric 
P212121 (Native-1) and dimeric P21 (Native-2) crystal forms. In panel A the Cα traces 
of the two dimers in the asymmetric unit of the Native-2 form (blue and lavender) are 
superimposed in two orthogonal views, along with the single dimer from the asymmetric 
unit of the Native-1 form (red). These structures superimpose very well (~0.5 Å rmsd for 
all three unique pairs of dimers), and it can be seen that the only significant differences 
lie in the C-terminal helices (which are extended in the Native-2 structure). The extended 
helices allow two Nudix dimers to crystallize as a tetramer in the P21 form – shown as 
Cα traces in panel B. The contents of one unit cell are drawn as viewed down the 
crystallographic 21 axis, with each of the two tetramers colored various hues of red or 
blue. Note the inter-dimer helix-helix contacts.   
Figure 5.5: Sequence alignment between the E. coli MutT and the PA Nudix. The 
sequences were aligned with CLUSTAL-W (Thompson et al., 1994) and the figure was 
generated by ALSCRIPT (Barton, 1993).  The sequence of the PA Nudix protein also 
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includes an 8 amino acid linker at the C-terminal end.  The identical residues were 
highlighted in black.  Helices and β strands of the two structures are marked with 
cylinders and arrows, respectively.  The two sequences align well only around the Nudix 
box signature motif (boxed residues).  The PA enzyme has more β strands and much 
shorter loops. 
Figure 5.6: Conserved Nudix box residues. The structure around the active site is 
shown as a ribbon representation with residues in strand β4 and conserved side chains of 
the catalytic helix shown as sticks.  The semi conserved hydrophobic side chains, Phe46 
and Ile52, are also shown.  All the conserved side chains are on one side of helix α1, 
while the side chains of Phe46 and Ile52 are buried and face the central β sheet.  
Hydrogen bonds from the conserved side chains are shown in red dashed lines. 
Figure 5.7: Structure superposition between the subunit A of PA Nudix and the E. 
coli MutT. The E. coli MutT structure (PDB code 1tum, Lin et al., 1997) is shown in red 
and its bound AMPCPP shown in ball-and-stick.  The two structures were aligned based 
on β1, α1 and part of β7 of the PA structure.  They have similar folds and the conserved 
residues in the Nudix motif (shown as black dots) are at similar positions.  However, 
away from helix α1 the two structures are quite different.  The active site cleft is much 
narrower and deeper in the PA Nudix structure.  The adenosine group of the AMPCPP in 
the E. coli MutT structure binds in the active site cleft.  A sulfate ion was found at the N-
terminus of α2 of the PA protein (shown as ball-and-stick), indicating a possible binding 
site for a phosphate group.  The figure was generated with MOLSCRIPT (Kraulis, 1991). 
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Figure 5.8: Rmsd in Å of the main chain atomic positions for the superimposed 
subunits of the Native-1 dimer. The solid line is from the structure of the iridium 
derivative crystal and the dashed line is from the native crystal.  Higher rmsd was 
observed for residues 18 – 25, 79 – 90 and 64 – 69, which form the walls of the active 
site cleft, indicating their flexibility.  The peak around residue 32 is due to partially 
disorder of the loop (higher B factors), while peaks around residues 110 – 120 and after 
135 are due to differences in crystal contacts of the two subunits.  A plot of the rmsd 
atomic positions between the dimers of the two different crystals (not shown) also gives 
the same peaks at residues 18 – 25, 79 – 90 and 64 – 69, but with a smaller scale. 
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Table 5.1. Statistics of data collection for PA Nudix. 
 
 Ir derivativea Native-1a Native-2b
Space group P212121 P212121 P21
Cell parameters (Å) 
a = 52.42 
b = 71.66 
c = 85.76 
a = 52.71 
b = 72.61 
c = 85.18 
a = 52.71 
b = 72.61 
c = 85.18 
β = 99.96° 
Resolution (Å) 100 – 1.85 100 – 1.8 90 – 2.4 
Unique reflections  
(Observed reflections) 
25455 
(348337) 
30654 
(398012) 
23707 
(84048) 
Completeness (last bin)c (%) 89.3 (52.0) 98.8 (96.4) 98.2 (97.0) 
Anomalous completeness  
(last bin)c (%)d 87.6 (69.8)   
I/σ (last bin)c 18.7 (3.2) 18.4 (3.2) 14.1 (3.0) 
Rsyme (last bin)c 0.076 (0.470) 0.080 (0.443) 0.093 (0.465) 
# subunit per asymmetric unit 2 2 4 
X-ray wavelength (Å) 1.1053 1.10 1.5418 
 
a. Data for the Ir derivative and Native-1 were collected at the synchrotron.  The cell 
dimensions for the two data sets are similar.  However, the two crystals have 
different packing, and therefore are not isomorphous. 
b. Native-2 crystals were obtained from drops equilibrated against 100 mM MES pH 
6.2 and 15% MPD.  Data were collected on an RAXIS IV++ detector. 
c. The highest resolution bin is from 1.92 to 1.85 Å for the Ir derivative data and from 
1.86 to 1.80 Å for the native data. 
d. Anomalous data were processed to 2.0 Å, with the last bin from 2.07 Å to 2.0 Å. 
e. Rsym = Σ|(Ihkl - <Ihkl>)|/ΣIhkl, where <Ihkl> is the average of Ihkl over all symmetry 
equivalents. 
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Table 5.2. Statistics for atomic refinement of PA Nudix. 
 
 Ir derivative Native-1 Native-2 
Resolution range for 
refinement (Å) 20 – 1.85 20 – 1.8 20 – 2.4 
# protein atoms 2374 2416 4732 
<B>-factor protein  
atoms (Å2)a 26.1 19.65 31.9 
# other molecules  
(<B>-factors) 
2 SO4 (25.2, 36.6); 
4 Ir (34.7);  
2 Ni (74.4); 
3 glycerol (37.1); 
5 acetate (46.2); 
149 H2O (34.4) 
2 SO4 (21.1, 42.6); 
2 Ni (66.1); 
6 glycerol (38.8); 
2 acetate (30.9); 
244 H2O (29.6) 
6 MPD 
(64.8); 
173 H2O 
(30.9) 
Rmsd bond length (Å) 0.017 0.019 0.013 
Rmsd bond angle (Å) 1.8 1.8 1.8 
Rfreeb 0.218 0.219 0.274 
Rworkb 0.182 0.183 0.190 
 
a. The Ir derivative crystal has a higher mosaicity (about 1.2°) than the native crystal  
(about 0.7°). 
b. R-factors were calculated using data in the resolution range for refinement without 
a σ cutoff.  Rfree was calculated with a set of data (8%) never used in the 
refinement.  Rwork was calculated against the data used in the refinement. 
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Figure 5.1: A section of the initial electron density map superimposed on the final    
                   coordinates. 
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Figure 5.2: Ribbon diagrams of the PA Nudix structure. 
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Figure 5.3: The topology of the PA Nudix structure. 
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Figure 5.4: A comparison of the Nudix crystal structures in the P212121 (Native-1) and P21 (Native-2) crystal forms. 
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Figure 5.5: Sequence alignment between the E. coli MutT and PA Nudix. 
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Figure 5.6: Conserved Nudix box residues. 
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Figure 5.7: Structure superposition between the subunit A of PA Nudix and the  
                   E. coli MutT. 
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Figure 5.8: RMSD in Å of the main-chain atomic positions for the superimposed    
                    subunits of the Native-1 dimer.   
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Appendix to the Dissertation: 
 
Various UNIX and Perl scripts used in this research  
 
 
 
 
A brief description of each script: 
 
make14mer.com – generates a 14-mer from a 7-mer input PDB file 
 
racc.pl –  rare codon calculator, to predict if rare Arg, Leu, Ile, or Pro codons may be a   
                problem in protein over-expression in E. coli 
 
make_homology_model.pl –  to create molecular replacement homology models from 
            an input sequence alignment and PDB file 
 
scripted_glrf.sh, alter.pl, and process_bigrun.pl –   
to calculate cross-rotation functions that are systematically   
             varied over the integration radius and resolution limits 
 
map_conservation_to_B.pl –  to map sequence conservation values to the B-factor  
                                                 fields of a PDB file 
 
symm.csh and write_pdbset.pl –  
calculates all non-crystallographic symmetry transformations and expands the 
monomeric subunit into the multimer (matrix of all pairwise RMSDs between 
subunits of the multimer is output as well) 
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 “/asimov2/users/cam/REDID_1108/14MER_MODEL/make14mer.com” 
 
#!/bin/csh -f 
 
# This c-shell script builds a 14-mer model given the most recent 7-mer structure  
# available 
#  
# The input consists of: 
# 
# (1) A PDB file containing most recent 7-mer structure ("hept_exp_from_mono6.pdb")  
# (2) A PDB file containing the atoms from which the center of gravity and rotational  
#     axes will be calculated ("cys7sg.pdb")  
# (3) Command line-input values for the desired translation distance (in Angstroms)  
#     and rotation angle (in degrees)  
# (4) NOTE: The input PDB files must contain the "CRYST" "SCALE" and "ORIGX" lines 
#           The chains must be labelled by distinct chainid's, starting from 'A'.    
# 
# The output consists of: 
# 
# (1) A PDB file containing the input 7-mer translated so that its desired COG lies at 
#     the origin ("translate1.pdb") 
# (2) A PDB file of the rotated heptamer ("lsqkab.pdb") 
# (3) A PDB file of the composite 14-mer ("make14mer_output.pdb") 
# (4) plus some log files if the last clean-up step is commented out 
 
##### INITIALIZE VARIABLES TO NULL ##### 
 
set v1; set v2; set v3 
set norm_v1; set norm_v2; set norm_v3  
set count 
set dist 
set angle 
 
##### ASK FOR THE FINAL TRANSLATION DISTANCE (IN ANGSTROMS) IF NOT INPUT ON COMMAND LINE  
##### 
##### ASK FOR THE FINAL DESIRED ROTATION ANGLE (IN DEGREES) IF NOT INPUT ON COMMAND LINE  
##### 
 
if ( ${1} == "") then 
   echo ""; echo "Program needs command line-input TRANSLATION DISTANCE \!\!\!"; echo "" 
   kill -9 $$ 
else set dist = $argv[1]; echo ""; echo "translation distance will be: $dist angstroms" 
endif  
 
if ( ${2} == "") then 
  echo ""; echo "Program needs a command line-input ROTATION ANGLE \!\!\!"; echo "" 
   kill -9 $$ 
else set angle = $argv[2]; echo ""; echo "rotation angle will be: $angle degrees" 
endif 
 
##### CALCULATE THE CENTER OF GRAVITY FOR THE SG atoms OF THE CYS RING OF THE 7-MER ##### 
 
pdbset xyzin cys7sg.pdb << eof-1 > cog.log  
SPACEGROUP C2 
COM 
eof-1 
 
##### TRANSLATE INPUT 7-MER SO THAT CENTER OF GRAVITY OF CYS SG LIES AT ORIGIN ##### 
 
echo "#\!/bin/csh -f" > translate1.com 
echo "pdbset XYZIN almost_pruned.pdb XYZOUT translate1.pdb << eof-2 > translate1.log" >> 
translate1.com 
echo "" >> translate1.com 
echo "TRANSFORM 1 0 0 -" >> translate1.com 
echo "          0 1 0 -" >> translate1.com 
echo "          0 0 1 -" >> translate1.com 
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echo -n "          " >> translate1.com 
echo -n "-"`(grep "   Center of Mass:" cog.log) | awk '{print $4}' ` >> translate1.com 
echo -n "  " >> translate1.com 
echo -n "-"`(grep "   Center of Mass:" cog.log) | awk '{print $5}' ` >> translate1.com 
echo -n "  " >> translate1.com 
echo -n "-"`(grep "   Center of Mass:" cog.log) | awk '{print $6}' ` >> translate1.com 
echo -n "  " >> translate1.com 
echo "" >> translate1.com 
echo "SPACEGROUP C2" >> translate1.com 
echo "eof-2" >> translate1.com 
 
chmod 755 translate1.com 
translate1.com 
 
##### USE AL_MOLEMAN TO SPLIT THE 7-MER INTO MONOMERS FOR UPCOMING USE IN ALIGN_V2 ##### 
 
al_moleman << eof > al_moleman.log 
 
translate1.pdb 
split 
split_ 
quit 
eof 
 
##### CALCULATE AND NORMALIZE THE VECTOR ABOUT WHICH ROTATION WILL BE PERFORMED ##### 
 
set v1 = `grep SG translate1.pdb | head -1 | awk '{print $7}' ` 
set v2 = `grep SG translate1.pdb | head -1 | awk '{print $8}' ` 
set v3 = `grep SG translate1.pdb | head -1 | awk '{print $9}' ` 
 
echo "" 
echo "unnormalized rotation axis = "$v1 $v2 $v3 
 
set count=0 
 
foreach z ($v1 $v2 $v3) 
set count=`expr $count + 1` 
echo "scale=5" > bc.script  
echo "l=sqrt(`echo $v1`^2 + `echo $v2`^2 + `echo $v3`^2)" >> bc.script 
echo "i=$z/l" >> bc.script 
echo "i" >> bc.script 
echo "quit" >> bc.script 
 
if ($count == 1) then  
set norm_v1 = `bc bc.script` 
endif 
if ($count == 2) then 
set norm_v2 = `bc bc.script` 
endif 
if ($count == 3) then 
set norm_v3 = `bc bc.script` 
endif 
 
end 
 
echo "" 
echo "normalized rotation axis = "$norm_v1  $norm_v2  $norm_v3; echo " "; 
 
##### CALCULATE THE VECTOR ALONG WHICH THE TRANSLATION WILL TAKE PLACE  
##### (i.e. THE 7-FOLD ROTATION AXIS)  
##### USING ALIGN_V2 PROGRAM. NOTE THAT IT'S ALREADY NORMALIZED IN THE ALIGN_V2 OUTPUT  
##### 
 
align_v2 << eof > split.log 
 
1 
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split_a.pdb 
 
PDB 
split_b.pdb 
 
PDB 
AUTO 
split_a_to_b.rot 
split_a_to_b.show 
stop 
eof 
 
set norm_t1 = `grep direction split.log | awk '{print $4}' ` 
set norm_t2 = `grep direction split.log | awk '{print $5}' ` 
set norm_t3 = `grep direction split.log | awk '{print $6}' ` 
 
echo 
echo -n "normalized vector along which translation will be performed (i.e. 7-fold axis) =  
" 
echo $norm_t1 $norm_t2 $norm_t3 
 
##### NOW SCALE THE TO-BE-APPLIED TRANSLATION VECTOR BY THE COMMAND LINE-INPUT AMOUNT 
##### 
 
bc << eof > temp1 
-`echo $dist` * $norm_t1 
quit 
eof 
set use_t1 = `awk '{print $1}' temp1` 
 
bc << eof > temp2 
-`echo $dist` * $norm_t2 
quit 
eof 
set use_t2 = `awk '{print $1}' temp2` 
 
bc << eof > temp3 
-`echo $dist` * $norm_t3 
quit 
eof 
set use_t3 = `awk '{print $1}' temp3` 
 
echo "" 
echo -n "the scaled translation vector that will be applied = " 
echo $use_t1 $use_t2 $use_t3; echo " "; echo " "; 
 
##### PERFORM DESIRED ROTATION & TRANSLATION ALONG CALCULATED AXES VIA DIRECTION COSINES 
##### 
 
echo "#\!/bin/csh -f" > lsqkab.com 
echo "lsqkab XYZIN2 translate1.pdb XYZOUT lsqkab.pdb << eof-z > lsqkab.log" >> lsqkab.com 
echo "ROTATE DCS  "$norm_v1"  "$norm_v2"  "$norm_v3"    "${angle}  >> lsqkab.com 
echo "TRANSLATE  "$use_t1"  "$use_t2"   "$use_t3  >> lsqkab.com 
echo "END" >> lsqkab.com 
echo "eof-z" >> lsqkab.com 
 
chmod 755 lsqkab.com 
lsqkab.com 
 
########### END OF SCRIPTS, so...##### 
########### clean up stuff  ########## 
 
cat translate1.pdb lsqkab.pdb > make14mer_output.pdb  
 
rm split* temp* cog.log XYZOUT crap* al_moleman.log 
rm translate1.com translate1.log bc.script lsqkab.com lsqkab.log 
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“/asimov2/users/cam/RAC/racc.pl” 
 
#!/joule2/programs/bin/perl 
 
# Calculates the number of rare (for E. coli) Arg, Leu, Ile, and Pro codons in input  
# nucleic acid sequence file, and number of consecutive rare Arg, Leu, Ile, and Pro  
# codons if > 1 
 
# Ask for the nucleic acid sequence file name (if it was not entered on the command line) 
# and open it: 
 
if ($ARGV[0] eq undef)  
 {  
  print "Enter the name of the nucleic acid sequence file (in GCG format):"; 
  chomp ($naseq = <STDIN>); 
  if ($naseq =~ /\./) 
 {$output_file = $naseq . "..racc"; 
  $output_file =~ s/\..*?\.//g;} 
  else {$output_file = $naseq . ".racc";} 
  print "\nA file named \"$output_file\" will contain the results that follow\n\n"; 
  open (OUTFILE, ">$output_file") || die "Can't open \"$output_file\" for writing\n\n"; 
  } 
 
else {chomp ($naseq = $ARGV[0]);} 
 
open (NASEQ, $naseq) || die "Can't open sequence file: $naseq\n"; 
 
# check that the NA sequence file is in GCG format: 
 
chomp ($okornot = <NASEQ>); 
unless ($okornot =~ /!!NA_SEQUENCE\b/)  
{ 
 print "\nThe nucleic acid sequence file \"$naseq\" is not in GCG format!\n"; 
 if ($ARGV[0] eq undef)  
    {print OUTFILE "\nNucleic acid sequence file \"$naseq\" is not in GCG format!\n";} 
} 
 
# read in and process the NA sequence:  
 
@seq = <NASEQ>; 
 
for ($i = 0; $i <= $#seq; $i++)  
{ 
  if (($seq[$i] =~ /[bdefhijklmnopqrsuvwxyz]/i) |  
      !($seq[$i] =~ /\d/) | !($seq[$i] =~ /[a-z]/i))  
 {$seq[$i] = "";} 
}  
 
$whole_seq = join("", @seq); 
$whole_seq =~ s/[^a-z]//ig; 
#$whole_seq =~ s/(\d)|(\s)//g;   an almost equivalent way to do it 
 
# calculate properties of interest: 
 
$seq_length = rindex($whole_seq, /\w/); 
print "\nFor the following sequence from the input file \"$naseq\":\n";  
print "\n$whole_seq\n"; 
print "\nThe length is: $seq_length nucleotides\n\n"; 
 
if ($ARGV[0] eq undef)  
{ 
 print OUTFILE "For following sequence from input file \"$naseq\":\n"; 
 print OUTFILE "\n$whole_seq\n"; 
 print OUTFILE "\nThe length is: $seq_length nucleotides\n"; 
} 
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#warn user if DNA sequence isn't an ORF (i.e. multiple of 3 in length) 
 
unless ($seq_length % 3 == 0)    
{ 
 warn "\nNote: the sequence file \"$naseq\" is not an ORF\n"; 
 if ($ARGV[0] eq undef)  
   {print OUTFILE "\nNote: the sequence file \"$naseq\" is not an ORF\n";} 
} 
 
# initialize rac hash variables: 
 
%rac = (); 
 
$rac{rac_1x} = 0;                  # number of single rare Arg codons 
$rac{rac_2x} = 0;                  # number of tandem rare Arg codon repeats 
$rac{rac_3x} = 0;                  # number of triple rare Arg codon repeats 
 
@rac{10, 11} = ("(aga)|(agg)|(cga)", 0);     # no. single rare Arg codons 
@rac{10, 12} = ("(agg)|(aga)|(cga)", 0);     # no. tandem rare Arg codon rpts 
@rac{10, 13} = ("(agg)|(aga)|(cga)", 0);     # no. triple rare Arg codon rpts 
 
@rac{20, 21} = ("cta", 0);         # number of single rare Leu codons 
@rac{20, 22} = ("cta", 0);         # number of tandem rare Leu codon repeats 
@rac{20, 23} = ("cta", 0);         # number of triple rare Leu codon repeats 
 
@rac{30, 31} = ("ata", 0);         # number of single rare Ile codons 
@rac{30, 32} = ("ata", 0);         # number of tandem rare Ile codon repeats 
@rac{30, 33} = ("ata", 0);         # number of triple rare Ile codon repeats 
 
@rac{40, 41} = ("ccc", 0);         # number of single rare Pro codons 
@rac{40, 42} = ("ccc", 0);         # number of tandem rare Pro codon repeats 
@rac{40, 43} = ("ccc", 0);         # number of triple rare Pro codon repeats 
 
 
# parse the sequence from $whole_seq into codons and count away: 
 
for ($i = 1; $i <= ($seq_length/3); $i++) 
{ 
  $codon[$i-1] = substr($whole_seq, ($i-1)*3, 3); 
 
 if ($codon[$i-1] =~ /(agg)|(aga)|(cga)/i) 
 { $rac{rac_1x}++; push(@rac_1x_positions, $i); } 
 
 if ($i >= 2) 
 { 
 if (($codon[$i-1] =~ /(agg)|(aga)|(cga)/i) & ($codon[$i-2] =~ /(agg)|(aga)|(cga)/i)) 
  { $rac{rac_2x}++; push(@rac_2x_positions, $i); } 
 } 
 
 if ($i >= 3) 
 {if (($codon[$i-1] =~ /(agg)|(aga)|(cga)/i) & ($codon[$i-2] =~ /(agg)|(aga)|(cga)/i) 
                                     & ($codon[$i-3] =~ /(agg)|(aga)|(cga)/i)) 
 { $rac{rac_3x}++; push(@rac_3x_positions, $i); } 
 } 
} 
 
########## now repeat the same for Leu, Ile, and Pro codons:   ########### 
 
for ($a = 10; $a <= 40; $a += 10) 
{ 
 
for ($i = 1; $i <= ($seq_length/3); $i++) 
 
{ $a1 = $a + 1; $a2 = $a + 2; $a3 = $a + 3; 
 
 if ($codon[$i-1] =~ /($rac{$a})/i) 
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 { $rac{$a1}++;  push(@posit_1x, $i); 
 } 
 
 if ($i >= 2) 
 { 
 if (($codon[$i-1] =~ /($rac{$a})/i) & ($codon[$i-2] =~ /($rac{$a})/i)) 
  { $rac{$a2}++;  push(@posit_2x, $i); 
  } 
 } 
 
 if ($i >= 3) 
 {if (($codon[$i-1] =~ /($rac{$a})/i) & ($codon[$i-2] =~ /($rac{$a})/i) 
                                      & ($codon[$i-3] =~ /($rac{$a})/i)) 
  { $rac{$a3}++;  push(@posit_3x, $i); 
  } 
 } 
} 
 
push(@posit_1x, ("$rac{$a}" . $a1/10)); 
push(@posit_2x, ("$rac{$a}" . $a2/10)); 
push(@posit_3x, ("$rac{$a}" . $a3/10)); 
 
} 
 
for ($i = 1; $i <= ($seq_length/3); $i++) 
{$codon[$i-1] = $codon[$i-1] . " ";} 
 
for ($i = 0; $i <= ($rac{rac_1x}-2); $i++) 
        {$rac_1x_positions[$i] = $rac_1x_positions[$i] . ", ";} 
for ($i = 0; $i <= ($rac{rac_2x}-2); $i++) 
        {$rac_2x_positions[$i] = $rac_2x_positions[$i] . ", ";} 
for ($i = 0; $i <= ($rac{rac_3x}-2); $i++) 
        {$rac_3x_positions[$i] = $rac_3x_positions[$i] . ", ";} 
 
 
print "Number of total single rare Arg codons: $rac{rac_1x}\n"; 
if ($rac{rac_1x} > 0) 
{print "occurring at codons: @rac_1x_positions \n";} 
 
print "Number of tandem rare Arg codon double repeats: $rac{rac_2x}\n"; 
if ($rac{rac_2x} > 0) 
{print "occurring at codons:  @rac_2x_positions \n";} 
 
print "Number of tandem rare Arg codon triple repeats: $rac{rac_3x}\n\n"; 
if ($rac{rac_3x} > 0) 
{print "occurring at codons:  @rac_3x_positions \n\n";} 
 
###### preliminary output formatting of rare codons for Leu, Ile, and Pro: ###### 
 
print "Too lazy to beautify this new part right now...Results are in order for 
Arginine, Leucine, Isoleucine, and Proline, respectively (delimited by numbers 
1.1, 2.1, 3.1, 4.1 for singles; 1.2, 2.2, 3.2, 4.2 for doubles; etc.).\n"; 
 
print "\nSingle rare codons at positions:\n@posit_1x \n"; 
print "\nDouble rare codons at positions:\n@posit_2x \n"; 
print "\nTriple rare codons at positions:\n@posit_3x \n"; 
 
 
###### END OF RaCC SCRIPT ###### 
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“/asimov2/users/cam/UTILITIES/make_homology_model.pl” 
 
#!/joule2/programs/bin/perl 
 
# This program begins with a sequence alignment, of the sort produced by the GCG 
# "bestfit" program. It tabulates the positions that are strongly conserved. 
# Then, all strongly conserved residues (i.e. paired by either ':' or '|' in the 
# GCG output), ALAs, and GLYs are left alone, while all other residues are 
# truncated to ALA as in the "make_poly_ala.pl" program. Extra residues in 
# the homology model probe protein that correspond to gaps in the actual protein 
# of interest will be deleted.  
# 
# NOTE: It is assumed that the input PDB file has been edited to contain only 1  
# copy of each unique chain that exists in the sequence alignment; and that the  
# beginning and ending residues in the PDB file correspond to those at the beginning  
# and end of the sequence aligned homology model protein (even though all other  
# residues in the PDB file will be unaltered).    
 
# input all of the file names, check that they're accessible 
 
print "\nEnter the name of the GCG .pair sequence alignment file: "; 
chomp ($sa_input = <STDIN>); 
 
open (SA_INFILE, $sa_input) || die "Can't open sequence alignment file 
\"$sa_input\"\n\n"; 
 
 
print "\nEnter 't' if the homologous protein of known structure is the top 
sequence or 'b' if it's the bottom sequence of the sequence alignment: "; 
chomp ($top_or_bot = <STDIN>); 
 
 
print "\nEnter the name of the PDB input file: "; 
chomp ($pdb_input = <STDIN>); 
if ($pdb_input =~ /\./) {$pdb_output = $pdb_input; $pdb_output =~ 
s/\./_HOMOLOGY_MODEL\./;} 
else {$pdb_output = $pdb_input . "_HOMOLOGY_MODEL\.pdb";} 
 
 
# process the .pair file to extract conserved residues and those that should be  
# deleted 
 
@strings = <SA_INFILE>; 
 
for ($i = 0; $i <= $#strings; $i++) 
 {  
   if ( $strings[$i] =~ /\s+\d+\s+[A-Ya-y\.]+\s+\d+\s+/ )   { $index = $i-1; 
   last; } 
 } 
 
for ($j = 0; $j < $index-1; $j++) { shift(@strings); } 
 
$k = $#strings;  
 
if ($k < 5) {$num_row_sets = 1;} 
else {$num_row_sets = $k / 4;} 
 
shift(@strings); 
 
#for ($x = 1; $x <= $k; $x++)  {print "\$strings[$x] = $strings[$x]";} 
#print "\n\n\n"; 
 
if ($num_row_sets == 1) { for ($n=1; $n<=3; $n++) {$prot[$n] = $strings[$n];} } 
 
else  
   {  
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     for ($n = 1; $n <= 3; $n++)  
        {  
          $prot[$n] = $strings[$n]; 
 
          if ($n == 2) 
               { 
                 for ($q = 1; $q < $num_row_sets; $q++) 
                    { $z = $n + (4 * $q); substr($strings[$z], 0, 9) = ""; 
chop($prot[2]); 
                      $prot[2] = $prot[2] . $strings[$z]; }  
               } 
 
          else {    for ($q = 1; $q < $num_row_sets; $q++)            
                    { $z = $n + (4 * $q);  
                      $prot[$n] = $prot[$n] . $strings[$z]; } 
               }      
       } 
   }  
 
for ($y=1; $y<=3; $y++)    { $prot[$y] =~ s/(\n|\r)//g; chomp($prot[$y]); } 
 
$prot[1] =~ s/ \d+\s+\d+ //g;  
$prot[3] =~ s/ \d+\s+\d+ //g;  
 
if ($top_or_bot eq "b") {$homo_prot = $prot[3]; $your_prot = $prot[1]; } 
else {$homo_prot = $prot[1]; $your_prot = $prot[3]; } 
$alignment = $prot[2]; 
 
# extract beginning and ending residue numbers for new MR search model PDB file: 
 
if ($homo_prot =~ /\s+(\d+)\s+.* (\d+)\s*/) { $res_begin = $1; $res_end = $2; } 
 
else {die "\nSomething is really wrong-- there are no residue numbers in homo_prot\n\n";}  
 
# print out current status:  
 
$homo_prot =~ s/\d/ /g; 
$your_prot =~ s/\d/ /g; 
 
substr($homo_prot, 0, 9) = ""; 
substr($your_prot, 0, 9) = ""; 
substr($alignment, 0, 9) = ""; 
 
# Turn the following lines on to print out the input, re-formatted for the next step:  
#print "your_prot =$your_prot\n"; 
#print "alignment =$alignment\n"; 
#print "homo_prot =$homo_prot\n"; 
#print "\n\nBegin residue = $res_begin\n"; 
#print "\nEnd residue = $res_end\n\n"; 
 
@your_prot = split(//, $your_prot); 
@alignment = split(//, $alignment); 
@homo_prot = split(//, $homo_prot); 
 
# Now make the comparisons and write out the verdict array: 
 
for ($w = 0; $w <= $#homo_prot; $w++) 
{ 
 if ($homo_prot[$w] eq ".")   { $verdict[$w] = "correct_the_index"; next;} 
 
 if (($homo_prot[$w] ne ".") & ($your_prot[$w] eq ".")) {$verdict[$w] = "delete";next;} 
   
 if (($alignment[$w] eq ":") | ($alignment[$w] eq "|")) {$verdict[$w] = "conserve";next;} 
   
 if (($homo_prot[$w] =~ /g/i) | ($homo_prot[$w] =~ /a/i)) {$verdict[$w]="conserve";next;} 
 
  $verdict[$w] = "truncate"; 
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} 
 
 
for ($j=0; $j <= $#homo_prot; $j++) { if ($homo_prot[$j] =~ /[a-yA-Y\.]/) { $index_end = 
$j; }  } 
 
#for ($t=0; $t<=$#homo_prot; $t++) 
#{print"\$homo_prot[$t]=$homo_prot[$t] \t $verdict[$t] \n";} 
#print"\nEnd value = $index_end\n\n"; 
 
# this next section corrects the index values so that the final_homo and final_verdict 
array indices  
# correspond to the actual homology model protein residue numbers, starting from 1 at the 
N' 
 
for ($i = 0; $i <= $index_end; $i++) 
{ 
 if ($verdict[$i] eq "correct_the_index") {$index_corrector++; next;}  
  
 $correct_index = $i + $res_begin - $index_corrector; 
 
 $final_homo_prot[$correct_index] = $homo_prot[$i]; 
 $final_verdict[$correct_index] = $verdict[$i];  
} 
 
# turn the next section on to print out the verdict array, i.e. a list of the verdicts 
# (delete, truncate, or conserve) for each homology model protein residue 
 
#for ($t=0; $t<=$#final_homo_prot; $t++) 
#{print"\$final_homo_prot[$t]=$final_homo_prot[$t] \t $final_verdict[$t] \n";} 
 
# process the PDB file: 
 
open (PDB_INFILE, $pdb_input) || die "Can't open PDB file \"$pdb_input\"\n\n"; 
open (PDB_OUTFILE, ">$pdb_output") || die "Can't open PDB file \"$pdb_output\" for 
writing\n\n"; 
 
print "\n\nOutput file \"$pdb_output\" contains the homology model coordinates.\n\n"; 
 
while (<PDB_INFILE>) 
{  
  if (!/^ATOM +\d+/) {print PDB_OUTFILE "$_"; } 
   
  else  
 
   { 
 
     $_ =~ /\s+(\d+)\s+.*\s+(\d+)\s+/ ; $res_num = $2;  
 
     if ($final_verdict[$res_num] eq "delete") {next;}                                 
#the delete verdict 
      
     if ($final_verdict[$res_num] eq "conserve") {print PDB_OUTFILE "$_"; next;}       
#the conserve verdict 
      
     if (  ($final_verdict[$res_num] eq "truncate") & ($_ =~ /^ATOM[ 0-9]{9}(N |CA|CB|C 
|O )/)    ) 
       {s/(VAL|LEU|ILE|MET|PRO|PHE|TRP|SER|THR|ASN|GLN|TYR|CYS|LYS|ARG|HIS|ASP|GLU)/ALA/; 
        print PDB_OUTFILE "$_"; next;}  
 
   } 
} 
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“/asimov2/users/cam/PAsurE_xtal/GLRF/scripted_glrf.sh” 
 
#!/bin/csh -f 
 
# a script to automatically perform several GLRF cross rotation function runs at several  
# values of 3 user-input parameters (integration radii, resolution windows, and models) 
# IMPORTANT: this works only in conjunction with the program GLRF and the perl script  
#            "alter.pl", and assumes you've already synthesized structure factors for the  
#       various models (e.g., with sfcal.com) in a file called "models.cal" 
#  
# command line syntax is:  
# " >scripted_glrf.sh model_file rad_low rad_high width_of_resol_win " 
# 
# The output is a file containing the top 5 peaks from each RF run... 
 
set rad_low rad_high resol_win models_file 
set curr_rad curr_res_low curr_res_high curr_model 
 
# set the command line-input variables 
 
set models_file = $argv[1] 
set rad_low = $argv[2] 
set rad_high = $argv[3] 
set resol_win = $argv[4] 
 
# regurgitate the user's command line input. don't worry about checking for  
# null inputs and setting default values. 
 
echo "" 
echo "VARIATION OF THE 1st PARAMETER (integration radius):" 
echo "*************************************************************" 
echo "GLRF will use a minimum radius of:" $rad_low 
echo "GLRF will use a maximum radius of:" $rad_high 
echo "GLRF will use these radii incremented by 1.0 Angstroms" 
echo "" 
echo "" 
echo "VARIATION OF THE 2nd PARAMETER (resolution):" 
echo "*************************************************************" 
echo "GLRF will calculate RFs over a sliding window of resolutions," 
echo "starting at a high resolution limit of 3.5 Anstroms, incrementing" 
echo "by 0.5 Angstroms, and with a fixed window width of:" $resol_win "Angstroms" 
echo "" 
echo "" 
echo "VARIATION OF THE 3rd PARAMETER (MR model):" 
echo "*************************************************************" 
echo "The filename containing the model names is:" $models_file 
echo "and the models specified in this file are:" 
echo "" 
cat $models_file 
echo "" 
echo "" 
 
# now the 3 nested loops that are the core of this script: 
 
set allmodels = `cat $models_file` 
 
bc << eof_bc > temp999 
`echo $resol_win` * 10 
quit 
eof_bc 
 
set resol_win = `awk '{print $1}' temp999 ` 
 
set absolut_hi_res = ` expr 35 + $resol_win ` 
 
foreach curr_model ( ${allmodels} ) 
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 set prefix = `(echo $curr_model | awk '{split($1,a,"."); print a[1]}')` 
     set curr_rad = $rad_low  
 
 while ($rad_low <= $curr_rad && $curr_rad <= $rad_high) 
 
    set curr_res_low = 35; set curr_res_high = `expr $curr_res_low + $resol_win` 
 
       while (35 <= $curr_res_low && $curr_res_low <= $curr_res_high)   
 
          echo "running alter.pl ${curr_model} radius=${curr_rad} 
res.range=${curr_res_low}-${curr_res_high} ..." >> big_run.log 
     rm scripted_cross_rf.prt 
     rm cross_rf_temp.com 
     alter.pl ${curr_model} radius=${curr_rad} res.range=${curr_res_low}-
${curr_res_high} 
     chmod 755 cross_rf_temp.com 
     cross_rf_temp.com 
     egrep "^           +[0-9]+ +[0-9]+ +[0-9]+ +[0-9]+ +[0-9]+\." 
scripted_cross_rf.prt | awk '{print $12}' | head -5 >> big_run.log 
     set curr_res_low = `expr $curr_res_low + 5`  
     set curr_res_high = `expr $curr_res_high + 5` 
        if ($curr_res_low >= $absolut_hi_res) break  
 
    end 
 
    set curr_rad = `expr $curr_rad + 1` 
    echo "" 
 
 end 
 
 echo "" ; echo "******************************" ; echo "" 
end 
 
rm temp999 
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“/asimov2/users/cam/PAsurE_xtal/GLRF/alter.pl” 
 
#!/joule2/programs/bin/perl 
 
open (IN, "scripted_cross_rf.com") || die "Cannot open file \"scripted_cross_rf.com\"\n"; 
open (OUT, ">>cross_rf_temp.com"); 
 
$model = "$ARGV[0]";  
$radius = "$ARGV[1]"; $radius =~ /(\d+)/; $radius = $1; 
$res_range = "$ARGV[2]"; $res_range =~ /(\d+)-(\d+)/; $res_hi = $1/10; $res_low = $2/10; 
 
print "$model\n$radius\n$res_hi\n$res_low\n" ; 
 
while (<IN>) 
 {  
 chomp ($_); 
 if ($_ =~ /aobsfile/)  
  { 
   $new = "aobsfile MODELS\/$model"; 
   print OUT "$new\n"; 
   next; 
  }  
 
 if ($_ =~ /resolution/) 
  { 
   $new = "resolution $res_low $res_hi"; 
   print OUT "$new\n"; 
          next; 
  } 
 
 if ($_ =~ /radius/) 
  { 
   $new = "radius $radius"; 
   print OUT "$new\n"; 
          next; 
  } 
 
 print OUT "$_\n"; 
 next;  
  
 } 
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“/asimov2/users/cam/PAsurE_xtal/GLRF/process_bigrun.pl” 
 
#!/joule2/programs/bin/perl 
 
# this script processes the output from scripted_glrf.sh into a format good for excel or 
some 
# other spreadsheet. 
 
$infile = $ARGV[0]; 
 
open (IN, $infile) || die "Cannot open file \"$infile\"\n"; 
 
print "MODEL\t\tInteg_radius\tHI RESOL LIM\tTOP 5 PEAKS in order\tLARGEST diff\n" ; 
print "******************************************************************************\n"; 
 
while (<IN>) 
 {  
 chomp ($_); 
 if ( $_ =~ /running alter\.pl (\w+\.cal) radius=(\d+) res\.range=(\d+)-\d+/ )  
  { 
   $model = $1; $radius = $2; $res_high_lim = $3/10; 
   $verdict = 1; $peaks = ""; next ; 
  } 
 
     else {        
          $peaks = $peaks ."\t". $_ ; $verdict++; 
   if ($verdict == 6)  
   { @top5 = split(/\s+/, $peaks); 
# Now calculate the diff btwn peak 1 & peak 2, 
# since this is what's really interesting for RF 
     $diff = $top5[1] - $top5[2];           
     print "$model\t$radius\t\t$res_high_lim\t$peaks\t$diff\n"; next ;  
          }  
        }  
     
   next ;   
  
 } 
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“~cam/PAsurE_xtal/MAD_Jan2002/STRUC_ANAL/map_conservation_to_B.pl” 
 
#!/joule2/programs/bin/perl 
# 
# This is a script that reads in 2 input files: argv[0] is the PDB file  
# and argv[1] is the file tabulating conserved residues in the format: 
# 
# "res#,ss(super strong)|s(trong)|m(edium)|w(eak)" ... 
# 
# where "res#" is the residue # and "superstrong", "strong", "medium",  
# or "weak" specify how strongly that site is conserved. 
# The output is a PDB file with all of the B-factors flattened to 20.00, 
# except for the "superstrong", "strong", "medium", or "weak" sites, which 
# are assigned B-values of 90.00, 70.00, 40.00, or 33.00, respectively. 
# 
# This is useful for programs like GRASP, which can color a surface by the 
# "B-factor" field of the PDB file. 
# 
# Cameron Mura (July 2001) 
# NOTE: make sure occupancies are 1.00 for any atoms with B-factors you want changed 
 
$pdb_in = $ARGV[0]; 
$site_file = $ARGV[1]; 
$bfac = ""; 
@cons = ""; 
$site_line = ""; 
  
open (PDB, $pdb_in) || die "Cannot open file \"$pdb_in\"\n"; 
 
while (<PDB>) 
 { 
   $line = $_;  
  chomp ($line);  
  $resnum = ""; $bfac = ""; 
   if ($line =~ /(^(ATOM|HET)\s+\d+\s+[\w\*]+\s+\w\w\w [A-
Z]\s+)(\d+)(.+)(1\.00\s+)(\d+\.\d+)(.*)/)  
    { 
     $resnum = $3; $bfac = "20.00"; 
    $counter = 0; 
    open (SITES, $site_file) || die "Cannot open file \"$site_file\"\n"; 
    while (<SITES>) 
    {if ($counter == 0)  
       { 
        $site_line = $_; chomp ($site_line); @cons = ""; 
          @cons = split(/,/, $site_line); 
          if ($cons[0] == $resnum and $cons[1] eq "ss" )     
 {$bfac = "95.00"; $resnum++; last;} 
        if ($cons[0] == $resnum and $cons[1] eq "s" )   
 {$bfac = "65.00"; $resnum++; last;}  
          if ($cons[0] == $resnum and $cons[1] eq "m" )   
 {$bfac = "45.00"; $resnum++; last;} 
                     if ($cons[0] == $resnum and $cons[1] eq "w" )     
 {$bfac = "30.00"; $resnum++; last;}  
  
        next;   
       } 
           } 
  close (SITES); 
 
     if ($bfac eq "") { $bfac = "20.00";} 
     $crap = $5 . $bfac; 
        print "$1$3$4$crap$7\n"; 
    } 
 } 
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“~cam/SMAP3/DATA/MAKE_28mer/symm.csh” 
 
#!/bin/tcsh -f 
# A script to calculate and expand NCS for any type of multimer ... 
# 
# For example, for the SmAP3 28-mer, subunit B was built most extensively. Now, one can 
# use this script to create a 28-mer with each subunit being a copy of ‘B’. The script 
# figures out the NCS operators and applies them (via “align_v2” and CCP4 “pdbset” 
# programs) to get several transformed PDB files ...  
# 
# command line syntax: >symm.csh inputPDBfile probechain 
# 
# where "inputPDBfile" is the COMPLETE multimer (e.g. SmAP3 28-mer), and 
#       "probechain" is the CHAINID for the monomeric subunit you want to 
#                    have copied 28-times over... 
# Cameron Mura, May 2002 
 
 
# get input ready 
# 
echo ""; 
set infile = $argv[1] 
set probechain = $argv[2] 
set prefix = `(echo $infile | awk '{split($1,a,"."); print a[1]}')` 
set align_out = $prefix.align.out 
echo "INPUT FILE IS: "$infile; echo "" 
echo "CHAINid USED TO EXPAND 28-mer: "$probechain; echo "" 
echo "PREFIX FOR SPLIT FILES WILL BE: "$prefix ; echo "" 
echo "PAIRWISE ALIGNMENTS WILL BE STORED IN: "$align_out ; echo "" 
 
# split input file into several files separated by chainID 
# 
al_moleman << EOF_moleman > moleman.log.temp 
 
${infile} 
split 
${prefix}_ 
quit 
EOF_moleman 
 
# re-name files so chainIDs get renumbered to ASCII equivalents 
# 
set num_files_deci = `ls ${prefix}_[0-9].pdb | wc -l` 
set num_files_char = `ls ${prefix}_[a-z].pdb | wc -l` 
set num_files_total = `expr $num_files_deci + $num_files_char` 
echo "Number of files_decimal: "$num_files_deci; echo "" 
echo "Number of files_character:  "$num_files_char; echo "" 
echo "Number of files_total:  "$num_files_total; echo "" 
 
# must rename the decimal ones before the character ones, otherwise they'll  
# definitely get overwritten by the a, b, c, etc... 
 
set x = 1 
while ($x <= $num_files_deci) 
set rename_value = `expr $x + $num_files_char` 
mv ${prefix}_${x}.pdb ${prefix}_${rename_value}.pdb 
set x = `expr $x + 1` 
end 
 
set index1 = 1 
while ($index1 <= $num_files_char) 
set temp_ind = `expr $index1 + 96` 
set to_rename2 = `perl -e 'print(chr($ARGV[0]),"\n")' $temp_ind ` 
mv ${prefix}_${to_rename2}.pdb ${prefix}_${index1}.pdb 
set index1 = `expr $index1 + 1` 
end 
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### HERE IS THE ALIGNMENT PART: ########### 
### 
### include the following line to do both all_atom- and main_chain-mode alignments: 
#foreach mode (all_atom main_chain) 
foreach mode (main_chain) 
 
if ($mode == "all_atom") set option = 1 
if ($mode == "main_chain") set option = 2  
 
echo "============================================================="; echo;  
echo "ALIGNMENT MODE is:" \"$mode\" \(align_v2 option $option\) ; echo; 
echo "============================================================="; echo; 
 
set i1 = 1 
 
while ($i1 <= $num_files_total) 
 
## comment-in the next line to do just an (upper) diagonal matrix of pairs: 
#set i2 = $i1  
# leave in THIS NEXT LINE to do full symmetric matrix worth of entries: 
set i2 = 1 
 
while ($i2 <= $num_files_total) 
 
echo "for aligning" $i2 "to" $i1 "the rmsd is:" 
 
### here's the "align_v2" part, don't mess with it: 
 
align_v2 << eof > temp_${i1}_to_${i2}.log 
 
${option} 
 
 
${prefix}_${i1}.pdb 
 
PDB 
${prefix}_${i2}.pdb 
 
PDB 
AUTO 
${prefix}_${i2}_to_${i1}.rot.temp 
${prefix}_${i2}_to_${i1}.show.temp 
stop 
eof 
 
cat ${prefix}_${i2}_to_${i1}.show.temp | grep 'rms deviation' 
cat ${prefix}_${i2}_to_${i1}.show.temp | grep 'corresponds to a' 
echo "-----------------------------------------------------------------------"; echo; 
 
####### apply the transformation matrix from CCP4: 
 
write_pdbset.pl ${prefix}_${i2}_to_${i1}.show.temp ${prefix}_${i2}.pdb 
${prefix}_${i2}_on_${i1}.new.pdb > pdbset_${i2}_to_${i1}.com 
chmod 755 pdbset_${i2}_to_${i1}.com 
pdbset_${i2}_to_${i1}.com > pdbset_${i2}_to_${i1}.log 
 
echo "-----------------------------------------------------------------------"; echo; 
echo "Transforming subunit ${i2} into position of ${i1} (via PDBSET) ..."; echo;  
echo "-----------------------------------------------------------------------"; echo; 
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########### clean-up stuff ########### 
rm temp_${i1}_to_${i2}.log 
rm pdbset_${i2}_to_${i1}.log 
rm ${prefix}_${i2}_to_${i1}.show.temp 
rm ${prefix}_${i2}_to_${i1}.rot.temp 
rm pdbset_${i2}_to_${i1}.com 
###################################### 
 
set i2 = `expr $i2 + 1` 
 
end 
 
############## 
# include following section to cat together the rotated files and originals into one  
# final file: 
#cat *to_`echo $i1`_fr.rot gpa_mono_`echo $i1`_fr.pdb > all_7rot_to_`echo $i1`.pdb 
#echo "**************************************************************************";echo; 
#echo Writing out PDB file of superimposed structures: \"all_7rot_to_`echo $i1`.pdb\"; 
echo 
#echo "**************************************************************************";echo; 
############## 
 
set i1 = `expr $i1 + 1` 
 
end 
 
#end 
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“~cam/SMAP3/DATA/MAKE_28mer/write_pdbset.pl” 
 
#!/joule2/programs/bin/perl 
 
# A Perl script to convert align_v2-formatted .show file to pdbset.com file 
# (just change CELL and SPACEGROUP cards below to generalize this) ... 
# Is meant to work in conjunction with "symm.csh" script to expand one subunit 
# of the SmAP3 28-mer into 28 copies...was written in generalizable format. 
# 
# Cameron Mura (May 2002) 
 
$show_in = $ARGV[0]; 
$pdbin = $ARGV[1]; 
$pdbout = $ARGV[2]; 
$on = 0; 
  
open (IN, $show_in) || die "Cannot open file \"$show_in\"\n"; 
#open (OUT, ">temp_pdbset.com") || die "Cannot open file \"temp_pdbset.com\"\n"; 
 
while (<IN>) 
 { 
   $line = $_;  
  chomp ($line);  
  if ($line =~ /Rotation matrix applied to latest set\: +([0-9\.\-]+ +[0-9\.\-]+ 
+[0-9\.\-]+\s*)/) 
    {$mat123 = $1; $on++; next;} 
         if ($on == 1 & $line =~ / +([0-9\.\-]+ +[0-9\.\-]+ +[0-9\.\-]+\s*)/) 
           {$mat456 = $1; $on++; next; } 
  if ($on == 2 & $line =~ / +([0-9\.\-]+ +[0-9\.\-]+ +[0-9\.\-]+\s*)/) 
           {$mat789 = $1; $on++; next; } 
  if ($on == 3 & $line =~ / +([0-9\.\-]+ +[0-9\.\-]+ +[0-9\.\-]+\s*)/) 
    {$mat101112 = $1; $on++; next; } 
  if ($on >= 4) { last ; } 
 } 
 
# print out the PDBSET lines: 
# (note that in the symm.csh script this is re-directed to a PDBSET .com file, which  
#  could be done at this stage instead (i.e. in this perl script), if necessary...) 
 
print "#!\/bin\/csh -f\n"; 
print "pdbset xyzin $pdbin xyzout $pdbout <<eof-1\n"; 
print "transform\t$mat123 -\n"; 
print "\t\t$mat456 -\n"; 
print "\t\t$mat789 -\n"; 
print "\t\t$mat101112 \n\n";  
print "CELL 83.322   172.428   148.108    90.000    89.986    90.000\n"; 
print "SPACEGROUP P21\n"; 
print "eof-1\n"; 
 
# THE END! 
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